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ABSTRACT  
The transfer of farming practices from low intensity farming systems for livestock 
production to commercial enterprises which employ intensive practices has resulted 
in the use of veterinary drugs becoming a critical component of food production. 
Resulting residues of veterinary drugs occurring in food of animal origin may give 
rise to potential health risks to consumers. The aim of this research is the 
development of analytical methods capable of screening and confirming increased 
number of these residues in more target matrices by Liquid Chromatography Tandem 
Mass Spectrometry (LC-MS/MS). Its focus is the analysis of nitroimidazole residues 
in food of animal origin and authorised and prohibited medicinal additives in animal 
feed.  
This research resulted in the development and validation of methods for analysis of 
nitroimidazoles (NMZs) in plasma, eggs, milk and honey and prohibited and 
authorised medicinal additives in animal feed. The analytical technique used in all 
methods was the highly selective and sensitive LC-MS/MS. This technique allowed 
for multi-analyte methods to be developed for different matrices. NMZ residues 
examined were metronidazole, dimetridazole, ronidazole, ipronidazole, ternidazole, 
ornidazole, carnidazole and tinidazole along with three metabolite, hydroxy-
metronidazole, 2-Hydroxymethyl-1-methyl-5-nitroimidazole (HMMNI) and 
hydroxy-ipronidazole. Chloramphenicol was included with the analysis of NMZs in 
the matrices of milk and honey. Fourteen medicinal additives; metronidazole, 
dimetridazole, ronidazole, ipronidazole, clopidol, carbadox, sulfadiazine, 
sulfamethazine, dinitolimide, chloramphenicol, ethopabate, avilamycin, tylosin and 
virginiamycin were analysed for in animal feed. The final method developed allowed 
for coccidiostats; halofuginone, robenidine, nicarbazin, diclazuril, decoquinate, 
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semduramicin, lasalocid, salinomycin, monensin, narasin and maduramicin to be 
analysed for at levels related to unavoidable carryover in feed.  
All veterinary residue methods used were validated in accordance with EU 
legislation; Commission Decision 2002/657/EC. This legislation is concerned with 
the performance of analytical methods and the interpretation of results. Validation 
criteria were examined using protocols set out in this legislation and these included 
specificity, accuracy, precision, repeatability, reproducibility, decision limits (CCα), 
detection capabilities (CCβ) along with measurement uncertainty (MU). In the four 
methods developed for the analysis of NMZ residues in plasma, egg, milk and honey 
the accuracy and precision for all analytes ranged from 87.2% to 108.9% and 3.7% 
to 11.3% respectively in all matrices. CCα and CCβ for all nitroimidazole residues 
ranged from 0.33 to 1.60 g L-1 / g kg-1 and 0.56 to 2.64 g L-1 / g kg-1 
respectively with MUs ranging from 18 to 90% for all compounds in the various 
matrices. Chloramphenicol CCα and CCβ values were below its minimum required 
performance level (MRPL) of 0.3 g L-1 / g kg-1. 
At present there is no legislation in place describing validation approaches for 
methods used for the analysis of medicinal additives in animal feed. Therefore for 
the validation of the two feed methods developed as part of this research the 
veterinary residue legislation was used as a basis. In the case of the analysis of 
coccidiostats at unavoidable carry over levels; the method was validated entirely in 
accordance with veterinary residue legislation, Commission Decision 2002/657/EC. 
However the method for the analysis of 14 prohibited medicinal additives in feed 
was validated with some adaptations to this legislation. To ensure that the method 
was fit for purpose a wide variety of feed was used in validation and a wider 
concentration range was examined. Parameters of specificity, accuracy, precision, 
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repeatability, reproducibility were all examined and deemed to be acceptable along 
with measurement uncertainty. 
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1.1 Introduction 
The production of food from animal origin in the form of meat, milk, eggs and honey 
is necessary in maintaining a sustainable food supply. Due to an increasing 
worldwide population there is a greater demand on food production but there is less 
space available to allow for it. In order to facilitate increased production, intensive 
farming practices have been implemented into the production of food from animal 
origins. To help aid these practices both authorised and prohibited veterinary drugs 
are either administered routinely as part of the feeding process or non-routinely in the 
form of injections, pour-ons or implants. This process of animal medication has 
become an integral part of animal husbandry. While this process leads to increased 
food production and less stock loss due to disease; it can result in the occurrence of 
veterinary residues in the food we eat. As a result of health risks, the issue of 
veterinary drug residues in foods of animal origin has become increasingly important 
throughout the European Union. 
The main human health risks associated with the occurrence of veterinary residues in 
food are related firstly to the safety of food and secondly to the production of 
pathogens in humans with antibiotic immunity due to the continuous intake of 
residues from food. Therefore the European Union has acted in order to reduce the 
occurrence of residues in food by bringing into force a number of pieces of 
legislation such as Council Directives 96/22/EC, 96/23/EC and Commission 
Recommendation 2005/925/EC to set limits for and in some cases prohibit the use of 
veterinary drugs in food producing animals. These legislative acts have resulted in 
the need for countries to improve their farming practices by meeting set limits for 
veterinary residues by following withdrawal times and recommendations for 
veterinary products. Failure to meet requirements in relation to levels of residues in 
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food can have serious economic consequences for the country involved as heavy 
fines and exclusion from trading are associated with breaches. Despite this increase 
in legislation there is still growing public concern over drug residues in food due to 
the improper use of veterinary drugs in intense farming practices. 
Due to an increasing population and a changing diet there has been an increase in the 
consumption of meat and dairy products, in particular poultry products [Abele et al., 
2004]. As a result, more intensive farming methods have evolved in order to meet 
this demand. Instead of mixed agricultural systems focusing on a number of areas on 
a small scale, current food production practices are commonly focused of one area of 
agriculture in the form of large commercial businesses with intensive farming 
systems in place for continuous production. This has resulted in a significant increase 
in the use of veterinary products such as coccidiostats and antibiotics to ensure stock 
is not lost to disease and growth promoting agents to ensure the largest profit can be 
made from the stock [Chevance et al., 2009; Raloff, 2002; VMD, 2008]. Also in 
addition to this there is an increased percentage of food imported into Europe from 
third countries. Legislation in place in these countries may not be in line with 
European requirements which may result in the occurrence of residues in our food at 
possibly harmful levels.  
Veterinary medicinal products used in animal production can be divided into a two 
main groups as set out in Council Directive 96/23/EC. These are Group A 
compounds which are unauthorized for use in food producing animals and Group B 
compounds which are authorized for use. Each group in divided into a number of 
classes of compounds and these classifications are seen in Table 1-1.  
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Table 1-1. Two Main Groups of Veterinary Medicinal Product  
 
Group A 
Prohibited Substances 
Group B 
Veterinary drugs and contaminants 
A1 
STILBENES 
B1 
ANTIMICROBRIALS 
B2a 
ANTHELMINTICS 
B3a 
ORGANOCHLORINES 
including PCBs,  
A2  
THYROSTATS  
B2b 
COCCIDIOSTATS 
B3b  
ORGANOPHOSPHATES
A3 
STEROIDS  
B2c  
CARBAMATES/ 
PYRETHROIDS 
B3c 
HEAVY METALS 
A4 
ZERANOL  
B2d 
SEDATIVES 
B3d 
MYCOTOXINS 
A5 
BETA-AGONIST  
B2e 
Non Steroidal Anti- 
Inflammatory Drugs 
B3e 
DYES 
A6 (Nitroimidazoles, 
Chloramphenicol) 
Prohibited compounds 
listed in Table 2 of  
Regulation 37/2010/EC 
 
B2f 
OTHERS e.g. 
corticoids 
 
The occurrences of residues in food that are in breach of levels stated in legislation 
can arise in a variety of different ways. These include either the improper use of 
licensed products or the illegal use of unlicensed and prohibited substances [Kennedy 
et al., 2000]. In relation to licensed products, there are numerous factors that can 
result in residues being present in food above authorised levels; some of these are 
listed in Table 1-2. If the user of the authorized substance (Group B) adheres to the 
product license and provided that the drug withdrawal periods are respected, drug 
residues should not occur in food at concentrations greater than the maximum 
residue limits (MRLs). Prohibited veterinary products (Group A) are ones that are 
not permitted for use in the production of food from animal origin. Some of the main 
reasons for the occurrence of prohibited veterinary drug residues in the human food 
chain can be seen in Table 1-2. 
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Table 1-2. Reasons for drug residues from authorized and prohibited substances.  
 Authorized Substances  Prohibited Substances 
1. Extended usage or excessive dosage of 
approved drugs 
1. The use of growth promoting 
hormones in order to increase the 
weight of animals and reduce amount 
of feed needed by animals to gain 
weight [Debackere et al., 1989] 
2. Poor records of treatment leading to 
problems identifying in Treated-animal 
resulting in overdosing 
2. The use of certain banned 
compounds that can be very effective at 
controlling particular infections e.g. 
nitrofurans [O’Keeffe et al., 2004] 
3. Use of incorrect veterinary drug for 
particular species. 
 
4. Contaminated feed being used as 
withdrawal feed for target animals as a result 
of carry over issues in feed mills. 
[Commission Directive 2009/8/EC]. 
3. The use of prohibited compounds 
that are very cheap and readily 
available. 
 
Studies carried out on residues and metabolites of prohibited veterinary drugs (Group 
A) have highlighted the possibility of their harmful health effects. Reports published 
by both The European Agency for the Evaluation of Medicinal Products (EMEA) 
and The International Agency for Research on Cancer (IARC) have both suggested 
that nitroimidazoles and chloramphenicol are possible carcinogens and are therefore 
are classed as A6 compounds and are prohibited for use in food producing animals. 
5 
Although Group A substances are considered more of a human health risk than 
Group B substances; their use is not without there consequences. Apart from allergic 
reaction one of the main reasons for the control of some group B substance is the 
similarity between animal antibiotics and there human counterparts. It is feared that 
the continuous use of these compounds in animals may result in the increase of 
antibiotic immune bacteria that could transferred to humans. Immunity such as this 
has been seen for tetracycline [Smith et al., 1957] and vancomycin in the late 1980s 
[Bates et al., 1993]. 
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With this ever increasing list of risks to human health, the European Commission has 
focused its attentions on consumer protection in relation to the use of veterinary 
drugs in animal husbandry. Legislation is continuously being updated and amended 
to assist with this. In order for each member state’s regulatory authority to enforce 
this legislation and ensure ongoing consumer protection throughout Europe there is a 
need for robust and sensitive analytical methods for the detection of these residues to 
be developed.  
 
1.2 Aims of the Study 
The main aim of this research was to develop and validate reliable, robust and 
suitably sensitive analytical methods for the analysis of veterinary drugs and their 
residues in various biological and feed matrices. These methods were validated 
taking into consideration all relevant European legislation, ensuring that all criteria 
with regards to analytical methods, target analytes and suitable matrices were 
satisfied. 
The initial part of the research dealt specifically with the analysis of 5-
nitroimidazoles in biological matrices of food producing animals. Analysis of the 
suspected carcinogenic 5-nitroimidazole compounds is limited and this was the case 
in Ireland prior to this research as the analysis of these compounds was limited to 
two hydroxy-metabolites in a single matrix. In addition studies have shown that 
matrices such as muscle and liver don’t allow for the best possible identification of 
abuse of these compounds. Prior to this research the analysis of these compounds 
often involved the examination of these unsuitable matrices. 
The focus of the research then moved to the analysis of animal feed for the presence 
of medicinal feed additives. High levels of veterinary drug residues in food that can 
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pose a risk to human health may be the result of animals being fed contaminated 
feed. Therefore the development of analytical methods for the analysis of a wide 
variety of these additives in animal feeds is an important part of the research.  
There were a number of specific aims within the research as a whole and these 
included: 
I. To help improve the surveillance capabilities of The State Laboratory with regards 
to the analysis of nitroimidazoles by the development of a number of novel, rapid, 
confirmatory, multi residue methods using liquid chromatography tandem mass 
spectrometry in a variety of biological matrices. 
a) Nitroimidazoles in Plasma. 
b) Nitroimidazoles in Eggs. 
c) Nitroimidazoles and Chloramphenicol in Milk and Honey 
II. In order to meet the requirements of EU legislation with regard to medicinal feed 
additives new liquid chromatography tandem mass spectrometry methods were 
developed. These included the analysis of: 
a) Prohibited Medicinal feed additives in pig and poultry feed 
b) Eleven Coccidiostats in animal feed at levels relating to unavoidable 
carry over from feed mills. 
III. To determine the potential misuse of nitroimidazole compounds in the Irish Egg 
Industry by the analysis retail survey egg samples.  
IV. Implementation of these methods into the National Reference Laboratory in Ireland 
designated for the control of the particular substance groups in question. 
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2.1. Introduction 
This chapter will give an overview of the main issues regarding veterinary drug 
analysis and the areas that should be taken into consideration when developing an 
analytical method. These issues include; 
 Background information on nitroimidazoles, their metabolism, their stability 
and their carcinogenicity.  
 Background information on chloramphenicol. 
 Background information on medicinal feed additives and their use in feed. 
 Review of the current legislation pertaining to veterinary drugs within the EU 
 Review of the current legislation pertaining to medicinal feed additives and 
cross contamination issues. 
 Review of validation protocols within the EU 
 Review of extraction and purification procedures used in residue analysis for 
the compounds of interest, highlighting the relevant matrices. 
 Review of LC-MS/MS and its uses in the field of veterinary residue analysis. 
 
2.2 Overview of Veterinary Drugs Investigated 
1.2.1. Nitroimidazoles 
In the initial part of this research; the class of veterinary drugs of most interest was 
nitroimidazoles. This was due to the fact that although they are prohibited for the use 
in food producing animals, there remained a shortage of methods that could analyse 
for these carcinogenic compounds in a wide variety of matrices to ensure that a 
potential risk to human health was identified. 
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Nitroimidazoles are imidazole heterocycles with nitrogen groups incorporated in the 
structure. Examples of these compounds are metronidazole [1-(2-hydroxyethyl)-2-
methyl-5-nitroimidazole (MNZ)], dimetridazole [1,2-dimethyl-5-nitroimidazole 
(DMZ)], ronidazole [1-methyl-2-[(carbamoyloxy)-methyl]-5-nitroimidazole (RNZ)], 
ipronidazole [2-isopropyl-1-methyl-5-nitroimidazole (IPZ)], carnidazole [1-(2-
ethylcarbamothioic acid O-methyl ester)-2-methyl-5-nitroimidazole (CNZ)], 
ornidazole [1-(3-chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole (ONZ)], 
ternidazole [1-propanol-2-Methyl-5-nitroimidazole (TRZ)] and tinidazole [1-(2-
ethylsulfonylethyl)-2-methyl-5-nitroimidazole (TNZ)]. These examples are known as 
5-nitroimidazoles as they contain a NO2 group on the 5 ring position. This base 
structure is seen in Figure 2-1 along with the different compounds investigated as 
part of this research. 
5-Nitroimidazoles are active against most obligate anaerobic bacteria and variety of 
protozoa where organism resistance is rare but have limited activity against aerobic 
bacteria [Bishop, 2005]. Nitroimidazole compounds that were licensed as veterinary 
medicines include metronidazole, dimetridazole and ronidazole. Metronidazole was 
the most commonly used 5-Nitroimidazole and can be used to treat a wide variety of 
infection in animals.  It is used in the treatment of humans and animals for infections 
caused by Trichomonas, Histomonas and Clostridium. It can be used for treatment of 
dysentery in pigs and in combination with neomycin can treat retentio secundinarum 
in cows [EMEA Report, Metronidazole].  
Dimetridazole is used mainly in the poultry industry in particular for the treatment of 
histomoniasis in turkeys and trichomoniasis in pigeons. It has also been used in the 
treatment of cattle for genital trichoniasis and pigs for haemorrhagic enteritis. 
[EMEA Report, Dimetridazole]. The final nitroimidazole that was licensed for use in 
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animal husbandry was ronidazole. This was used for the treatment of similar diseases 
such as histomoniasis in turkeys, genital trichoniasis in cows and haemorrhagic 
enteritis in pigs [EMEA Report, Ronidazole].  Articles published on nitroimidazoles 
have also shown that dimetridazole [Griffin, 1972] and ronidazole [Taylor, 1974] are 
effective in the treatment of swine dysentery. Another nitroimidazole, carnidazole, 
can also be used for the treatment and prophylaxis of trichomoniasis in pigeons 
[Bishop, 2005]. 
The antimicrobial effect of all 5-nitroimidazole derivatives is due to the same mode 
of action as each other i.e. the metabolic reduction of the nitro group by susceptible 
anaerobic microorganisms. The metabolic reduction of the nitro group is performed 
by microbial ‘nitroreductases’ [Voogd, 1981; Johnson, 1993]. This allows 
nitroimidazoles to be successful in the treatment of Trichomonas, Histomonas and 
Clostridium, as they interact with DNA destroying its ability to act as a template for 
DNA and RNA synthesis [Bishop, 2005]. 
Nitroimidazole compounds are believed to be carcinogenic and mutagenic to 
humans. The majority of studies have been carried out on metronidazole. The results 
of these studies show that it is believed to be a human carcinogen based on sufficient 
evidence of carcinogenicity in experimental animals [IARC 1977, 1982, 1987]. 
Animal studies have shown that mice treated with metronidazole have shown 
increased incidence of lung tumors for both sexes and lymphomas in female mice 
[Rustia et al., 1972]. Oral administration of the compound also caused mammary 
fibroadenomas and adenocarcinomas, and pituitary, testicular, and liver tumors in 
rats [IARC 1977, 1982, 1987]. There is however inadequate evidence for the 
carcinogenicity of metronidazole in humans [IARC 1982, 1987]. 
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Figure 2-1: Basic 5-Nitroimidazole Structure and various different compounds examined in this 
research 
 
The European Agency for the Evaluation of Veterinary Products (EMEA) has 
published summary reports on three nitroimidazole compounds; metronidazole 
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[EMEA Report, Metronidazole], dimetridazole [EMEA Report, Dimetridazole] and 
ronidazole [EMEA Report, Ronidazole]. While the reports suggest the studies carried 
out on humans are insufficient and inconclusive to prove or disprove carcinogenicity 
of these compounds, results in animal studies are conclusive [Rustia et al., 1972; 
IARC 1977, 1982, 1987]. This, in their opinion, is enough to consider these 
compounds as carcinogenic and in the interest of human health they are prohibited 
for use in food producing animals. The legislation covering this is discussed fully in 
section 2.3. 
A number of studies carried out on these compounds have shown that they are 
rapidly metabolised in bovine, porcine and avian species [MacDonald et al., 1971; 
Craine et al., 1974; Cala et al., 1976; Rosenblum et al., 1972]. The main metabolite 
of DMZ, IPZ and MNZ results from the oxidation of the side chain in the C-2 
position of the imidazole ring to form hydroxy metabolites [MacDonald et al., 1971; 
Craine et al., 1974]. RNZ has a different degradation pathway but results in an 
identical metabolite to that of DMZ [Cala et al., 1976; Rosenblum et al., 1972]. The 
metabolite of DMZ and RNZ is HMMNI (2-hydroxymethyl-1-methyl-5-
nitroimidazole), of MNZ is MNZ-OH (1-(2-hydroxyethyl)-2-hydroxymethyl-5-
nitroimidazole) and of IPZ is IPZ-OH (1-methyl-2-(2′-hydroxyisopropyl)-5-
nitroimidazole). There structures can be seen in figure 2-2. As these compounds still 
contain the imidazole ring their carcinogenicity cannot be overlooked [EMEA 
Report, Metronidazole]. Also these metabolites can be an indication of potential 
misuse of prohibited nitroimidazole compounds and therefore should also be 
analysed for.  
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Figure 2-2. Structure of the hydroxy-metabolites MNZ-OH, HMMNI and IPZ-OH  
 
The most recent study carried out on nitroimidazole metabolism by Polzer et al., 
2004 examined the amount of parent drug and the corresponding main hydroxy-
metabolite in various matrices taken from treated turkeys and as a result a number of 
conclusions were made. The study demonstrated that the metabolites of DMZ and 
IPZ, HMMNI and IPZ-OH, should be chosen as target analytes to prove illegal 
treatment whereas to check for a treatment with RNZ or MNZ, the measurement of 
the parent drug is to be preferred. This is due to the fact that these are the most 
abundant residues left after administering nitroimidazoles. However the study also 
goes on to state that the ratio of parent drug to metabolite in the case of dimetridazole 
was found to vary with the length of the withdrawal time. Therefore it might be 
prudent to look for both the metabolite and parent residue for dimetridazole to ensure 
non compliant samples are identified. In addition to this without respective data on 
the behaviour of the other nitroimidazoles, a recommendation was made to monitor 
both, the parent drug and the respective metabolite, whenever possible in order to 
identify any possible abuse of these compounds. [Polzer et al., 2004] 
Methods used to analyse nitroimidazoles in food producing animals will be discussed 
fully in section 2.4.2. However studies on the stability and homogeneity of 
nitroimidazoles have been carried out by the European Union Reference Laboratory 
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(EURL) for nitroimidazoles in Berlin to identify suitable matrices and marker 
analytes for their analysis [Polzer et al., 2004 and 2005]. These involved the analysis 
of turkeys administered nitroimidazoles in controlled experiments. In several animal 
studies turkeys were treated with different nitroimidazoles (DMZ, MNZ, RNZ, IPZ). 
Apart from the identification of target analytes as mentioned previously the main 
observations of their studies were; the repeatability of the analysis of muscle samples 
was unacceptable due to the inhomogeneity of the matrix and a rapid degradation of 
the analytes was observed during sampling and continues during storage in a non-
frozen state [Polzer et al., 2004 and 2005].   
They showed clearly that in the stability studies they carried out, nitroimidazoles are 
not stable in muscle and liver and suggested that care must be taken to ensure an 
immediate and efficient cooling directly after sampling. The also showed that 
inhomogeneity of the analytes in muscle and liver and recommended to thoroughly 
homogenise sufficient quantities of these matrices in order to obtain representative 
sample material, e.g. by lyophilisation [Polzer et al., 2004 and 2005]. 
Even with the implementation of these measures depletion studies of dimetridazole 
show there is a rapid disappearance of analyte in liver and muscle. In contrast they 
found that in plasma and eggs a longer detection period of the nitroimidazole 
residues is possible. They also found that these residues are more stable and there is 
no problem with inhomogeneity in the matrix of plasma and eggs. Furthermore, they 
feel that the matrix is readily available and is therefore very well suited for residue 
control purposes [Polzer et al., 2004 and 2005]. Finally, the study determined that the 
same is true for retina. It stated that the highest concentrations of nitroimidazoles 
were measured in this matrix.  
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As these studies are carried out in turkeys the results could differ from poultry to 
larger animals such as pigs. That said these studies have suggested that, in order to 
accurately ensure that the misuse of nitroimidazoles is not taking place sampling, 
matrix and marker analyte selection is crucial. Taking this into consideration 
matrices that should be used for the analyses of nitroimidazoles are plasma, retina 
and eggs and once sampled should be cooled immediately [Polzer et al., 2004 and 
2005].   
 
1.2.2. Chloramphenicol 
Chloramphenicol (CAP) is a broad spectrum bacteriostatic antibacterial [Bishop, 
2005] whose structure can be seen in figure 2-3. Like nitroimidazoles it is prohibited 
for the use in food producing animals. Much of the same European legislation 
governs both compounds. The analysis of CAP is often performed in single analyte 
methods (section 2.4.3) and it was felt that to combine these into one method would 
be beneficial.  
Chloramphenicol is active against a wide range of illnesses and infections including 
rickettsial and chlamydophilial infections, numerous obligate anaerobes, gram 
positive aerobes, and non-enteric aerobes such as Bordetella and Haemophilus 
[Burnham et al., 2000]. CAP is a simple lipid-soluble compound which readily 
crosses the cellular barrier. For this reason it is a very effective medicinal product as 
it diffuses throughout the body and reaches infection sites inaccessible to many other 
antibacterial drugs which include areas such as cerebrospinal fluid and the internal 
structures of the eye. The process by which CAP exerts its effect is by inhibiting 
bacterial protein synthesis. [Bishop, 2005].   
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Figure 2-3. Structure of Chloramphenicol 
 
Studies on the carcinogenicity of CAP in humans suggest that it is believed to be a 
human carcinogen. Case reports have shown leukemia to occur after medical 
treatment for chloramphenicol-induced aplastic anemia [IARC 1990]. Three case 
reports have also documented the occurrence of leukemia after chloramphenicol 
therapy in the absence of intervening aplastic anemia. In a case-control study in 
China, elevated risks of childhood leukemia were found, which increased 
significantly with the number of days chloramphenicol was taken [Shu et al. 1987, 
1988]. Two case-control studies [Issaragrisil et al. 1997; Laporte et al. 1998] found 
high, but nonsignificant, increases in the risk of aplastic anemia associated with the 
use of chloramphenicol in the six months before onset of aplastic anemia. However, 
two case-control studies [Zheng et al., 1993; Doody et al., 1996] found no 
association between the use of chloramphenicol and the risk of adult leukemia, 
suggesting that children may be a particularly susceptible subgroup. One report by 
Zahm et al., 1989 found an association between chloramphenicol use and increased 
risk of soft-tissue sarcoma. When considered together, the many case reports 
implicating chloramphenicol as a cause of aplastic anemia, the evidence of a link 
between aplastic anemia and leukemia, and the increased risk of leukemia found in 
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some case-control studies support the conclusion that chloramphenicol exposure is 
associated with an increased cancer risk in humans.  
Another issue with CAP is that it is metabolized more slowly in babies and infants 
than in adults, which can result in gray baby syndrome. This syndrome is 
characterized by cardiovascular collapse in infants, apparently caused by 
accumulation of active, unconjugated chloramphenicol in the serum, resulting from 
low inactivation through glucuronide conjugation in the liver [Burnham et al., 2000]. 
Taking this information into consideration, the European Union has prohibited the 
use of CAP in animals used in food production. The legislation governing this is 
discussed fully in section 2.3. 
 
1.2.3. Veterinary Medicinal Additives 
A major area of interest of this research was based on the development of methods 
for the analysis of medicinal additives in animal feed. New legislation governing the 
control of these additives is discussed in section 2.3.2. A wide range of compounds 
are detailed in this legislation which are either prohibited for use as a feed additive or 
are detailed specifically for certain species of animal. These medicinal additives 
include; compounds prohibited for use in food producing animals such as 
nitroimidazoles (section 2.2.1) and chloramphenicol (section 2.2.2); compounds 
specifically allowed only in medicated feed such as sulphonamides and compounds 
no longer allowed to be used as feed additives such as antibacterial growth promoters 
(AGPs) e.g. tylosin and virginiamycin. The other list of compounds that is governed 
by this new legislation are ionophore coccidiostats and histomonostats that are, as a 
result of this legislation, the only medicinal products that are allowed to be used as 
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feed additives but only for specific species. The two lists covered by the legislation 
can be seen in Table 2-3.  
Previously there were a wide variety of medicinal products that were added to feed to 
help improve the general health of the livestock while also aiding in growth 
promotion of the animals. The majority of these additives are now prohibited by the 
new legislation. The history behind particular compounds investigated in this 
research is as follows. Carbadox (CAR) and olaquindox (OLA) have been approved 
for use as feed additives for pigs since 1974 and 1976 respectively. CAR and OLA 
are antimicrobial growth promotants (AGPs) used mainly in swine feed for growth 
promotion, to improve feed efficiency, increase the rate of weight gain, control swine 
dysentery and bacterial enteritis in young swine [Boison et al., 2009]. These 
compounds have been expressly prohibited from inclusion in animal feedingstuffs in 
the EU since 1998 as they are believed to be carcinogenic and mutagenic [Regulation 
2788/98/EC]. Other AGPs were also prohibited for use as feed additives around this 
time. These included spiramycin, virginiamycin and tylosin phosphate which were 
used for growth promotion as well as disease treatment and prophylaxis [Situ et al., 
2005] but were prohibited as they were believed to contribute to bacterial resistance 
in humans. [Regulation 2821/98/EC]. 
The concerns over antibiotic immunity and bacterial resistance are the major driving 
force behind prohibiting medicinal feed additives. The use of antimicrobial feed 
additives can result in the development of antibiotic immunity which could be 
transferred to humans. The first evidence of this occurring with antibiotics was 
tetracycline [Smith et al., 1957] and later vancomycin in the late 1980s [Bates et al., 
1993] and most recently streptogramin resistances [Butaye et al., 2001]. This new 
legislation prohibits the use of any medicinal feed additives except for the use of 
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coccidiostats and histomonostats [Recommendation 2005/925/EC]. It is envisaged 
that these will also be prohibited as feed additives before 2013 [Regulation 
1831/2003/EC]. After this date, medical substances in animal feeds will be limited to 
therapeutic use by veterinary prescription [Castanon, 2007].  
Until then eleven coccidiostats including monensin, narasin and nicarbazin are the 
only compounds permitted for use as feed additives. These compounds are only 
licensed for use in particular animals and therefore they are only allowed for the use  
as feed additives in feed intended for that specific target species [Recommendation 
2005/925/EC]. Coccidiostats constitute the main choice to fight against coccidiosis. 
Coccidiosis is an infectious disease caused by several species of Eimeria and 
Isospora protozoa which results in significant loss of stock causing serious 
economical consequences in farming industry. In the European Union, coccidiostats 
are authorized mainly as feed additives, according to the Regulation 1831/2003/EC 
for the prevention and treatment of coccidiosis in rabbits and chickens. As a result of 
issues with carry over in feed mills the contamination of feed with coccidiostats 
needs to be monitored. Levels are set out in legislation for sensitive and less sensitive 
non-target animal species, withdrawal feed and non-target feed for ‘continuous food-
producing animals’, such as dairy cows or laying fowl [Regulation 2009/8/EC] in 
order ensure animal and human welfare. This legislation is discussed fully in section 
2.3.2. 
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2.3. Outline of European Legislation 
2.3.1. Legislation regarding Substances that are prohibited for the use in Food 
Producing Animals 
As a result of carcinogenic and other health risks some veterinary products 
previously used for treatment in animal husbandry, such as nitroimidazoles and 
chloramphenicol were prohibited firstly in Annex IV of Commission Regulation 
2377/90 but are now included in table 2 of Council Regulation 37/2010/EC. 
Regulation 2377/90 was one of the first substantial pieces of legislation published by 
the European commission which tried to encompass the large amount of veterinary 
drugs in use and as a result try to limit the residues resulting from them. This was 
done by introducing maximum residue limits (MRLs) and this regulation defined 
what MRLs are and described the procedure for the establishment of MRLs for 
veterinary medicinal products in foodstuffs of animal origin. A definition of MRL is 
the maximum concentration of residue resulting from the use of a veterinary 
medicinal product (expressed in mg/kg on a fresh weight basis) which may be 
accepted by the European Community to be legally permitted or recognized as 
acceptable in or on a food. It is based on the type and amount of residue considered 
to be without any toxicological hazard for human health as expressed by the 
acceptable daily intake (ADI), or on the basis of a temporary ADI that utilizes an 
additional safety factor. It also takes into account other relevant public health risks as 
well as food technology aspects. When establishing a MRL, consideration is also 
given to residues that occur in food of plant origin and/or come from the 
environment. Furthermore, the MRL may be reduced to be consistent with good 
practices in the use of veterinary drugs and to the extent that practical analytical 
methods are available. It also gave a definition of what constitutes residues of 
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veterinary medicinal products.  They are all pharmacologically active substances, 
whether active principles, excipients or degradation products and their metabolites 
which remain in foodstuffs obtained from animals to which the veterinary medicinal 
product in question has been administered. 
Also included in this legislation were five annexes that cover the range of veterinary 
products in use and the allowed or prohibited residues resulting from that use. These 
annexes taken from Regulation 2377/90 are listed below. 
Annex 1: List of pharmacologically active substances for which maximum residue 
levels have been fixed. 
Annex 2: List of substances not subject to maximum residue levels.  
Annex 3: List of pharmacologically active substances used in veterinary medicinal 
products for which maximum residue levels have provisionally been fixed. 
Annex 4: Lists of pharmacologically active substances for which no maximum levels 
can be fixed.  
Annex 5: Information and particulars to be included in an application for the 
establishment of a maximum residue limit for a pharmacologically active substance 
used in veterinary medicinal products. 
The compounds listed in Annex 4 include dimetridazole, ronidazole, metronidazole 
and also chloramphenicol. As a result of their suspected negative human health 
effects, no MRL could be established and therefore they are prohibited for use in 
food producing animals. Other nitroimidazoles such as ipronidazole were never 
issued a veterinary licence for the use in food producing animals and therefore are 
also prohibited. 
Regulation 2377/90 has recently been replaced by Council Regulation 470/2009/EC. 
This new regulation allowed for the use of a maximum residue limit established in 
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one species or foodstuff to be used for another species or another foodstuff. The new 
legislation also allowed for the provision of reference points of action for prohibited 
substances in order to harmonise trade between member states. These reference 
points of action would also take into account what concentrations of residue it is 
possible to measure in the laboratory. This regulation also refers to another new 
regulation that would replace Annexes 1-4 of 2377/90. This new regulation 37/2010; 
was brought in to simplify matters and only contains one Annex with two tables. The 
first table lists all the authorised substances in alphabetical order and the second table 
lists all the prohibited substances in alphabetical order. 
As the compounds of interest in this study, nitroimidazoles and chloramphenicol, are 
in table 2 of regulation 37/2010 i.e. compounds that are prohibited substances, there 
is no maximum residue limit set for these and as such there is a zero tolerance policy 
towards their use within the EU. In practice however it is not possible to measure 
zero. In order to harmonise, to some extent, performance of laboratories from 
different Member States the Minimum Required Performance Level (MRPL) concept 
was devised, however legislative MRPLs have only been set for a small number of 
prohibited substances including, medroxyprogesterone acetate, chloramphenicol, 
malachite green and some nitrofuran metabolites (Table 2-1) [Commission Decision  
2003/181/EC, Commission Decision 2004/25/EC]. These levels correspond to the 
average limits above which the detection of a substance or its residues can be 
construed as methodologically meaningful and therefore be used as the reference 
point for action to ensure a harmonised approach throughout the EU. Therefore all 
methods used to analyse for the compounds with MRPLs must be able to confirm 
there presence at this level. As chloramphenicol has an MRPL of 0.3μg/kg all 
methods developed for analysis of it in meat, eggs, urine, aquaculture products, milk 
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and honey must have the capability to confirm its presence at this level and therefore 
the method should be validated at this level. 
Table 2-1: All Minimum required performance levels taken from legislation.  
Substance and/or metabolite Matrices MRPL 
Chloramphenicol 
Meat, Eggs, Milk, Urine, 
Aquaculture products, 
Honey 
0.3μg/kg 
Medroxyprogesterone acetate Pig kidney fat 1μg/kg 
Nitrofuran metabolites: 
furazolidone, furaltadone, 
nitrofurantoin, nitrofurazone 
Poultry meat, Aquaculture 
products 
1μg/kg Total 
combined residue 
Sum of malachite green and 
leucomalachite green 
Meat of aquaculture 
products 
2μg/kg 
 
As there are very few legislative MRPLs, the European Union Reference 
Laboratories (EURL) which are in charge of the control veterinary residues in 
Europe went about producing a Guidance Document in 2007 [CRL Guidance 2007] 
that outlined recommended concentration/levels (RC/RL) that laboratories should 
aspire to measure for prohibited substances with no MRPL. The document also 
specified which matrices should be sampled and also what marker residue should be 
analysed for (parent drug or metabolite). The information given in this document in 
relation to nitroimidazoles can be seen in Table 2-2. 
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This document recommends that as a minimum, laboratories should analyse for 
DMZ, MNZ, RNZ, IPZ and their hydroxy metabolites HMMNI, MNZ-OH and IPZ-
OH at a RL of 3 μg/kg in matrices such as plasma, retina and eggs. Therefore any 
methods that are developed for the analysis of NMZs must take these 
recommendations into consideration when selecting matrix, target analytes and levels 
at which to validate. 
Table 2-2. EURL recommendations for nitroimidazoles adapted from CRL Guidance Document 
2007. 
Substances Matrix 
Recommended 
Concentaration * 
Nitroimidazole: 
Dimetridazole, 
Ronidazole, 
Metronidazole 
 
hydroxy metabolites: 
MNZ-OH, 
HMMNI 
Poultry: 
Plasma, 
Serum, 
Eggs 
 
Pigs (and others species): 
Plasma, 
Serum, 
Muscle 
3ppb 
* CCβ for screening methods or CCα for confirmatory methods should be lower than the value expressed 
in this column 
 
2.3.2. Legislation Relating to Veterinary Products which are used as Feed Additives 
In the European Union the use of feed additives is authorised according to 
Regulation No. 1831/2003 as long as various criteria are fulfilled including the need 
to provide suitable methods of analysis for official control of these compounds in 
feedingstuffs. Other requirements that need to be specified are the target animal, the 
level of active substance in feed and in some cases, as with coccidiostats, the 
withdrawal period before slaughter when the use of these substances are prohibited. 
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More recent legislation published in the EU, has gone about prohibiting the use of 
many veterinary products for use as feed additives. Commission Recommendation 
2005/925/EC prohibits the use of many antibiotics, coccidiostats and antibacterial 
growth promoters as feed additives. This recommendation lists medicinal substances 
that should be monitored and the substances are divided into two groups; medicinal 
substances authorised as feed additives for certain animal species or categories e.g. 
ionophore coccidiostats and medicinal substances no longer authorised as feed 
additives e.g. carbadox, nitroimidazoles, tetracyclines. The two lists can be seen in 
Table 2-3. 
Table 2-3: List of medicinal substances that should be monitored according to Commission 
Recommendation 2005/925/EC. 
1. Medicinal substances authorised as feed 
additives for certain animal species or categories 
2. Medicinal substances no longer 
authorised as feed additives 
decoquinate (Deccox) Amprolium 
diclazuril (Clinacox 0,2 %) amprolium/ethopabate 
halofuginone hydrobromide (Stenorol) Arprinocid 
lasalocid A sodium (Avatec 15 %) Avilamycin 
maduramicin ammonium alpha (Cygro 1 %) Avoparcin 
monensin sodium (Elancoban G100, 100, G200, 200) Carbadox 
narasin (Monteban) Dimetridazole 
narasin — nicarbazin (Maxiban G160) Dinitolmid 
robenidine hydrochloride (Cycostat 66 G) Flavophospholipol 
salinomycin sodium (Sacox 120G, 120) Ipronidazole 
semduramicin sodium (Aviax 5 %) Meticlorpindol 
 meticlorpindol/methylbenzoquate 
 Nicarbazin 
 Nifursol 
 Olaquindox 
 Ronidazole 
 Spiramycin 
 Tetracyclines 
 tylosin phosphate 
 Virginiamycin 
 zinc bacitracin 
 other antimicrobial substances 
 
This legislation went about harmonising the existing legislation on residues in 
animals and the existing legislation governing feedingstuffs. Compounds that are 
prohibited in food of animal origin are prohibited as feed additives e.g. 
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nitroimidazoles and compounds with MRLs in food of animal origin are only 
permitted in medicated feed e.g. tetracyclines. This has helped to reinforce the farm 
to plate philosophy i.e. ensure control of harmful residues through every stage of 
food production and as a result ensure consumer protection. Following the 
publication of this legislation no antibiotics other than coccidiostats and 
histomonostats can be marketed and used as feed additives within the European 
Union. Coccidiostats constitute the main choice to fight against coccidiosis. This is a 
major disease in poultry as well as in many other hosts [Matabudul et al., 1999].  
Following on from this legislation a problem was identified with carryover of 
coccidiostats from feed with additives added and non additive feed. This is due to the 
fact that feed business operators may produce within one establishment a broad range 
of feeds. Different types of products may have to be manufactured after each other in 
the same production line. It may happen that unavoidable traces of a product remain 
in the production line and end up in the beginning of the production of another feed 
product. This transfer from one production lot to another is called ‘carry-over’ or 
‘cross-contamination’ and may occur for instance when coccidiostats or 
histomonostats are used as authorised feed additives. This may result in the 
contamination of feed produced subsequently by the presence of technically 
unavoidable traces of those substances in ‘non-target feed’, i.e. in feed for which the 
use of coccidiostats or histomonostats are not authorised, such as feed intended for 
animal species or categories not provided for in the additive authorisation. This 
unavoidable cross-contamination may occur at all stages of production and 
processing of feed but also during storage and transport of feed as cited in Regulation 
2009/8/EC. This may lead to high concentrations of coccidiostats in non-target feed; 
which could pose a health risk to both the species itself and to humans.  
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As a result of concerns over the production of animal feed and in order to avoid 
carry-over, the Feed Hygiene Regulation 2005/183/EC was published. This lays 
down specific requirements for feed businesses using coccidiostats and 
histomonostats in the production of feed. In particular, the operators concerned have 
to take all appropriate measures concerning facilities and equipment, production, 
storage and transport in order to avoid any cross-contamination [Regulation 
2005/183/EC]. 
Taking into account the application of good manufacturing practices set out in the 
feed hygiene regulation there are still levels of coccidiostat carryover that are 
considered unavoidable. The European Commission published legislation in the form 
of Regulation 2009/8/EC and this established maximum limits for unavoidable carry 
over of coccidiostats and histomonostats. Using the ALARA (As Low As 
Reasonably Achievable) principle the commission set maximum limits for 
unavoidable carry over. As a result and for the purpose of enabling the feed 
manufacturer to manage the unavoidable carry-over of coccidiostats, a carryover rate 
of approximately 3% of the authorised maximum content is considered acceptable 
with regard to feed for less sensitive non-target animal species, while a carry-over 
rate of approximately 1% of the authorised maximum content should be retained for 
feed intended for sensitive non-target animal species i.e. animals for which the 
additive might be harmful and ‘withdrawal feed’, i.e. feed used for the period before 
slaughter. The carry-over rate of 1% is also considered for allowed cross-
contamination of other feed for target species to which no coccidiostats or 
histomonostats are added, and as regards non-target feed for ‘continuous food-
producing animals’, such as dairy cows or laying hens, where there is evidence of 
transfer from feed to food of animal origin. The levels related to 1% and 3% carry 
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over of all the coccidiostats and histomonostats covered by this legislation are seen in 
Table 2-4. 
 
Table 2-4. 1% and 3% carry over of all the coccidiostats as stated in legislation 2009/8/EC. 
 
Compound 1% Carry Over (mg/kg) 
3% Carry Over 
(mg/kg) 
Halofuginone 0.03 0.09 
Robenidine 0.70 2.10 
Nicarbazin 0.50 1.50 
Diclazuril 0.01 0.03 
Decoquinate 0.40 1.20 
Semduramicin 0.25 0.75 
Lasalocid 1.25 3.75 
Salinomycin 0.70 2.10 
Monensin 1.25 3.75 
Narasin 0.70 2.10 
Maduramicin 0.05 0.15 
 
2.3.3. Legislation describing procedures for the control of residues 
Monitoring of veterinary residues in food of animal origin is carried out according to 
European legislation Council Directive 96/23/EC. This Directive lays down 
measures to monitor substances and groups of residues listed and defines the role of 
the national reference laboratories in monitoring. The main aims of this legislation is 
to give direction on the approach to be taken in monitoring illegal substances and 
incorrect use of authorised substances in food producing animals within the EU. As a 
result it is hoped that monitoring throughout the EU will be firstly effective but also 
consistent from one country to the next. In order to enable this harmonised approach 
this legislation lays down measures to monitor the substances and groups of residues. 
The legislation goes about setting up national reference laboratories in each member 
state that will be responsible for analysis of veterinary residues. Approaches to 
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sampling, frequency and numbers of samples taken and enforcement measures for 
non compliant results are all outlined in this legislation. This legislation also breaks 
up the different veterinary compounds into Group A and Group B. As mentioned 
previously Group A substances are those whose use are prohibited in food producing 
animals. The residues of compounds which were studied as part of this thesis i.e. 
nitroimidazoles and chloramphenicol are both categorised as A6 compounds in 
96/23/EC.  
 
2.3.4. Guidelines concerning the analytical performance and interpretation of 
results of residue methods.  
As a result of legislation for the control of residues in food of animal origin, 
analytical methods for the analysis of the controlled substances needed to be 
developed. These methods needed to be sensitive, selective and fit for purpose. In 
order to ensure this the European Commission initiated the production of a 
legislation to ensure any method developed met certain quality criteria. This 
legislation lays down performance criteria for the analytical methods to be used for 
the analysis of certain substances and residues thereof in live animals and animal 
products according to Council Directive 96/23/EC. The resulting piece of legislation 
is Commission Decision 2002/657/EC and it is concerned with the performance of 
analytical methods and the interpretation of results. The severe implications on 
countries where abuse of prohibited compounds (Group A) is identified resulted in 
the need for more rigorous criteria to be specified within 2002/657/EC for 
confirmation of the presence of these substances. 
According to Commission Decision 2002/657/EC validation; in the case where no 
certified reference material is available; should be carried out as follows: 
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 Prepare a set of samples of identical matrices, fortified with the analyte to 
yield concentrations equivalent to 1, 1.5 and 2 times the MRPL/RL or 0.5, 1 
and 1.5 times the MRL.  
 At each level the analysis should be performed with at least six replicates. 
 Analyse the samples and calculate the concentration present in each sample. 
 Repeat these steps on at least two other occasions. 
 Values for recovery, repeatability, within-laboratory reproducibility and the 
analytical limits of Decision Limit (CCα), Detection capability (CCβ) are 
calculated from the results obtained.  
Technical guidelines and required performance criteria are detailed within 
Commission Decision 2002/657/EC and specific ones relevant to this research in 
terms of quantitative methods are as follows; 
 Specificity: A method shall be able to distinguish between the analyte and the 
other substances under the experimental conditions. An estimate to which extent 
this is possible has to be provided. Strategies have to be employed in order to 
overcome any foreseeable interference with substances when the described 
measuring technique is used. These strategies include the use of internal 
standards such as homologues, analogues, metabolic products of the residue of 
interest used to correct for any interferences. It is of prime importance that 
interference, which might arise from matrix components, is also investigated. 
 Confirmatory Requirements: For a analytical instrument to be deemed 
confirmatory, it must have a certain number of identification points while 
meeting criteria for relative ion intensities and relative retention times.  
 Identification Points: As the methods developed in this research concern 
the analysis of prohibited compounds i.e. NMZs and CAP the method 
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used for their analysis needs to achieve 4 identification points. The 
number of identification points gained by a particular method depends on 
the detector employed. Tandem mass spectrometry using a number of 
different triple quadrupole mass spectrometers operated in multi reaction 
monitoring mode was utilised as the determination step for all methods 
developed within the research carried out as part of this thesis. This 
technique is classified within 2002/657/EC as being low-resolution mass 
spectrometry (LR-MS), when operated in multi reaction monitoring 
mode; it gains one identification point for each precursor ion and 1.5 
identification points for each product ion monitored. So if two product 
ions are monitored, which result from one precursor ion, a total of 4 
identification points is achieved. List of MS techniques and the 
identification points associated as given in the directive are seen in Table 
2-5. 
 
Table 2-5. The relationship between a range of classes mass spectrometry detectors and 
identification points earned (CD 2002/657) 
 
MS Technique Identificaton points earned per ion 
Low resolution mass spectrometry (LR) 1.0 
LR-MSn precusor ion 1.0 
LR-MSn transition products 1.5 
HRMS 2.0 
HR-MSn precusor ion 2.0 
HR-MSn transition products 2.5 
n: multiple mass spectrometers e.g tandem mass spectrometry (MS/MS)  
 Ion Ratio: The relative intensities of the detected ions, expressed as a 
percentage of the intensity of the most intense ion, shall correspond to 
those of the calibration standard, either from calibration standard 
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solutions or from spiked samples, at comparable concentrations, 
measured under the same conditions, within the tolerances given in the 
legislation seen in Table 2-6.  
 
Table 2-6. Maximum permitted tolerances for relative ion intensities using a range of mass 
spectrometric techniques (CD 2002/657) 
 
Relative Intensity 
(% of base peak) 
EI- GC-MS 
(relative) 
CI-GC-MS, GCMSn, 
LC-MS, LCMSn  
(relative) 
> 50% ± 10% ± 20% 
> 20% to 50% ± 15% ± 25% 
> 10% to 20% ± 20% ± 30% 
≤ 10% ± 50% ± 50% 
 
 Relative Retention Times: The ratio of the chromatographic retention time 
of the analyte to that of the internal standard, i.e. the relative retention 
time of the analyte, shall correspond to that of the calibration standards at 
a tolerance of ± 0.5 % for GC and ± 2.5 % for LC. 
 Calibration Curves: When calibration curves are used for quantification: 
 at least five levels (including zero) should be used in the construction of 
the curve, 
 the working range of the curve should be described, 
 the mathematical formula of the curve and the goodness-of-fit of the data 
to the curve should be described, 
 acceptability ranges for the parameters of the curve should be described. 
 Recovery: During the analysis of samples the recovery shall be determined in 
each batch of samples, if a fixed recovery correction factor is used. If the 
recovery is within limits, the fixed correction factor may then be used. Otherwise 
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the recovery factor obtained for that specific batch shall be used; unless the 
specific recovery factor of the analyte in the sample is to be applied in which case 
the standard addition procedure or an internal standard shall be used for the 
quantitative determination of an analyte in a sample. % Recovery = 100 × 
measured content/fortification level 
 Trueness/Accuracy: When no certified reference materials (CRMs) are available, 
it is acceptable that trueness of measurements is assessed through recovery of 
additions of known amounts of the analyte(s) to a blank matrix. The recovery can 
be determined as described above. Data for recovery are only acceptable when 
they fall within the ranges shown in Table 2-7. 
 
Table 2-7. Minimum trueness of quantitative methods (CD 2002/657) 
 
Mass Fraction Range 
≤ 1 µg/kg -50% to 20% 
> 1 µg/kg to 10µg/kg -30% to 10% 
≥10 µg/kg -20% to 10% 
 
 Precision: The inter-laboratory coefficient of variation (CV) for the repeated 
analysis of a reference or fortified material, under reproducible conditions, shall 
not exceed the level calculated by the Horwitz Equation.  
 The equation is: CV = 2(1 – 0.5 log C).  
 Where C is the mass fraction expressed as a power (exponent) of 10 (e.g. 
1 mg/g = 10-3).  
 Examples are shown in the Table 2-8. 
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Table 2-8. Examples for reproducibility CVs for quantitative methods at a range of analyte 
mass fractions. (CD 2002/657) 
 
Mass Fraction Reproducibility CV (%) 
1 µg/kg (*) 
10 µg/kg (*) 
100 µg/kg 23 
1000 µg/kg (1 mg/kg) 16 
(*) For mass fractions lower that 100 µg/kg the application of the Horwitz equation gives 
unacceptably high values. Therefore, the CVs for concentrations lower than 100 µg/kg shall be 
as low as possible 
 
 Analytical Limits:  decision limit, CCα, and detection capability, CCβ, are also 
specified in this legislation and were intended in some way to take the place of 
performance characteristics; limit of detection (LOD) and limit of quantification 
(LOQ). CCα is defined as “the concentration at and above which it can be 
concluded with an error probability of α that a sample is non-compliant 
(contains the analyte)”. CCβ is defined as “the smallest content of the substance 
that may be detected, identified and/or quantified in a sample with an error 
probability of β”. In β% of the cases, a non-compliant sample will be classified 
as compliant, and therefore reveals a false-negative result (Figure 2-4 gives a 
graphical illustration of these concepts).  
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X B  Mean Response of the blank sample  
 
SB  Standard deviation of the blank sample 
 
X S  Mean Response of contaminated sample 
 
SS   Standard Deviation of the contaminated sample 
 
α  Rate of false non-compliant results 
 
β  Rate of false compliant results 
 
CCα  Response with a given α -error and 50% β-error 
 
CCβ  Response with a very small α-error and β-error 
 
Figure 2-4: Adapted from 2002/657/EC illustrating CCα and CCβ 
 
A variety of approaches on how these performance characteristics could be 
determined are also set out in this document. The approach used in this research 
is as follows; 
 For the calculation of CCα blank material is used, which is fortified at 
and above the MRPL/RL in equidistant steps. The samples are analysed 
and after identification, a plot of the signal against the added 
concentration is made. The corresponding concentration at the y-
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intercept plus 2.33 times the standard deviation of the within-laboratory 
reproducibility of the intercept equals the decision limit. This is 
applicable to quantitative assays only (α = 1 %). 
 For the calculation of CCβ, the corresponding concentration at the 
decision limit plus 1.64 times the standard deviation of the within-
laboratory reproducibility of the mean measured content at the decision 
limit equals the detection capability (β = 5 %). 
The document describes approaches on how all these parameters can be determined, 
however it does not obligate laboratories to use these approaches; as stated in the 
document “Other approaches to demonstrate that the analytical method complies 
with performance criteria for the performance characteristics may be used, provided 
that they achieve the same level and quality of information”. 
 
2.4. Extraction and Purification Procedures  
2.4.1. Introduction to Sample Preparation 
Sample preparation is an essential stage in the analytical process. It takes place 
between sampling and measuring the prepared sample by means of an instrumental 
technique. It involves the extraction of the analyte of interest from either biological 
or feed matrix followed by the purification of this extract to help remove matrix 
components that may interfere with the instrument of detection. Although 
advancements in technology in the form of Ultra high performance liquid 
chromatography (UHPLC) and in tandem mass spectrometry (MS/MS) have reduced 
the need for labour intensive extraction protocols, sample preparation still plays a 
key role. However approaches and techniques used in sample extraction and 
purification have changed dramatically.  
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Historically analytical methods were performed on non specific instruments such as 
HPLC-UV. As a result methods used in the analysis of veterinary residues were often 
single analyte or at most single class methods which involved labour intensive 
extraction and purification protocols. These techniques often struggled to reach 
required sensitivity and therefore large sample sizes were necessary and large 
amounts of solvent were required for extraction. Quite often these methods included 
complex purification steps consisting of one or more solid phase extraction (SPE) 
steps (Figure 2-5), in order to make extracts suitable for non-specific detection 
techniques such as LC-UV [Sun et al., 2007; Civitareale et al., 2004; Dousa et al., 
2000].  
 
Figure 2-5. Schematic of Solid Phase Extraction operation 
 
Recently the advancements in mass spectrometry have allowed for the development 
of methods for the analysis of potentially hundreds of compounds in a single 
experiment [Peters et al., 2009; Kaufmann et al., 2011]. These advancements have 
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resulted in a shift from complex labour intensive sample preparations to more 
generic extraction protocols and purification techniques being utilised. Resulting 
from this shift, a number of articles have been published involving generic sample 
preparation protocols which allow for a number of classes of drugs to be analysed in 
the same method [Boschera et al., 2010; Stubbings et al., 2009]. 
There are many benefits in using a generic extraction procedure for analysis of 
veterinary residues. There are significant economic benefits to this approach due to 
the fact that more analytes can be analysed in a single run with less solvent use and 
in a shorter time. Another benefit is that different classes of compounds previously 
analysed separately can now be analysed in a single run and as a result samples can 
be analysed for more residues in the same time. This also allows for more samples to 
be batched together allowing for reduced sample turnaround times. While the 
advantages of generic sample preparations are beneficial there are drawbacks to this 
approach when used with LC-MS in particular ion suppression which will be 
discussed in detail in section 2.5.4. 
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2.4.2. Extraction Methods and Purification Methodologies for Nitroimidazoles 
Table 2-9: Overview of methods used for the analysis of nitroimidazoles as discussed in section 
2.4.2 
Reference
No. of 
compounds 
analysed
Matrix Extraction Method Measurement Technique
LOD    
(μg kg-1)
Daeseleire 2000 3 Egg Extraction with ACN; Evaporated and filtered LC-MS/MS 0.50
Mohamed 2008 7 Egg Extraction with ACN and NaCl; Clean-up on MIPs SPE LC-MS/MS 1.00
Mottier 2006 7 Egg Extraction with ACN and NaCl; Clean-up on Oasis HLB SPE LC-MS/MS 0.60
Xia 2006 4 Egg, Muscle
Extraction with ACN and NaCl; Evaporated and 
filtered LC-MS/MS 0.80
Carretero 2008 1 Muscle
Extraction by ASE; Samples homogenised with 
EDTA washed sand and extracted with water at 
high temperature and pressure
LC-MS/MS 32.00
Clare Ho 2005 2
Muscle, 
Kidney, 
Liver
Extraction with Toluene mixed with Hexane; Clean-
up on amine SPE cartridges GC-MS/MS 1.90
Connolly 2007 5 Muscle Extraction with Ethyl Acetate; Evaporated and re-constituted in HBS-EP Optical Biosensor 2.00
Matusik 1992 4 Muscle
IPZ and IPZ-OH extracted with Benzene; Purified on 
Silica columns. DMZ and HMMNI extracted with 
acidic buffer and then extracted into Methylene 
Chloride
LC-MS/MS 10.00
Mottier 2006 7 Muscle, Fish
Extraction with Potassium Phosphate solution and 
Ethyl Acetate; Upper layer defatted with Hexane LC-MS/MS 0.60
Polzer 2001 7 Muscle Extraction by enzymatic hydrolysis; Clean-up on Kieselguhr SPE GC-MS 2.80
Stubbings 2005 3 Muscle, Egg
Extraction with ACN; Extract dried with Sodium 
Sulphate; Acidified with Acetic Acid before clean-up 
on SCX SPE
HPLC-UV 5.00
Sun 2007 7 Muscle Extraction with Ethyl Acetate; Clean-up on SCX SPE HPLC-UV 0.80
Xia 2007 4 Liver Extraction with Ethyl Acetate; Defatted with Hexane; Clean-up on Oasis MCX SPE LC-MS/MS 0.50
Xia 2008 6 Muscle 
Samples incubated overnight with HCl and 2-
nitrobenzaldehyde; Neutralised with di-potassium 
hydrogen phosphate and NaOH; Clean-up on Oasis 
HLB SPE
LC-MS/MS 0.20
Xia 2009 7 Kidney Extraction with Ethyl Acetate; Defatted with Hexane; Clean-up on MCX SPE LC-MS/MS 0.50
Aerts 1991 4
Plasma, 
Egg, 
Faeces
Extraction with Aqueous Buffer; Clean-up on 
Extrelute SPE followed by liquid-liquid partitioning 
with Isooctane
HPLC-UV 10.00
Fraselle 2007 7 Plasma
NaCl/Potassium Phosphate buffer and Protease 
solution added to samples; pH adjusted to 3 with 
HCl and hydrolised overnight; Defatted with Hexane 
and pH adjusted to 6 with NaOH; Clean-up on 
Chromobond XTR SPE
LC-MS/MS 1.25
Thompson 2009 7
Plasma, 
Kidney, 
Liver, 
Milk, 
Egg
Extraction with ACN followed by ultra-centrifugation Optical Biosensor 3.00
Capitan-Vallvey 2002 5 Water Extraction with ACN; Clean-up on HLB SPE LC-MS 0.20
Ding 2006 3 Royal Jelly
Samples dissolved in NaOH solution; Liquid-liquid 
extraction with Ethyl Acetate LC-MS/MS TBC
Stolker 2008 2 Milk Extraction with ACN and dilution with water; Clean-up on Strata-X SPE UPLC-TOF-MS 17.70
Zhou 2007 5 Honey Extraction with Ethyl Acetate; Clean-up on amino SPE HPLC-UV TBC
Egg Method
Tissue Methods
Plasma Methods
Other Matrices Methods
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The complexity of the matrices involved and also the high sensitivity that developed 
methods should be capable of achieving in order to identify treated animals are two 
main aspects that developed methods need to address. Nitroimidazole compounds 
were permitted for use in the European Union until the mid 1990s. As a result this 
research carried out on these compounds was limited until recently. Therefore 
methods for the analysis of these compounds are still relatively undeveloped in 
matrices recommended for analysis by EURL. Although in recent years more 
methods have been developed, these are limited in the analytes that they analyse for 
and in a lot of cases the sample matrix analysed is muscle and liver which as 
discussed previously is not suitable. 
As discussed previously the selection of a suitable matrix for the analysis of these 
compounds is important to ensure abuse of these compounds is identified. Studies 
carried out by the EURL on the stability and homogeneity of nitroimidazoles in 
incurred muscle (i.e. in muscle of animals administered nitroimidazoles) [Polzer et 
al., 2004; 2005] show that there is not a homogenous distribution of these analytes in 
turkey muscle and they also observed a rapid degradation in analyte concentration 
stored for prolonged periods above 4 °C. In contrast it was discovered that for 
plasma, retina and egg samples the analytes were stable during storage under the 
same conditions as the muscle samples which resulted in stable concentrations and 
allowed detection of these compounds for longer periods after medication had been 
halted. Therefore, it is advised that plasma, retina and eggs be used as target matrices 
for the residue control of nitroimidazoles [Polzer et al., 2004; 2005]. The EURL has 
also put forward RL of 3 µg kg-1 (or ng mL-1) for nitroimidazoles and therefore 
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developed methods used in their analysis must be sensitive enough for analysis, to at 
least this level. 
Extraction methods largely depend on the matrix involved. Matrices differ greatly 
from one to the next. Although the extraction solvent may be the same the presence 
and absence of purification steps in the form of SPE is determined by the matrix in 
question. For this reason this section is broken up into extraction methods for 
specific matrices i.e. Egg, Tissue, and Plasma etc. 
 
2.4.2.1.Egg Methods 
There are a number of methods that exist for the determination of nitroimidazoles in 
the matrix of egg. The majority of these methods involve extraction with acetonitrile 
and the addition of NaCl. This is followed by either a purification step by SPE or by 
filtering before analysis. Mottier et al., 2006 published a method for the detection of 
4 nitroimidazoles and their three marker metabolites in eggs using detection by LC-
MS/MS. Acetonitrile and NaCl were added to egg samples and the mixture was 
centrifuged. The resulting extracts were then purified on Oasis HLB SPE cartridges. 
The method was capable of detecting all analytes to a concentration of at least 0.6 µg 
kg-1. Mohamed et al., 2008 developed a method for the detection of 4 
nitroimidazoles and their three marker metabolites in eggs using detection by LC-
MS/MS. Acetonitrile was again used to extract the compounds of interest from egg, 
NaCl was then added to the resulting extract, the samples were centrifuged and the 
upper layer removed. In this method Molecular Imprinted (MIPs) SPE cartridges 
were then used for purification. The method was proficient in detecting each analyte 
to a concentration of at least 1 µg kg-1. MIPs are cross-linked polymers with specific 
binding sites for a particular analyte. They possess recognition sites that, in terms of 
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size, shape and functionality, are complementary to the print molecule. MIPs provide 
good selectivity as separation materials, which is their most widely investigated use, 
their use as preconcentration and clean-up sorbents in MISPE (molecularly imprinted 
SPE) has recently been used [Mohamed et al., 2008]. One limitation of MIPs is that, 
depending on the synthetic procedure, there may be leaching of the template from the 
polymer, even after extensive washing, and this contaminates the sample. Since 
MIPs are made with large quantities of template, a small number of imprint 
molecules may remain in the resulting polymer and these may leak later during SPE, 
thus interfering with trace analysis. 
The next two methods omit the use of an SPE step and replace it with a filtering step. 
Xia et al., 2006 developed a method for the determination of 4 nitroimidazoles in 
egg, poultry muscle and porcine muscle. Samples were again extracted with 
acetonitrile and NaCl, samples were then concentrated by evaporation and filtered 
with detection by LC-MS/MS. The method had the capability to detect all analytes to 
0.8 µg kg-1.  Daeseleire et al., 2000 published work on a method for the 
determination of RNZ, DMZ and MNZ in egg with detection by LC-MS/MS. This 
time only acetonitrile was added to the egg samples to extract the analytes.  The 
samples were then concentrated and filtered. In this case no SPE purification was 
employed. Compounds were detected to levels of 0.5 µg kg-1. 
From examination of these published methods it is clear that extraction with 
acetonitrile and the addition of NaCl is a popular and effective extraction technique 
for the analysis of nitroimidazoles in egg matrices. This is often followed by 
purification by SPE but methods have shown that this can be omitted but only for 
less analytes as SPE methods which analyse for seven residues. Our research will 
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attempt to adapt the rapid extraction protocols that omit SPE purification to allow for 
the analysis of a greater number of analytes than previously seen.    
 
2.4.2.2.Tissue Methods (Liver, Kidney and Muscle) 
Many methods exist for the determination of nitroimidazoles in tissue samples even 
though recent studies suggest that this may not be a suitable matrix for the detection 
of nitroimidazoles due to problems with stability. Xia et al., 2007 developed a 
method for the detection of 3 nitroimidazoles and one metabolite in porcine liver 
with detection by LC-MS/MS. Liver samples were extracted with ethyl acetate, the 
extract was then evaporated to dryness, reconstituted in 0.1 M HCl and defatted with 
hexane. The extracts were further purified on Oasis MCX SPE cartridges. The 
method was capable of detecting each analyte at 0.5 µg kg-1. Mottier et al., 2006 
reported a method for the detection of 7 nitroimidazoles in poultry muscle and fish 
using LC-MS/MS for determination. A potassium phosphate solution is added to the 
samples followed by ethyl acetate; this solution is then mixed and the upper organic 
layer removed. The extracts are then defatted with hexane; the method could detect 
each analyte to concentrations of 0.6 µg kg-1. Matusik et al., 1992 developed a 
method for the detection of 4 nitroimidazoles in turkey muscle with detection by LC-
MS/MS. DMZ and its metabolite and IPZ and its metabolite are extracted using two 
different approaches. IPZ and IPZ-OH were extracted using benzene in the presence 
of borax with purification on silica columns. DMZ and HMMNI were extracted with 
an acidic buffer and then extracted into methylene chloride. Compounds could be 
determined to levels of 10 µg kg-1. Clare Ho et al., 2005 developed a method for the 
detection of 2 nitroimidazoles in poultry muscle and liver and porcine kidney and 
liver. Samples were extracted with toluene mixed with hexane and purified on amine 
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SPE cartridges. Residues are determined by GC-MS/MS, the method was capable of 
detecting each analyte to a concentration of 1.9 µg kg-1.  Polzer et al., 2001 
developed a method for the detection of 7 nitroimidazoles in poultry and porcine 
muscle using detection by GC-MS. Samples underwent an enzymatic hydrolysis 
followed by purification on kieselguhr SPE cartridges. The method was capable of 
detecting residues to a concentration of 2.8 µg kg-1. Xia et al., 2008 developed a 
multi-class, multi-residue method for the detection of 6 nitroimidazoles as well as a 
number of nitrofurans in porcine muscle. Hydrochloric acid and 2-nitrobenzaldehyde 
were added to the samples which were incubated overnight. Samples were then 
neutralized to pH 7 with di-potassium hydrogen phosphate and sodium hydroxide 
and purified on Oasis HLB SPE cartridges. The method was able to detect residues to 
a level of 0.2 µg kg-1 by LC-MS/MS. Carretero et al., 2008 utilized accelerated 
solvent extraction (ASE) for extraction of RNZ from muscle samples. Samples were 
homogenized with EDTA washed sand and extracted with water at high temperature 
and pressure. The method was only able to detect residues to a level of 32 µg kg-1 by 
LC-MS/MS. Stubbings et al., 2005 developed a screening method for the analysis of 
3 nitroimidazoles in poultry muscle and egg with detection by HPLC-UV. Samples 
were extracted with acetonitrile then dried with sodium sulphate and acidified with 
glacial acetic acid before being purified on Bond Elut strong cation exchange SPE 
cartridges. The method was able to detect each analyte to a concentration of 5µg kg-1. 
Sun et al., 2007 reported a screening method for the detection of 7 nitroimidazoles in 
porcine and poultry muscle. Samples were extracted with ethyl acetate and purified 
using SCX SPE cartridges; determination was carried out by LC-UV. The developed 
method could detect each residue to a level of at least 0.8 µg kg-1. Xia et al., 2009 
describes a method for the determination for 4 nitroimidazoles and 3 metabolites in 
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porcine kidney by LC-MS/MS. The compounds of interest were extracted from 
tissues with ethyl acetate. The crude extracts were subject to liquid–liquid partition 
with hexane followed by solid-phase extraction using mixed-mode strong cation-
exchange column. The method could detect to levels of 0.5ug kg -1. Connolly et al., 
2007 developed a screening method for the detection of 5 nitroimidazoles in poultry 
muscle with detection by optical biosensor. Samples were extracted with ethyl 
acetate, evaporated to dryness and resuspended in 0.5 ml HBS-EP (0.01 M HEPES 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) [pH 7.4], 0.15 M NaCl, 3 mM 
EDTA, 0.005% surfactant P20). The method could detect each of the residues to at 
least 2 µg kg-1. 
Taking into consideration studies on the homogeneity and stability of nitroimidazole 
residues, it was decided that the extraction of muscle and liver samples do not ensure 
that the possible abuse of these compounds is detected. Therefore it was felt that their 
analysis should be from matrices such as plasma and eggs. Although the studies 
carried out pertain specifically to avian matrices it was felt that in order to ensure the 
methods developed were best suited for the routine analysis of nitroimidazoles in all 
species that plasma is chosen for analysis; along with eggs, milk and honey for 
specific species. 
 
2.4.2.3.Plasma/Serum 
Although plasma is one of the matrices recommended by the EURL for the analysis 
of nitroimidazoles there are only a few methods published for this matrix. Aerts et 
al., 1991 developed a screening method for the detection of 4 nitroimidazoles in 
plasma, egg and faeces with LC-UV detection. The samples were extracted in an 
aqueous buffer and purified on Extrelut SPE cartridges followed by liquid-liquid 
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partitioning with isooctane. The method was able to detect all analytes to a level of 
10 µg kg-1. 
Fraselle et al., 2007 developed a method for the detection of 7 nitroimidazoles in 
porcine plasma by LC-MS/MS. A NaCl/Potassium phosphate buffer as well as a 
protease solution was added to the plasma. The pH was adjusted to 3 with HCl and 
the mixture was allowed to hydrolyze overnight. The mixture was then defatted with 
hexane adjusted to pH 6 with NaOH and purified on Chromabond XTR SPE 
cartridges. The method could detect each residue to at least 1.25 µg kg-1. The method 
by Fraselle includes a hydrolysis step to free bound residues, there is some debate on 
whether this step is required for serum samples; Thompson et al., 2009 does not 
include this step. Thompson et al., 2009 developed a screening method for 4 
nitroimidazoles and their 3 marker metabolites in serum, kidney, liver, milk and 
eggs. Acetonitrile was used for extraction followed by ultra centrifugation of the 
extract. Detection was carried out using an optical biosensor technique and the 
method was capable of detecting all residues to a level of 3 µg kg-1. 
It is quite clear from examination of published articles that despite reports 
recommending it, the analysis of nitroimidazoles in plasma is still not common 
practice. No rapid extraction methods exist for the confirmatory analysis of 
nitroimidazoles in plasma. By adapting the acetonitrile and NaCl method used in the 
used the extraction of nitroimidazole residues in eggs; it is felt that a rapid method 
could be developed to allow for an increased number of analytes to be analysed for.   
 
2.4.2.4.Other 
From investigation of literature only one method could be found that allows for the 
analysis of NMZs in honey. Zhou et al., 2007, published a method for the analysis of 
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5 NMZs in honey by HPLC-UV. Samples were extracted with ethyl acetate and 
evaporated. The residue containing the NMZs was dissolved in ethyl acetate–hexane 
and subjected to solid-phase extraction cleanup by amino extraction columns. The 
eluent was evaporated, reconstituted and injected onto the column.  
In relation to the analysis of nitroimidazoles in milk there are a limited number of 
published methods available [Ortelli et al., 2009; Stolker et al., 2008; Thompson et 
al., 2009]. These methods are all screening methods using either optical biosensor 
[Thompson et al., 2009] or accurate mass instruments [Ortelli et al., 2009; Stolker et 
al., 2008]. Stolker et al., 2008 developed a multi class, multi analyte method for the 
detection of various groups of veterinary residues in milk using UPLC-TOF-MS. IPZ 
and its hydroxy metabolite IPZ-OH were the only nitroimidazole compounds 
included. Milk was mixed with acetonitrile to precipitate proteins and the supernatant 
was diluted in water. This was then applied to Strata-X SPE columns and finally 
determined by MS. The method could reach 17.7 µg kg-1for the detection of IPZ and 
7.7 µg kg-1for IPZ-OH. From investigation of literature there are no methods for the 
confirmatory analysis of NMZs in milk or honey at the levels desired. 
Two other methods published for the analysis of nitroimidazoles are Ding et al., 
2006 who developed a method for the determination of 3 nitroimidazoles in royal 
jelly by LC-MS/MS. Samples were dissolved in sodium hydroxide solution to 
disassociate target analytes from the matrix. Liquid-liquid extraction methods using 
ethyl acetate as solvent were utilised to clean up the sample. The other was published 
by Capitan-Vallvey et al., 2002 on the analysis of 5 NMZs in water by LC-MS. The 
extraction procedure was based on HLB (Hydrophilic-lipophilic balance) solid-phase 
extraction with acetonitrile followed by an evaporation step. The method was 
capable of identifying nitroimidazole residues at 0.2 µg L-1. 
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It is quite clear that the matrices of milk and honey are not considered when methods 
for the analysis of nitroimidazoles are developed. This is most likely due to the fact 
that nitroimidazoles were previously not used routinely in honey and milk production 
practices. That being said, nitroimidazoles can be used to treat genital tricchoniasis in 
cattle and recently, reports from China suggest that the use of nitroimidazoles in 
beekeeping is being practiced [Zhou et al., 2007]. Nitroimidazoles may be used to 
prevent and control Nosema apis in hives [Official Method (2003)]. Taking this into 
consideration the EURL for NMZs has suggested that honey be tested to ascertain 
any possible misuse of nitroimidazoles and if non-compliant results are found then 
this matrix should be included in monitoring plans. They also state that countries 
with high milk production should also analyse for these analytes in milk as their 
possible misuse in this matrix cannot be discounted. Therefore it was felt that the 
development of methods for the analysis of nitroimidazole residues in these two 
matrices should be developed. This would be performed by using previously 
developed methods for the other matrices as a starting point for the analysis of milk 
and honey. 
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2.4.3. Extraction Methods and Purification Methodologies for Chloramphenicol 
Table 2-10: Overview of methods used for the analysis of chloramphenicol as discussed in 
section 2.4.3 
Reference
No. of 
compounds 
analysed
Matrix Extraction Method Measurement Technique
LOD    
(μg kg-1)
Forti 2005 1 Honey
Dissolution of samples in water before extraction 
with DCM and Acetone mixture; Evaporated and 
reconstituted in phosphate buffer; Clean-up on 
C18 SPE cartridges
LC-MS/MS 0.07
Huang 2006 1 Honey, Milk, Egg
Dissolution of samples in 20mM phosphate 
solution at pH 4.0; Samples passed through 
extraction tube containing a monolith 
microextraction polymer
LC-MS 0.02-0.04
Penney 2005 1
Milk, Eggs, 
Muscle, Liver, 
Kidney
Extraction with ACN and defatted with Hexane; 
Evaporated and reconstituted in mobile phase; 
Samples filtered prior to injection
LC-MS 0.20-0.60
Rejtharova 2009 1
Urine, Feed, 
Water, Milk, 
Honey
Extracion with ACN, Clean-up on MIP SPE 
cartridges GC-MS-NCI <0.30
Rocha-Siqueira 2005 1
Shrimp, Fish, 
Eggs; Poultry, 
Porcine and 
Bovine muscle
Extraction with phosphate solution followed by 
LLE with Ethyl Acetate LC-MS/MS 0.10
Rodziewicz 2008 1 Milk Powder Extraction with Ethyl Acetate and de-fatted with Hexane LC-MS/MS 0.09
Ronning 2006 1
Meat, 
Seafood, Egg, 
Plasma, 
Honey, Milk, 
Urine
Extracion with ACN; Chloroform added to remove 
water; Evaproated and reconstitued in Methanol 
and water before injection
LC-MS/MS 0.02
Shen 2005 1 Seafood, Meat, Honey
Extraction with phosphoric buffer solution (pH = 
6.88)/ Ethyl Acetate; Samples de-fatted with 
Hexane and purifed by SPE
ELISA, HPLC-UV, 
GC-ECD, GC-MS-
EI-SIM, GC-MS-
NCI-SIM
<0.30
Vinci 2005 1 ? Extraction with ACN and defatted with Hexane LC-MS/MS 0.15
Vivekanandan 2005 1 Honey Samples were diluted with water and purified using diatomaceous-based LLE cartridges LC-MS/MS 0.05
Hormazabal 2001 2 Meat, Milk
Extraction with ACN; water removed by CHCl3; 
Clean-up on Bond Elut SPE cartridges
? 1.
Shen 2009 4 Muscle, Liver
Extraction with Ethyl Acetate; Extracts frozen to 
remove lipids; Further purified by LLE with 
Hexane and SPE clean-up on HLB cartridges
GC-MS-NCI 0.10
Sheridan 2008 15 Honey Extraction by Acid Hydrolysis; Clean-up on HLB SPE cartridges LC-MS/MS 0.20
Wang 2007 3 Royal Jelly
Samples homogenised with water before 
extraction with Ethyl Acetate; Evaporated and 
reconstituted in phosphate buffer solution; Clean-
up on C18 SPE cartridges
LC-MS/MS 0.10
Xie 2006 3 Feed Extraction with Ethyl Acetate; Clean-up on C18 SPE cartridges LC-MS/MS 0.10
Zhang 2008 4 Chicken Muscle
Extraction with Ethyl Acetate and defatted with 
Hexane; Clean-up on MCX SPE cartridges LC-MS/MS 0.10
Single Analyte Methods
Multi-Analyte Methods
00
 
 
As discussed previously the use of CAP, due to health concerns, has been prohibited 
in food producing species. In order to ensure this is enforced effectively a legislative 
MRPL of 0.3 ng mL-1/µg kg-1 has been issued for CAP which means all methods 
used in the analysis of this compound should be able to, at least, achieve this level. In 
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order to achieve enough sensitivity a common trend in analysis of CAP is the use of 
SPE as the sample purification technique. Common cartridge chemistries used in the 
analysis of CAP are Oasis HLB [Shen et al., 2009], Oasis MCX [Zhang et al., 2008] 
and the selective technique of Molecular Imprinted Polymers (MIPs) [Rejtharova et 
al., 2009; Boyd et al., 2007]. The need for very sensitive methods and increased 
sample purification in order to see down to the MRPL has resulted in CAP often 
being analysed in single analyte methods although some multi amphenicol methods 
do exist. An investigation into published literature found there are numerous methods 
available for the analysis of CAP in all matrices but found that some were quite 
labour intensive with use of SPE and resulted in the analysis of only one analyte 
[Rejtharova et al., 2009; Ronning et al., 2006], although there are some multi-
amphenicol and multi-class methods available [Zhang et al., 2008; Shen et al., 2009]. 
Some of the more recently published methods are examined now under two headings 
single analyte and multi-analyte. 
 
2.4.3.1.Single Analyte Chloramphenicol Methods 
The majority of methods for the analysis of CAP are single analyte methods utilising 
SPE purification. Ronning et al., 2006 developed a method that analysed for CAP 
residues in meat, seafood, egg, honey, milk, plasma and urine with liquid 
chromatography–tandem mass spectrometry. Meat, seafood, egg, honey and milk 
samples were extracted with acetonitrile. Chloroform was then added to remove 
water. After evaporation, the residues were reconstituted in methanol/water before 
injection. The urine and plasma were applied to a Chem Elut extraction cartridge, 
eluted with ethyl acetate, and hexane washed. These samples were also reconstituted 
in methanol/water after evaporation. CCα and CCβ for all matrices were 0.02 and 
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0.04 μg kg-1. Rejtharova et al., 2009 described a method for the analysis of CAP in 
urine, feed, water, milk and honey samples by GC-MS-NCI (Negative Chemical 
Ionization) using molecular imprinted polymer clean-up. CAP could be detected well 
below the MRPL in all matrices. Huang et al., 2006 presented a single analyte 
method for the analysis of CAP in honey, milk, and eggs using polymer monolith 
micro-extraction followed by liquid chromatography-mass spectrometry 
determination. A poly(methacrylic acid-ethylene glycol dimethacrylate) monolithic 
capillary column was selected as the extraction medium. After dissolution in 20 mM 
phosphate solution at pH 4.0 and centrifugation, honey, eggs, or milk samples were 
directly passed through the extraction tube. The limits of detection for the method 
were 0.02 μg kg-1, 0.04 μg L-1, and 0.04 μg kg-1 in honey, milk, and eggs, 
respectively. Shen et al., 2005 developed a method for the screening, determination 
and confirmation of chloramphenicol in seafood, meat and honey using ELISA, 
HPLC-UVD, GC-ECD, GC-MS-EI-SIM and GCMS-NCI-SIM methods. Extraction 
was with phosphoric buffer solution (pH = 6.88)/ethyl acetate, followed by defatting 
with hexane. For confirmation on GC-MS the samples underwent purification with 
SPE using LC-Si and LC-C18 cartridges. Forti et al., 2005 described the detection 
and identification of CAP in honey. After a preliminary dissolution in water, samples 
were extracted with a mixture of dichloromethane/acetone and evaporated to dryness 
and reconstituted in a phosphate buffer solution. These were further cleaned up on an 
octadecyl (C18) SPE cartridge. CAP was determined by LC-MS/MS, using 
electrospray ionization in the negative ion mode with CCα of 0.07 μg kg-1 and CCβ 
of 0.10 μg kg-1.  
While the use of SPE is common there are published methods that omit this step. 
Vivekanandan et al., 2005 published a method for the analysis of CAP in honey by 
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LC-MS/MS. Samples were diluted with water and were purified using diatomaceous-
based supported liquid-liquid extraction cartridges. The LOD and LOQ of the 
method were 0.05 μg kg-1 and 0.1 μg kg-1 respectively. Rodziewicz et al., 2008 
published a method for the analysis CAP in milk powder by LC-MS/MS with 
negative electro-spray ionisation. Samples were extracted by using liquid-liquid 
extraction steps with ethyl acetate and lipids were removed using hexane. The CCα 
and CCβ of the method were 0.09 and 0.11 μg kg-1 respectively. Penney et al., 2005 
published a liquid chromatography/mass spectrometry (LC/MS) method for the 
determination of CAP residues in milk, eggs, chicken muscle and liver, and beef 
muscle and kidney. CAP is extracted from the samples with acetonitrile and defatted 
with numerous hexane washes. Samples are evaporated to dryness and reconstituted. 
They are then filtered before injection. The method detection limits of CAP ranged 
from 0.2 to 0.6 μg kg-1for the various matrices. Rocha Siqueira et al., 2005 developed 
a LC-ESI-MS/MS method for determining chloramphenicol residues in fish, shrimp, 
poultry, eggs, bovine and swine samples. The samples were extracted with a 
phosphate extraction solution followed by liquid-liquid extraction with ethyl acetate. 
The LOQ of the method was 0.1 μg kg-1. Finally a method was presented by Vinci et 
al., 2005. CAP was extracted in acetonitrile and after liquid-liquid partitioning with 
n-hexane is identified and quantitatively determined by ion trap liquid 
chromatography/electrospray ionisation tandem mass spectrometry (LC/ESI-
MS/MS) analysis in the negative ionisation mode. The CCα and CCβ of the method 
were 0.15 and 0.22 μg kg-1 respectively. 
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2.4.3.2.Multi-Analyte Methods including Chloramphenicol Analysis 
While the majority of methods published on the analysis of CAP are single analyte 
methods there are a number of multi-amphenicol methods published. Xie et al., 2006 
published a method for the determination of chloramphenicol, thiamphenicol and 
florfenicol residues in original animal food by HPLC-ESI-MS/MS. The samples 
were extracted with basified ethyl acetate and cleaned up with C18 column. The 
detection limit of the method was 0.1 μg/kg. Shen et al., 2009 developed a method 
capable of analysing for CAP, thiamphenicol (TAP), florfenicol (FF), and florfenicol 
amine (FFA) in poultry and porcine muscle and liver. Extraction was with ethyl 
acetate. The organic extracts were frozen to remove lipid and further purified by 
liquid-liquid extraction (LLE) with hexane and SPE using Oasis HLB cartridges. The 
target compounds were derivatized with BSTFA + 1% TMCS prior to GC-NCI/MS 
determination. A LOD of 0.1 μg/kg for CAP was obtained. Zhang et al., 2008 
published a LC-ESI-MS/MS method for the determination of CAP, TAP, FF and 
FFA in chicken muscle. Samples were extracted with basified ethyl acetate, defatted 
with hexane, and cleaned up on Oasis MCX cartridges. LOD was 0.1 μg/kg for CAP. 
Wang et al., 2007 presented a method for simultaneous determination of residues of 
CAP, TAP and FF in royal jelly by using LC-MS/MS. After a preliminary 
homogenization of honey with water, samples were extracted with ethyl acetate, and 
evaporated to dryness, reconstituted in phosphate buffer solution followed by clean 
up on a C18 SPE cartridge. The method was capable of analysing for CAP at 0.1 μg 
kg-1.  
Apart from these multi-amphenicol methods there are a few multi-class methods 
which include the analysis of CAP.  Sheridan et al., 2008 developed a method for the 
analysis of 14 sulfonamide antibiotics and chloramphenicol in honey by liquid 
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chromatography-electrospray ionization-tandem mass spectrometry in negative mode 
for all 15 analytes. The method describes the use of an acid hydrolysis step to 
liberate the sugar-bound sulphonamides followed by a SPE method using Oasis HLB 
to remove potential interferences. The method had a limit of detection of 0.2 µg kg-1 
for CAP. Hormazabal et al., 2001 developed a method for determination of 
chloramphenicol and ketoprofen in meat and milk. The samples were extracted with 
acetonitrile, the organic layer was separated from water with CHCl3, evaporated to 
dryness and then purified using Bond Elut SPE columns. The limit of detection for 
CAP was 1 μg L-1.  
Upon examining these published articles it was felt that incorporating the analysis of 
CAP with the analysis of nitroimidazoles would be beneficial. As CAP is often 
analysed on its own with the use of intensive extraction protocols the economic 
impact on the laboratory is significant. Therefore it’s incorporation with 
nitroimidazole analysis greatly reduces labour hours, solvent usage and increases 
instrument capabilities, which greatly benefits the monitoring laboratory. Taking this 
into consideration methods were developed to allow for the analysis of both 
nitroimidazole and chloramphenicol residues in milk and honey.  
 
2.4.4. Extraction Methods and Purification Methodologies for Veterinary Medicinal 
Additives in Animal Feed 
An overall search of published literature on the analysis of veterinary products as 
feed additives shows that there are a limited number of methods available to analyse 
for them. In many cases there is only single analyte or at best single class methods 
available. Investigation into these methods shows that there is a wide variety of 
extraction and purification methods involved in their analysis. As the legislation is 
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divided into two lists, the published methods will be discussed under these two sets 
of compounds. The first will be methods for the analysis of prohibited medicinal 
additives and the second will be methods for the analysis of coccidiostats which are 
still permitted for use as feed additives. 
  
2.4.4.1.Prohibited Medicinal Feed Additives 
Table 2-11: Overview of methods used for the analysis of prohibited feed additives as discussed 
in section 2.4.4.1 
56 
Reference
Class of 
Compounds 
Analysed
Matrix Extraction Method Measurement Technique
LOD    
(mg kg-1)
Barbosa 2007;   
Vinas 2007;       
Wang 2006
Nitrofurans Feed Organic solvent extraction followed by SPE clean-up LC-MS, HPLC-DAD <0.01
Caballero 2002; 
Houglum 1997 Tetracyclines Feed
Organic solvent extraction followed by SPE 
clean-up HPLC-UV <0.10
Capitan-Vallvey 2007 Nitromidizoles Feed Extraction with phosphate buffer solution (pH = 2); Clean-up on HLB SPE cartridges LC-MS 0.05
Civitareale 2004 Antibacterial Growth Promoters Feed
Extraction with methanol; Clean-up on CN SPE 
cartridges HPLC-UV/DAD <1.00
Dousa 2000; 
Tollomelli 1992; 
Ramos 1991
Nitromidizoles Feed Organic solvent extraction followed by SPE clean-up HPLC-UV 1.00
Dusi 2000 Nicarbazine and Clopidol Feed
Extraction with DMF; Clean-up on Alumina-
basic SPE cartridge HPLC-UV 1.00-2.50
Gramse 2004 Tylosin Feed Extraction with methanol; Clean-up on C18 SPE cartridges HPLC-UV 0.22
Hajee 2001 Virginiamycin Feed Extraction with Ethyl Acetate; Clean-up on Sep-Pak Silica Gel and HLB SPE cartridges LC-UV, LC-MS 2.70
Higgins 2002 Tylosin and Virginiamycin Feed
Extraction by ASE using 65% aqueous acetone 
(pH = 2) ELISA 10.00
Hormazabal 2002
AGPs and 
Ionophore 
Coccidiostats
Feed
Samples homogenised with 
methanol/acetone/THF; Samples mixed with 
water and centrifuged; Supernatant diluted and 
filtered through Spin-X microcentrifuge tube
LC-MS 1.50-2.50
Kesiunaite 2008 Antibacterial Growth Promoters Feed
Extraction using matrix solid phase dispersion 
(MSPD) HILIC-UHPLC-DAD 0.10
Qin 2005 Sulphonamides Feed Organic solvent extraction followed by SPE clean-up; Dilution before injection LC-MS/MS <0.02
Situ 2006 Antibacterial Growth Promoters Feed
Analysis using Enzyme-linked Immuno-sorbant 
Assay (ELISA) Kit ELISA 1.00-4.00
Squadrone 2008 Amprolium Feed
Extraction with methanol/water (80:20 v/v); 
Extract filtered (filter paper 90g/m2); Filtrate 
diluted with mobile phase before injection
LC-MS 0.20
Van Poucke 2003; 
2005; 2006
Antibacterial 
Growth Promoters Feed
Extraction with methanol/water (7:3 v/v); 
Extract diluted before clean-up on HLB SPE 
cartridges
LC-MS <1.00
Vinas 2006 Chloramphenicol Feed Samples mixed with water; 2 LLE with Ethyl Acetate; Clean-up on SPE cartridge LC-DAD 0.70
Wu 2009 Antibacterial Growth Promoters Feed
Extraction with ACN/water (60:40 v/v); Clean-
up on HLB SPE cartridges LC-MS/MS <0.02  
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As discussed previously NMZs and CAP are banned for use in food producing 
animals and therefore are also prohibited for use as feed additives. While there are 
numerous methods for the analysis of these compounds in biological matrices there 
are only a few methods developed which allow for their analysis in animal feed. The 
majority of methods that are used for the analysis of nitroimidazoles in feed are 
HPLC-UV methods with the use of SPE purification for the analysis of, at most, 
three analytes [Dousa, 2000; Tollomelli et al., 1992; Ramos et al., 1991]. Although 
one method is published which includes the analysis of six analytes by LC-MS, 
Capitan-Vallvey et al., 2007 presented a method that allowed for the analysis of 
metronidazole, ronidazole, dimetridazole, secnidazole, tinidazole and ipronidazole in 
feedstuff. The 5-nitroimidazoles were extracted from animal feed with a pH 2 
phosphate buffer solution followed by a SPE based on HLB cartridges. The method 
was applied successfully to determine 5-nitroimidazoles in feedstuff at level of 0.05 
mg kg−1. For analysis of CAP only two methods could be found in feed. One of these 
methods published by Vinas et al., 2006 allows for the determination of CAP 
residues in animal feeds by liquid chromatography with photo-diode array detection. 
Feed was mixed with water and then underwent two liquid-liquid extractions (LLE) 
with ethyl acetate. Purification was performed using a Discovery DSC-18Lt SPE 
cartridge. LOD using the proposed procedure was 0.7 μg kg−1.  
Another set of antibiotic compounds prohibited for use in food producing animals are 
nitrofurans and in turn are banned for use as feed additives. From examination of 
literature there are three papers published for their analysis in feed. These methods 
analyse for a number of nitrofuran analytes by either LC-MS or HPLC-DAD with 
purification usually in the form of SPE [Barbosa et al., 2007; Vinas et al., 2007; 
Wang et al., 2006]. 
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Compounds such as sulphonamides and tetracyclines are now prohibited for use as 
feed additives although they are still permitted for use in medicated feed. While there 
are numerous methods for the analysis of both of these class of compounds in 
biological matrices [Shen et al., 2010; Carretero et al., 2008;  Soto-Chinchilla et al., 
2007; Sergi et al., 2007 Shao et al., 2007] there are very few methods for their 
analysis in animal feed. Qin et al., 2005 developed a method for the qualification and 
quantification of 10 sulfonamides in animal feedstuff by LC-MS/MS. Samples were 
solvent extracted, purified using SPE and diluted before injection. The LOQs for the 
10 sulphonamides ranged from 0.5 - 2.0 μg/kg. In the case of tetracyclines there are 
no MS methods published that are capable of analysing animal feed although some 
chromatography methods are available [Caballero et al., 2002; Houglum et al., 
1997]. 
The rest of the compounds in the prohibited feed additives list could be classified 
under the broad title of antibacterial growth promoters (AGPs). This list includes 
compounds such as tylosin, virginiamycin, avilamycin, spiramycin, zinc bacitracin, 
olaquindox, carbadox, aprinocid, methyclorpindol (Clopidol), dinitolimide 
amprolium and ethopabate. The analysis of some of these compounds in feed has in 
some cases not been published before whereas some analytes have been investigated 
as part of collaborative European wide studies. 
A number of journal papers have been published as a result of the EC funded 
Feedstuffs-RADIUS project. This was a study in particular into the analysis of AGPs 
in animal feed. Situ et al., 2006 published a method for the screening of zinc 
bacitracin, spiramycin, tylosin, virginiamycin and olaquindox in animal feedstuffs by 
the use of an enzyme-linked immuno-sorbent assay (ELISA) kit. The detection limits 
for the developed immunoassays were to detect concentrations of 4 mg kg-1, or more, 
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of olaquindox and 1 mg kg-1 or more of the other compounds. A number of papers 
have been published by van Poucke et al., 2003, 2005, 2006 on the area of AGPs 
analysis in animal feed by LC-MS. Some of these research papers were also funded 
by the Feedstuffs-RADIUS project. The three papers use the same method as a 
starting point with small alterations and are for the analysis of zinc bacitracin, 
spiramycin, tylosin, virginiamycin and olaquindox. Feed was extracted with 10 ml of 
methanol/water (7:3 v/v), and 3 ml of this extract was purified on an OASIS HLB 
column after dilution with 27 ml of water. The detection capability of the method for 
all compounds was <1 mg kg-1. 
Apart from van Pouke et al., there are very few confirmatory methods for the 
analysis of AGPs in feed. Some of these methods are capable of seeing low levels of 
analyte but some are in the ppm range. Wu et al., 2009 developed a method by LC-
MS/MS for the simultaneous determination of carbadox, olaquindox, mequindox and 
quinocetone in swine feed. The analytes were extracted from the feed with 
acetonitrile/water (60:40, v/v), and then further purified by solid-phase extraction 
using Oasis HLB cartridges. The LOQs for the four compounds were <20 μg kg−1. 
Squadrone et al., 2008 published a LC-MS method which was able to detect 
amprolium in chicken feed. The samples were extracted with 100 mL 
methanol/water 80/20 (v/v) and blended for 60 min. An aliquot of these extracts was 
filtered on paper filter (90 g m−2, 250 mm) and collected into a 50 mL flask. These 
filtrates were diluted 1:10 with initial mobile phase and filtered before injection. 
LOQ of the method was 0.2 mg kg−1. Hormazabal et al., 2002 developed a method 
for the determination of amprolium (AMP), ethopabate (ETB), lasalocid (LAS), 
monensin (MON), narasin (NAR) and salinomycin (SAL) in feed by LC-MS. Feed 
samples were homogenized with methanol-acetone-tetrahydrofuran. After addition of 
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water, the samples were mixed and centrifuged. The compact bottom layer was re-
extracted with methanol-water. After centrifugation, the combined supernatants were 
diluted and filtered through a Spin-X micro-centrifuge tube. Three separate LC 
method were needed using three different columns in order to analyse for all 
analytes. The limits of detection were close to 2 mg kg−1 for AMP, LAS, MON, and 
NAR, 1.5 mg kg−1 for ETB, and 2.5 mg kg−1 for SAL in chicken feed. Hajee et al., 
2001 published a method for the detection of virginiamycin at sub-additive level in 
pig, calf, piglet, sow, poultry, cattle and laying hen feeds by LC-UV/LC-MS. 
Virginiamycin was extracted from animal feeds with ethyl acetate after wetting of 
the feed with water followed by clean-up on Sep-Pak silica gel and OASIS HLB 
cartridges. The LOQ of the method was 2.7 mg kg−1. 
The rest of the published methods dealing with the analysis of AGPs in animal feed 
are screening methods using chromatography or immunoassay techniques. Dusi et 
al., 2000 described a method for the determination of nicarbazin and clopidol in 
poultry feeds by LC. Ground feed samples were extracted using aqueous 
dimethylformamide (DMF) after mixing with water. Co-extracted feed constituents 
were removed with a solid-phase extraction on alumina-basic columns and the 
eluates were directly analysed. LOD for nicarbazin and clopidol were 1 mg kg−1 and 
2.5 mg kg−1 respectively. Kesiunaite et al., 2008 developed a method involving 
matrix solid-phase dispersion (MSPD) extraction and hydrophilic interaction ultra-
high-pressure liquid chromatography (HILIC-UHPLC) with photodiode array 
detection for the determination of carbadox and olaquindox in feed. Feed sample and 
0.5 g of C18 sorbent were placed into an agate mortar and gently blended for about 2 
min using a pestle and mortar to obtain a homogeneous mixture. The blend was then 
transferred into a 15 mL syringe with a frit on the bottom and a second frit was 
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placed over the dispersed sample with slight compression. The analytes were eluted 
from the cartridge with 10 mL of acetonitrile–methanol mixture (8:2, v/v) applying 
slight vacuum. This was then evaporated, reconstituted and filtered before injection. 
The method could analyse levels of 0.1 mg kg-1for olaquindox and carbadox. 
Civitareale et al., 2004 developed a method for the analysis of tylosin and spiramycin 
by HPLC-UV/DAD. After methanolic extraction, samples were cleaned up on SPE 
CN columns before analysis. Detection limits for the method were 176 and 118 μg 
kg-1 for spiramycin and tylosin respectively. Gramse et al., 2004 published a method 
for the determination of tylosin in feeds. The method involves extraction of tylosin 
with methanol, concentration under a stream of nitrogen, and cleanup using C18 SPE 
cartridge followed by analysis using HPLC-UV. The limit of detection and 
quantitation of the method was 0.216 and 0.720 mg kg-1 respectively. Higgins et al., 
2002 developed a method for the screening of avoparcin, bacitracin zinc, spiramycin, 
tylosin and virginiamycin by immunoassay. Extraction of analytes from 5g portions 
of test samples was performed by use of a Dionex ASE200 accelerated solvent 
extraction system with use of 65% aqueous acetone (adjusted to pH 2 by addition of 
12 ml of 1M-HCl per litre of solvent). All compounds could be screened at levels 
less than 10mg/kg. 
It is quite clear from the published articles that there is no single method available to 
analyse for a broad range of these prohibited medicinal additives in animal feed. This 
is probably because legislation pertaining to these compounds in feed is relatively 
new and the range of compounds incorporated is quite diverse. Therefore it is 
anticipated the application of a generic extraction and purification protocol will allow 
an increased amount of analytes to be analysed in a single run, therefore increasing 
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the analytical capabilities of the laboratory and in doing so increase the likelihood of 
finding possible breaches of this legislation.     
 
2.4.4.2.Coccidiostats 
Table 2-9: Overview of methods used for the analysis of coccidiostats in feed as discussed in 
section 2.4.4.2 
Reference
No. of 
compounds 
analysed
Matrix Extraction Method Measurement Technique
LOD       
(mg kg-1)
Campbell 2006 3 Feed Extraction with methanol and water (9:1 v/v); Samples shaken and diluted before injection LC-UV 1.00
Delahaut 2010 11 Feed
Extraction with 10% Na2CO3solution and ACN; Samples 
agitated before centrifugation; Samples extracted a 
second time with ACN; Both organic extracts combined; 
An aliquot of extract evaportated and reconstituted before 
injection
LC-MS/MS
1% 
unavoidable 
carryover
Ebel 2004 2 Feed
Extraction with methanol; Samples filtered and de-fatted 
with hexane; Samples concentrated by evaporation 
before injection
LC-MS <1.00
Focht 2008 1 Feed
Extraction with 0.5% HCl acidified methanol; Samples 
sonicated and shaken; Samples diluted amd filtered 
before injection
LC-FD 1.00
Hormazabal 2005 4 Feed
Samples homogenised with methanol/acetone/DHF; 
Samples mixed and centrifuged; After centrifugation 
supernatant was extracted with hexane; Evaporated to 
dryness and re-constituted in ACN and water; Filtered 
through Spin-X microcentrifuge tube before injection
LC-MS 0.20-0.60
Jong 2004 (a) 1 Feed Extraction with ACN and methanol (1:1) LC-UV <20.00
Jong 2004 (b) 1 Feed Extraction with methanol LC-UV 2.00
Kot-Wasik 2005 1 Feed Extraction with acidified methanol by ASE; Clean-up on Aluminium Oxide cartridges HPLC-UV / LC-MS 0.02
Krabel 2000 1 Feed Extraction with ACN and water (4:1 v/v); Filtered before injection LC-UV 0.25
Mortier 2005 (a) 1 Feed Extraction with methanol LC-MS/MS <0.01
Mortier 2005 (b) 6 Feed Extraction with methanol LC-MS/MS <0.01
Sanchez 2008 1 Feed
Extraction with 1% Calcium Chloride in methanol solution 
using mechanical agitation; Samples centrifused and 
diluted; Filtered before injection
LC-FD 1.00
Thalmann 2004 1 Feed Extraction with methanol and phosphate solution (9:1 v/v) LC-UV <20.00
Turnipseed 2001 4 Feed Extraction with hexane and ethyl acetate; Clean-up on silica SPE cartridge LC-MS 1.00-50.00
Vincent 2008 6 Feed
Extraction with methanol and water (9:1 v/v); Aliquot of 
extract cleaned-up on IST Isolute SPE cartridge before 
analysis
LC-MS/MS 0.01
Vincent 2011 6 Feed Extraction with ACN; Samples sonicated and agitated before centrifugation; Quantification by Standard Addition LC-MS/MS
1% 
unavoidable 
carryover
Wang 2000 2 Feed
Extraction with ACN; mixed for 1hr and then filtered; 
Clean-up on C18 SPE cartridge; Eluate diluted before 
analysis
MALDI-TOF-MS 2.40
  
The majority of methods published for the analysis of coccidiostats in animal feed 
are for the analysis of single analytes by LC-UV. These include a number of papers 
that validate LC methods as part of collaborative studies. These collaborative studies 
include the following methods. Sanchez et al., 2008 developed a method for the 
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analysis of decoquinate in supplements, premixes, and complete animal feeds (i.e 
feed ready for use) at medicating and trace levels. Decoquinate was extracted from 
feed previously ground to homongeniety with 1% calcium chloride-methanol 
solution using mechanical agitation for 90 min. After centrifugation for 5 min and 
dilution of medicated levels (if necessary) into an acceptable analytical range. The 
diluted extracts are filtered and analyzed by reversed-phase LC with fluorescence 
detection and is capable of analysing to levels of 1 mg kg−1. Focht, 2008 developed a 
LC method for the analysis of lasalocid in medicated premixes and complete animal 
feeds and at trace-level in feeds. The method employs a 0.5% HCl acidified methanol 
extraction followed by 20 min sonication in a water bath heated to 40°C. Samples are 
then shaken on a mechanical shaker for 1 h and stored overnight, followed by an 
additional 10 min shaking the following morning. Sample extracts are diluted if 
necessary with extractant, filtered, and injected onto an LC with fluorescence 
detection and is capable of analysing to levels of 1 mg kg−1.. 
Other single analyte LC methods include two methods published by de Jong et al., 
2004 (a); Jong et al., 2004 (b) describing the analysis of nicarbazin in broiler feeds 
and premixtures and maduramicin in feedingstuffs and premixtures at medicated 
levels. The extraction solvent was an acetonitrile-methanol (1:1) mixture for 
nicarbazin and was just methanol for maduramicin.  Analysis was performed on LC-
UV instrument and the LOD was <20 mg kg−1 for nicarbazin and 2 mg kg−1 for 
maduramicin. Kot-Wasik et al., 2005 published an analytical procedure for the 
determination of robenidine in animal feeds. Robenidine was extracted from samples 
with acidified methanol using ASE. Extracts were dried and subjected to clean-up 
with aluminium oxide cartridges. Analysis was performed by HPLC coupled to DAD 
UV and MS. LOQ was determined to me 0.1 and 0.02 mg kg−1 for DAD-UV and MS 
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detection, respectively. Thalmann et al., 2004 developed a reversed-phase LC 
method for the analysis of narasin in feedingstuffs and premixtures. The extraction 
solvent was methanol-K2HPO4 solution (9:1, v/v). Narasin was detected at 600 nm 
after post column derivatization with dimethylamino-benzaldehyde. The LOD was 
found to be <20 mg kg−1. Krabel et al., 2000 developed a method for the analysis of 
nicarbazin in animal feed. Feed is extracted with 200 ml acetonitrile/H2O (4:1, v/v). 
An aliquot of the extract is filtered before analysis by LC-UV. The method has a 
LOD of 250 μg kg-1 and a LOQ of 500 μg kg-1.  
Some LC-UV methods are capable of analysing for more analytes. Campbell et al., 
2006 published a method for the analysis of monensin, narasin, and salinomycin in 
mineral premixes, supplements, and complete animal feeds at medicating and trace 
levels. The method uses methanol-water (9:1, v/v) extraction with mechanical 
shaking for 1 h, filtration, and dilution if necessary. Determination of the 3 
ionophores is by reversed-phase LC using post-column derivatization with vanillin 
and detection at 520 nm.  That said, the majority of multi analyte methods use LC-
MS as the instrument of analysis. Hormazabal et al., 2005 described a LC-MS 
method for the determination of lasalocid, monensin, narasin and salinomycin in 
feed. Samples were homogenized with methanol-acetone-tetrahydrofuran. The 
samples were mixed and centrifuged. After centrifugation, 100 μL supernatant was 
extracted with hexane, evaporated to dryness, diluted with acetonitrile-water, filtered 
through a Spin-X micro-centrifuge tube, and injected into the LC/MS. The LOQ of 
the method for all the analytes ranged from 0.2 to 0.6 mg kg−1. Turnipseed et al., 
2001 published a LC-MS method for the analysis of monensin, lasalocid, 
salinomycin, and narasin. The drugs were extracted from the feed matrix using 
hexane-ethyl acetate and isolated using a silica solid-phase extraction cartridge. 
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These ionophores were confirmed in both medicated feeds and non medicated feeds 
fortified with these drugs at the 1-50 mg kg−1 level. Ebel et al., 2004 published a 
method on the LC-MS analysis of monensin and lasalocid in feed samples. The 
samples were extracted with methanol. The extracts were filtered and then defatted 
with hexane. These were concentrated up by evaporation before injection. The 
method was capable of detecting compounds below 1 mg kg−1. While Wang et al., 
2000 published a method for the analysis of salinomycin and narasin in poultry feed 
using MALDI-TOF MS. Ground feed samples were extracted with 10 ml acetonitrile 
for 1 h and the mixture was filtered. The filtrate was applied to a C18 SPE cartridge. 
The eluate was diluted before analysis. The LOD for both analytes was 2.4 mg kg−1. 
With the publication of European legislation Regulation 2009/8/EC laying down 
levels of unavoidable carry over for eleven coccidiostats in non target feed there is a 
need for confirmatory methods for the quantitation of these analytes at various levels 
in feed. LC-MS/MS offers a useful tool in the effort to ensure this legislation is 
enforced. Previous methods for the analysis of some of these compounds in feed 
show that LC-MS/MS is capable of confirming analytes at levels related to 
unavoidable carry over. Mortier et al., 2005 (a) published a LC-MS/MS method for 
the detection of the coccidiostat diclazuril in poultry meat and feed. Feed samples are 
extracted with methanol. A portion of the extract is evaporated to dryness and then 
reconstituted in mobile phase. The samples are then filtered before injection onto the 
LC-MS/MS. Mortier et al., 2005 (b) published another method using the same 
extraction protocol for the quantitative detection of the chemical coccidiostats 
halofuginone, robenidine, diclazuril, nicarbazin and dimetridazole and its main 
metabolite 2-hydroxydimetridazole in poultry eggs and feed. CCα and CCβ of the 
method were no higher than 10.7 and 14.5 μg kg-1 respectively for all analytes in 
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feed. While Vincent et al., 2008 developed a LC-MS/MS method for the analysis of 
monensin, salinomycin, narasin, lasalocid, semduramicin and maduramicin in animal 
feed. Samples were extracted with 100 ml of a MeOH: H2O mixture (90:10, v: v) for 
60 min by agitation. 5ml of the extract was purified on IST Isolute cartridge before 
analysis. The LOD and LOQ of the method were different for various analyte/matrix 
combinations but were in all cases below 0.014 and 0.046 mg kg−1. 
More recently two papers have been published with the objective of analysing feed at 
levels relating to unavoidable carryover as stated in Regulation 2009/8/EC (Table 
2.4). One of these methods published by Vincent et al., 2011 was capabable of 
analysing for the six ionophore coccidiostats listed in the legislation. 5g of feed is 
extracted with 40ml of ACN. The mixture was then placed in an ultrasonic bath for 
30 mins and this was followed by a head to head agitation for 60mins. The sample is 
centrifuged and seven 2ml aliquots are taken and used for analysis by utilising a 
standard addition approach. The method was validated and is capable of analysing 
the six compounds at levels relating to 1% and 3% unavoidable carry over values as 
stated in legislation.  
The only method to include the analysis of feed for all 11 coccidiostats in a single 
method is one published by Delahaut et al., 2010. Feed samples were extracted with 
a 10% Na2CO3 solution (w/v) and acetonitrile. The samples were shaken for 30 min 
on a mechanical agitator and then centrifuged. The supernatant was transferred into a 
tube and extraction with acetonitrile was repeated a second time and both organic 
extracts were combined. Finally, 1ml of acetonitrile extract was transferred into a 
tube and evaporated to dryness under nitrogen in a heated water bath. The sample 
was re-dissolved in 1ml acetonitrile/water mixture (80:20, v/v) before analysis by 
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LC-MS/MS. The method was validated using the levels permitted in feed of non 
target animals as stated in 2009/8/EC. 
After investigation of the published literature it is apparent that there are very few 
methods available that can be applied in order to enforce Commission Regulation 
2009/8/EC. To date only two methods have been published with the specific aim to 
analyse for these compounds at levels related to unavoidable carryover into non 
target feed. The similarities between the methods are that both use acetonitrile as the 
extraction solution because its polarity is the most suitable for the extraction of these 
compounds. It is also clear that dilution of sample extract rather that concentration 
results in improved repeatability of the methods due to the fact that the 
concentrations of the ionophore coccidiostats is above the analytical range of many 
mass spectrometers and also the matrix of feed is complex and dilution results in 
reduced interference from the matrix. Using these two papers as a starting point it is 
hoped that a method for the analysis of all eleven coccidiostat compounds can be 
developed for use in the analysis of the different feeds that are encountered in the 
laboratory on a routine basis.      
 
2.5. LC-MS/MS 
2.5.1. Introduction to Mass Spectrometry 
After World War II, mass spectrometry began to have a broad application in 
chemistry and in particular organic chemistry. By the early 1950’s there were a 
number of US companies building magnetic sector mass spectrometers. However it 
wasn’t until the mid 1960’s and the combination of gas chromatography with mass 
spectrometry did the use of mass spectrometry in the analysis of compounds become 
more prominent. The further development of GC-MS resulted in it becoming an 
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indispensable tool in a number of areas such as environmental, medical, food and 
flavour industries and also in forensics [Watson et al. 2009]. Its development 
continued from these early instruments into the extremely sensitive and selective 
instruments that are available today.  
A definition of a mass spectrometer published by Price, 1991 is an instrument in 
which ions are analyzed according to their mass-to-charge ratio, and in which the 
number of ions is determined electrically. For the most part, there are four basic 
components that are standard in all mass spectrometers (Figure 2-6). These are; a 
sample inlet, an ionization source, a mass analyzer and an ion detector. Although 
there are many variation of mass spectrometers the process by which all sample 
molecules are analysed is similar regardless of instrument configuration. Sample 
molecules are introduced into the instrument through a sample inlet. Once inside the 
instrument, the sample molecules are converted to ions in the ionization source, 
before being electrostatically propelled into the mass analyzer. Ions are then 
separated according to their m/z within the mass analyzer. The detector converts the 
ion energy into electrical signals, which are then transmitted to a computer. 
 
 
 
Figure 2-6: Basis components of a mass spectrometer 
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2.5.2. Instrument Selection LC-MS versus GC-MS 
Upon commencing this research a decision needed to be made on what instrumental 
technique would result in improved methods for the analysis of pharmaceutical 
compounds in a variety of animal and feed matrices. According to CD 2002/657/EC 
there are only a number of instruments that can be used for the confirmatory analysis 
of veterinary residues in food matrices. The most commonly available of these is 
mass spectrometry. Therefore the majority of methods published in this area either 
use GC-MSn or LC-MSn for confirmatory analysis. Historically GC-MS was the 
most commonly used analytical instrument. This was as a result of GC-MS being a 
more mature technology, being less expensive and having an extensive list of 
established and approved operational protocols. However with improvements in the 
manufacture of LC-MS systems and increased research on there use, LC-MS is fast 
becoming the instrument of choice for analysis of veterinary residues in food 
matrices. The main reason for this is that liquid chromatography offers tremendous 
potential for analyzing non-volatile, polarized and ionized materials with reduced 
sample purification, extraction and more importantly there is no need for 
derivatisation. 
For analysis by GC-MS, compounds need to be both volatile at the temperature 
needed for separation and also thermally stable. As a result, analysis by GC–MS, in 
many cases requires derivatization of the analytes in veterinary residue analysis. This 
is carried out by a number of processes such as silylation, acylation or 
oxime/silylation depending on the individual properties of the compounds to be 
analysed. However this can cause problems and this is seen in the case of 
nitroimidazoles where derivatisation results in the same trimethylsilylether product 
formed from the derivatisation of RNZ and HMMNI with BSA [Polzer et al., 2001]. 
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This is as a result of the breaking up of carbamoyloxymethyl group of RNZ during 
derivatisation. For this reason, a distinction between RNZ and HMMNI, which is the 
metabolite of DMZ and RNZ, cannot be made with the use of GC-MS. In addition to 
this a number of nitroimidazoles such as IPZ are not derivatisable with BSA [Polzer 
et al., 2001]. 
The derivatisation process increases sample preparation times and in the case of 
nitroimidazoles does not allow for the analysis of all compounds. However in some 
cases GC-MS is a more specific and sensitive technique. This is due to the fact that 
gas chromatography and mass spectrometry are compatible because analytes need to 
be in the gas phase in order to be analysed by mass spectrometry. This gives GC-MS 
an advantage in terms of sensitivity over LC-MS in the analysis of some veterinary 
residues. The majority of the analyte which passes through the GC column will enter 
the mass spectrometer and be analysed. This is not the case with LC-MS as the 
combination of liquid chromatography and mass spectrometry is not as compatible as 
with GC which results in the large amount of analyte being lost when the sample is 
converted from liquid to gas phase ions. To allow for the use of this hyphenated 
technique the use of an interface is required. The primary purpose of this interface is 
the removal of the mobile phase and this results in the loss of analyte and a reduced 
amount ionised analyte reaching the mass analyzer. The types of interfaces and 
ionisation utilised in LC-MS are discussed further in the next section 2.5.3. 
Taking this information into consideration, the most suitable instrument for use in 
multi residue methods is LC-MS. The reason for this is that unlike GC-MS it can be 
used for the analysis of all non volatile compounds without the need for 
derivatisation. This results in increased analytical capability as more analytes can be 
analysed for in single runs. Any problems with derivatisation are overcome by its 
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omission and as a result would allow all nitroimidazole residues to be analysed and 
distinguishable from each other. In the case of the feed methods it was felt that the 
only option for analysis was by LC-MS as the number and diversity of the 
compounds that needed to be incorporated into the method would not be achievable 
using GC-MS due to problems with derivatising all analytes with a single 
derivatising agent. 
   
 
2.5.3. Liquid Chromatography to Mass Spectrometry: Interfaces and Ionisation 
Techniques 
As mentioned previously the main obstacle in the development of the hyphenated 
technique LC-MS was the converting the analyte in the mobile phase to gas phase 
ions in order for them to be analysed by the MS. This resulted in the need for an 
interface linking the two techniques. This interface works at atmospheric pressure 
and allows for the liquid to be changed into gas phase and also ionises the analyte. 
This interface type is known as atmospheric pressure ionisation (API) interface. 
There are many different designs of this interface but an example of one can be seen 
in Figure 2-7.  
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 Figure 2-7. Diagram of API interface 
 
Although ionisation is carried out at atmospheric pressure there are numerous 
different ionisation techniques that may be used with LC-MS. The most common 
ones used in veterinary residue analysis are electrospray ionization (ESI), 
atmospheric pressure chemical ionization (APCI) and atmospheric pressure photo 
ionization (APPI). From examination of Figure 2-8 it is clear that ESI works best 
over a broader range of different analytes. Compounds with higher polarity and 
molecular weights can only be analysed by ESI. Therefore it was decided that ESI 
was the best ionisation technique in this research as it was applicable to all the 
compounds that were to be analysed. 
 
Figure 2-8. Portrayal of various ionization techniques such as ESI, APCI, and APPI as a 
function of compound polarity and molecular weight. 
 
ESI is generally accomplished by forcing the LC mobile phase containing the analyte 
through a small capillary into an electric field of high positive or negative electrical 
potential typically of the order of 3-5 kV depending on whether positive ionization 
(higher voltages) or negative ionization (lower voltages) is required. (Figure 2-9). 
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Analyser 
(10-4/10-5 mbar) 
(Source http://www.astbury.leeds.ac.uk/facil/MStut/mstutorial.htm) 
Figure 2-9. Components of an ESI interface  
 
When the solution reaches the end of the tube the strong electric field forces it to be 
nebulized into a spray of small highly charged droplets of solution in solvent vapour. 
Before entering the mass spectrometer the spray passes through a heated chamber, 
through which a flow of drying gas, typically air or nitrogen, is continually passed at 
high flow rates evaporating the solvent rapidly. Thus as the charged droplets get 
smaller, the electrical surface charge density increases until it reaches a point where 
the repulsive forces between charges of the same polarity at the surface of the droplet 
are greater than the cohesive forces of surface tension which hold the droplet 
together. This results in a “Coulombic explosion” (Figure 2-10), which produces a 
number of smaller droplets and this continues until charged analyte ions are formed 
which can be analysed by the mass spectrometer.  
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(Source http://www.bris.ac.uk/nerclsmsf/techniques/hplcms.html) 
Figure 2-10. A simplified mechanism of ion formation in the electrospray ionization process. 
 
2.5.4. LC-MS and Ion Suppression 
While the advantages of LC-MS are in its capability to analyse for a very broad 
range of analytes with reduced sample purification and without the need for 
derivatisation, it is not without its own adverse aspects and limitations. Its main 
pitfall is a phenomenon known as ion suppression which occurs as a result of the 
presence of high concentrations of background matrix components. These 
components are primarily made up of endogenous substances for example organic or 
inorganic molecules present in the sample and that remain in the final extract; while 
other causes may be exogenous substances, i.e. molecules not present in the sample 
but may enter from various external sources during the sample preparation [Antignac 
et al., 2005].  
These matrix components can result in ion suppression by a number of mechanisms 
[Antignac et al., 2005]. These mechanisms include; 
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 Decrease in evaporation efficiency due to the presence of matrix which results 
in increased viscosity and surface tension of droplets produced by ESI or APCI 
 Co-precipitation of analytes with non volatile material such as macromolecules 
can also reduce their transfer into gas phase. 
 Competition between analytes and interfering components for ionization 
 Matrix can cause analytes to be basic in the gas phase and result in instability of 
analyte ions produced. This can result in neutralization processes which can 
affect analyte response. 
These processes can all contribute to the occurrence of ion suppression which have 
consequences for results acquired in LC-MS. These consequences are; 
 The detection capability is reduced due to the decrease of the analyte signal. 
 The repeatability is also affected, because the degree of suppression may vary 
greatly from one sample to another.  
 Ion ratio, linearity, and quantification, are also affected due to the variability of 
this unpredictable phenomenon.  
 Ion suppression may lead to existing analytes to go undetected, to the 
underestimation of its real concentration or to the unsatisfactory results for 
identification criteria, with immediate consequences in terms of false negative 
(compliant) results.  
 Finally if affecting the internal standard rather than the analyte, ion suppression 
may also lead sometimes to an overestimation of the analyte concentration with 
increased risk of false positive (non-compliant) results for maximum residue 
limit (MRL) compounds.  
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Therefore to avoid these consequences it is critical to always take ion suppression 
into consideration when developing a LC-MS method. There are a number of 
approaches that can be looked at in order to overcome these possible pitfalls 
[Antignac et al., 2005]. These include; 
 Modifying the mass spectrometric conditions if possible. This can be done by 
altering ionization technique as (ESI, APCI, APPI) as ion suppression may 
differ between different ionization techniques. Alternatively different ionization 
modes (positive or negative), or equipments with different source design can 
also reduce affect of ion suppression. Finding this type of solution is 
advantageous because it does not require any change in the rest of the developed 
analytical procedure (sample preparation and chromatographic condition)  
 Another solution to overcome this problem is to use adequate internal standard, 
in order to balance the disturbance of the analyte signal by an equivalent 
disturbance on the internal standard. The best way to achieve this is to use a 
compound with a chemical structure and a retention time as close as possible to 
those of the analyte. For this purpose, C13-labelled or deuterated analogues of 
the analytes being tested significantly reduce signal variability observed for the 
analyte and consequently improve the repeatability of the measurement. 
 Another way to reduce ion suppression is to adjust the LC conditions in order to 
shift the analyte of interest away from the matrix components. 
76 
 The previously described approaches only allow for the balancing of matrix 
effects or minimizing the consequences of ion suppression, but they do not 
eliminate it as the cause is not treated. The only way to definitively circumvent 
this problem remains to improve the sample preparation and purification, in 
order to limit the presence of interfering compounds in the final extract. 
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The conclusion of the article published by Antignac et al., 2005 on ion suppression 
in LC-MS is that only a combination of sufficient sample purification and practical 
internal standard choice may ensure optimum performance in terms of repeatability 
and quantification. Therefore throughout this research ion suppression was always 
taken into consideration by the sourcing of suitable internal standards and by 
examining a variety of matrices in development and validation of methods to ensure 
that no effects were observed. 
  
2.5.5. Types of Mass Analyzers 
 Quadrupole: The quadrupole is the most widely used analyser due to its ease of 
use, mass range covered, good linearity for quantitative work, resolution and 
quality of mass spectra. The quadrupole is composed of two pairs of metallic 
rods. One set of rod is at a positive electrical potential, and the other one at a 
negative potential. A combination of DC and Rf (radio frequency) voltages is 
applied on each set. The positive pair of rods is acting as a high mass filter; the 
other pair is acting as a low mass filter. The resolution depends on the dc value 
in relationship to the Rf value. The quadrupoles are operated at constant 
resolution, which means that the Rf to DC ratio is maintained constant. For a 
given amplitude of the dc and Rf voltages, only the ions of a given m/z (mass 
to charge) ratio will resonate and have a stable trajectory to pass through the 
quadrupole and be detected. Other ions will be de-stabilized and hit the rods. 
As seen in figure 2-11. 
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 Figure 2-11. Quadropole Mass Analyzer 
 
 Ion Trap: The principle of the trap is to store the ions in a device consisting of 
a ring electrode and two end cap electrodes. The ions are stabilized in the trap 
by applying a Rf voltage on the ring electrode. For maximum efficiency, the 
ions must be focussed near the centre where the trapping fields are closest to 
the ideal and the least distorted - maximizing resolution and sensitivity. This is 
achieved by introducing a damping gas (99.998% helium) that collisionally 
cools injected ions, damping down their oscillations until they stabilize. By 
ramping the Rf voltage, or by applying supplementary voltages on the end cap 
electrodes, or by combination of both, it is possible to: destabilise the ions, and 
eject them progressively from the trap or keep only one ion of a given m/z 
value in the trap, and then eject it to observe it specifically. The ion trap 
analyzer can be seen in figure 2-12. 
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Figure 2-12. Ion Trap Mass Analyzer 
 
 Time of Flight: In a Time–Of–Flight (TOF) mass spectrometer, ions formed in 
an ion source are extracted and accelerated to a high velocity by an electric 
field into an analyser consisting of a long straight ‘drift tube’. The ions pass 
along the tube until they reach a detector. After the initial acceleration phase, 
the velocity reached by an ion is inversely proportional to its mass (strictly, 
inversely proportional to the square root of its m/z value). Since the distance 
from the ion origin to the detector is fixed, the time taken for an ion to traverse 
the analyser in a straight line is inversely proportional to its velocity and hence 
proportional to its mass (strictly, proportional to the square root of its m/z 
value). Thus, each m/z value has its characteristic time–of–flight from the 
source to the detector. In order to increase the resolution, the ion trajectory is 
bent by an electronic mirror, the reflectron. When going through the reflectron, 
the dispersion of ions of the same m/z value is minimized, leading to a great 
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improvement in resolution. The TOF instrument with and without the 
reflectron is seen in figure 2-13. 
 
Figure 2-13. TOF Instrument with and without Reflectron . 
 
2.5.6. Tandem Mass Spectrometry and Confirmatory Criteria 
While the use of single mass analyzers is quite common, it is possible for ions to 
undergo separation by two different mass analysers in the same experiment. This is 
known as tandem mass spectrometry and it is a popular technique used in the 
analysis of veterinary residues in biological and feed matrices. This technique is 
concerned with the analysis of product ions formed from precursor ions as a result of 
their fragmentation due to collision induced dissociation.  The most commonly used 
mode in tandem mass spectrometry for this purpose is “selected reaction monitoring” 
(SRM) usually carried out on a triple quadrupole instrument (Figure 2-14) [Le Bizec 
et al., 2009]. As suggested previously quadrupoles have become the most widely 
used mass analysers in mass spectrometry [Dawson 1995]. In SRM mode, the 
molecular ion of the target compound is isolated in the first mass analyser, it 
subsequently undergoes fragmentation and only specific product ions are monitored 
in the second mass analyser. Le Bizec et al., 2009 states that this technique offers 
many advantages for the analysis of trace levels of substances in complex matrices. 
The main advantage this technique gives is a significant decrease in noise observed 
in the signal of target analytes as a result of the small probability that interferences 
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from other compounds present in the final extract will have the same or very close 
molecular weights and product fragments as the analyte of interest.  
 
Figure 2-14. Diagram of triple quadrupole mass spectrometer (MS/MS) 
 
The production of a precursor and two product ions in tandem mass spectrometry as 
discussed previously in section 2.3.4 yields four identification points (IPs). As a 
result this approach is classified as a confirmatory technique. The relative response 
of the two product ions (ion ratio) acts as a confirmatory criterion. Ion ratios for non 
compliant samples can be compared to the ion ratio of the analyte of interest which is 
usually determined from matrix matched calibration standards. This approach is 
similar to approaches for confirmation adopted by other regulatory bodies such as the 
Association of Official Racing Chemists (AORC), the US Food and Drug 
Administration (FDA), the International Olympic Committee (IOC) and the World 
Anti-Doping Agency (WADA) [Van Eenoo, 2004]. Triple quadrupole LC-MS/MS in 
SRM mode with 1 precursor and two product ions was the analytical technique 
utilised in all methods developed as part of this research.  
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3.1 Abstract 
A rapid LC-MS/MS method has been developed and validated for the simultaneous 
identification, confirmation and quantitation of ten nitroimidazoles in plasma. The 
method validated in accordance with Commission Decision (CD) 2002/657/EC and 
is capable of analysing for Metronidazole (MNZ), Dimetridazole (DMZ), Ronidazole 
(RNZ), Ipronidazole (IPZ) and their hydroxy metabolites MNZ-OH, HMMNI 
(Hydroxymethyl, Methyl Nitroimidazole), IPZ-OH. The method is also capable of 
analysing Carnidazole (CRZ), Ornidazole (ORZ) and Ternidazole (TRZ) which are 
rarely analysed by modern methods. MNZ, DMZ and RNZ have a Recommended 
Level (RL) of 3 ng mL-1 which this method is easily able to detect for all the 
nitroimidazole compounds. Plasma samples are extracted with acetonitrile, and NaCl 
is added to help remove matrix contaminants. The acetonitrile extract undergoes a 
liquid-liquid wash step with hexane; it is then evaporated and reconstituted in mobile 
phase. The reconstituted samples are analysed by liquid chromatography tandem 
mass spectrometry (LC-MS/MS). The decision limits (CC range from 0.5-1.6 ng 
mL-1 and the detection capabilities (CC, range from 0.8-2.6ng mL-1. The results of 
the inter-assay study, which was performed by fortifying bovine plasma samples (n = 
18) on three separate days, show the accuracy calculated for the various analytes 
range between 101-108%. The precision of the method, expressed as CV% values for 
the inter-assay variation of each analyte at the three levels of fortification (3, 4.5 and 
6.0 ng mL-1), ranged between 4.9-15.2%. A Day 4 analysis was carried out to 
examine species variances in animals such as avian, ovine, porcine and equine.  
Keywords: Nitroimidazoles; Method Validation; Liquid Chromatography- tandem 
Mass Spectrometry; Plasma 
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3.2 Introduction 
Nitroimidazoles are imidazole heterocycles with a nitrogen group incorporated in the 
structure. Examples of these compounds are metronidazole (1-(2-hydroxyethyl)-2-
methyl-5-nitroimidazole, MNZ), dimetridazole (1, 2-dimethyl-5-nitroimidazole 
DMZ), ronidazole (1-methyl-2-[(carbamoyloxy) methyl]-5-nitroimidazole, RNZ), 
ipronidazole (2-isopropyl-1-methyl-5-nitroimidazole, IPZ), carnidazole (1-(2-
ethylcarbamothioic acid O-methyl ester)-2-methyl-5-nitroimidazole, CNZ), 
ornidazole (1-(3-chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole, ONZ) and 
ternidazole (2-Methyl-5-nitroimidazole-1-propanol; 3-(2-Methyl-5-nitroimidazol-1-
yl)propan-1-ol, TRZ). These examples are known as 5-nitroimidazoles as they 
contain a NO 2 group on the 5th position on its ring which is seen in Figure 3-1 and 
Figure 3-2.  
These compounds are metabolised in bovine, porcine and avian species [Mottier et 
al., 2006]. The main metabolite of DMZ, IPZ and MNZ results from the oxidation of 
the side chain in the C-2 position of the imidazole ring to form hydroxy metabolites. 
RNZ has a different degradation pathway but results in an identical metabolite to that 
of DMZ [Mottier et al., 2006]. These metabolites are HMMNI (2-hydroxymethyl-1-
methyl-5-nitroimidazole), MNZ-OH (1-(2-hydroxyethyl)-2-hydroxymethyl-5-
nitroimidazole) and IPZ-OH (1-methyl-2-(2′-hydroxyisopropyl)-5-nitroimidazole). 
Structures of the nitroimidazole compounds and their metabolites are shown in 
Figure 3-1. 
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5-Nitroimidazole Compounds                                        Metabolites 
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  Figure 3-1:  Chemical Structures of CRL Suggested Compounds and Metabolites 
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Figure 3-2: Chemical Structures of Three other 5-nitroimidazoles that the method can analyze 
for. 
Ornidazole
Ternidazole
Carnidazole
 
These compounds can be used for the prophylactic and therapeutic treatments of 
diseases such as histominiasis and coccidiosis in poultry, genital tricchoniasis in 
cattle and hemorrhagic enteritis in pigs. They are believed to be carcinogenic and 
mutagenic to humans and as a consequence were banned for the use in food 
producing animals within the European Union under Regulation 2377/90. They are 
also banned for use in the U.S.A and China [Xia et al., 2007]. The analysis of these 
compounds is required under Council Directive 96/23/EC. 
As a result of this ban, there is a need for rapid multi-residue analytical methods that 
have the capability of including a wide range of these analytes in order to ensure 
compliance with legislation. Previously the analysis of these compounds was carried 
out in liver and muscle [Xia et al., 2007; Polzer et al., 2001] but studies on the 
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stability and homogeneity of nitroimidazoles in incurred muscle [Polzer et al., 2004; 
Polzer et al., 2005] show that there is not a homogenous distribution of analyte in 
turkey muscle and also there is a rapid reduction in analyte concentration in muscle 
stored for prolonged periods above 4 °C. In contrast it was discovered that for 
plasma, retina and egg samples the analytes were stable during storage under the 
same conditions which resulted in constant concentrations and allowed detection of 
these compounds for longer periods after medication had been halted. Therefore, 
plasma, retina and eggs have been recommended as target matrices for the residue 
control of nitroimidazoles [Polzer et al., 2004; Polzer et al., 2005]. Current methods 
that are used for the analysis of these compounds are limited to the analysis of at 
most seven nitroimidazole compounds [Mottier et al., 2006, Sun et al. 2007], but the 
majority analyse for fewer [Xia et al., 2006; Polzer et al., 2001; Fraselle et al., 2007 
Wang, 2001; Capitan-Vallvey et al., 2002; Hurtaud-Pessel et al., 2000; Ho et al., 
2005; Ding et al., 2006; Mortier et al., 2003; Thompson et al., 2009]. These methods 
use varied extraction protocols including the use of acetonitrile [Mottier et al., 2006] 
or ethyl acetate [Xia et al., 2006; Sun et al. 2007] as extraction solvent. In some 
cases the samples were extracted using a buffer of NaCl/KH2PO4 with protease and 
adjusting the pH to 3 with 25% HCl [Fraselle et al., 2007; Polzer et al., 2001]. This 
was performed as it was believed that nitroimidazole compounds may be protein 
bound.  
The majority of these current methods then employ a solid phase extraction step 
(SPE) in order to clean up their extract. [Mottier et al., 2006; Xia et al., 2007; Xia et 
al., 2006; Polzer et al., 2001; Polzer et al., 2004; Polzer et al., 2005; Fraselle et al., 
2007; Sun et al. 2007] and methods that do not employ SPE [Ding et al., 2006; 
Mortier et al., 2003] were not used to analyse plasma. Various techniques have been 
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used for the analysis of these compounds such as HPLC-UV [Sun et al. 2007] and 
GC-MS/MS [Polzer et al., 2001; Ho et al., 2005]. The use of GC-MS/MS limits the 
number of analytes that can be analysed due to problems arising from derivatisation, 
due to the fact that HMMNI and RNZ form the same derivatisation products [Xia et 
al., 2007]. Presently more methods are now being developed for this analysis by LC-
MS/MS which allow for a greater number of analytes being analysed [Mottier et al., 
2006; Xia et al., 2007; Xia et al., 2006; Capitan-Vallvey et al., 2002]. This 
overcomes the problem of derivatisation and allows for quicker run times. 
From examination of published literature no method was found that was capable of 
analysing the ten nitroimidazoles listed in this paper. The sample preparation 
described in this study is more efficient than previously published methods due to the 
absence of a SPE step. In previous studies a deconjugation step was utilised by 
addition of either a protease or an acid to deconjugate possible protein bound 
residues. In this study it was found that this step was not necessary by investigation 
of incurred samples of plasma received from the Community Reference Laboratory 
(CRL) in Berlin. A recently published method also omits this deproteination step 
[Thompson et al., 2009].  
A rapid, sensitive and specific multi-residue method for the detection and 
confirmation of a wide variety of nitroimidazoles in plasma has been developed and 
validated in accordance with CD 2002/657/EC. A recommended level (RL) for 
MNZ, DMZ and RNZ of 3 ng mL-1 has been proposed by the CRL hence this was 
used in validating these three compounds. This RL was also applied to the remaining 
seven compounds for which no RL has been proposed. During validation, all 
compounds were analysed in a single chromatographic run at 1, 1.5 and 2 times the 
RL (3 ng mL-1) with six replicates at each level. Selectivity, linearity, recovery, 
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accuracy and precision were established and values for CCα and CCβ were 
determined. 
 
3.3 Experimental 
3.3.1 Materials and reagents 
All analytical standards of nitroimidazoles, including deuterated substances were 
provided by the CRL (BVL, Berlin, Germany) except HMMNI, MNZ-OH, HMMNI-
d3, MNZ-OH-d2, DMZ- d3 and RNZ -d3 (all from WITEGA Laboratorien Berlin, 
Germany), RNZ (Sigma, St. Louis, MO, USA) and DMZ (Fluka, St. Louis, MO, 
USA). Water LC-MS grade (Fluka, St. Louis, MO, USA). Methanol, Acetonitrile 
and Hexane HPLC Grade (Reagecon, Clare, Ireland). Sodium Chloride was AnalaR 
grade (VWR, Poole, England). Individual stock standards at 1mg mL-1 in ethanol 
were prepared and are stored at 4ºC for 1 year. Individual intermediate standard 
solutions (10 and 1µg mL-1) in methanol were prepared and working standard 
solutions (mixture of (dueterated) nitroimidazoles) (200 and 500ng mL-1) were 
prepared in methanol and are stored at 4ºC for 3 months. 
 
3.3.2        LC-MS/MS Instrumentation 
90 
The LC-MS/MS system is a TSQ Quantum Ultra EMR coupled to a Finnigan 
Surveyor LC system (Thermo Fisher, Waltham, MA, USA). The instrument is 
controlled by Xcalibur software (Version 1.4). Separation was achieved using a (100 
 2)mm, 3m particle size, Luna C18 column (Part No. 00D-4251-B0) protected by 
a Security Guard guard cartridge system (202)mm, both supplied by Phenomenex 
(Torrance, California, USA). The oven temperature was set at 40ºC. The 
chromatographic separation performed on gradient mode using water acidified with 
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0.1% acetic acid (mobile phase A) and acetonitrile acidified with 0.1% acetic acid 
(mobile phase B), at a flow of 0.25mL min-1. The initial conditions (0-4min) were 
95% A. Then the conditions changed to 5% A (4-7min) and these were maintained 
until 9 min, the conditions returned to 95% A in 3min (9-12min), and were 
maintained until the end of the run at 20min. The ionisation used was positive  
electrospray ionisation (ESI) mode with a spray voltage of 4350V. The individual  
MRMs with their respective collision energies are listed in Table 3-1. 
 
3.3.3 Plasma samples 
 Bovine, porcine, ovine, avian and equine plasma was obtained from local abattoirs 
and stored at –20 C in polypropylene centrifuge tubes (50mL). Samples of this 
plasma were analysed and those found to contain no detectable residues of the 
analytes of interest were used as negative controls. Chromatograms of blank plasma 
are seen in Figure 3-3.  
 
3.3.4 Sample extraction and clean-up 
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Bovine plasma (5mL) was pipetted into polypropylene centrifuge tubes (50mL). 
These were fortified with mixed internal standard (50 µL of 200 ng mL-1) which 
corresponded to 2 ng mL-1. Samples were fortified at 3, 4.5 and 6 ng mL-1 by adding 
mix working standard solution (30, 45 and 60 L portions of 500 ng mL-1) and these 
were vortexed (20secs). Acetonitrile (10mL) was added and vortexed. NaCl (2g) was 
added to this slurry which was then centrifuged (4500 rpm for 10min). The top 
organic layer from each sample was then transferred to polypropylene tubes (15mL) 
and evaporated (60ºC) to 6mL under nitrogen. Hexane (5mL) was added and the 
tubes were then vortexed (30secs). The hexane layers were discarded and the extracts 
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were evaporated to dryness under the same conditions. The extracts were 
reconstituted in Water: Acetonitrile (95:5, 200µL) and filtered through 0.2µm 
syringe filters. An aliquot (20µL) was injected onto the LC column. Chromatogram 
of a 2.5ng mL-1 fortified plasma sample is seen in Figure 3-4.  
 
Table 3-1: Parent/Daughters fragmentations and corresponding collision 
energies.
Nitroimidazole Parent/Daughter Collision Energies 
Compound Parent Ion Daughter Ions Collision Energies 
96.4 18 
DMZ 142.2 
81.4 28 
82.5 25 
MNZ 172.0 
128.2 15 
140.1 15 
55.7 20 RNZ 201.2 
110.3 18 
124.3 18 
IPZ 170.0 
109.4 25 
140.2 13 
55.7 18 HMMNI 158.2 
110.3 15 
123.2 16 
MNZ-OH 188.2 
126.2 17 
168.1 14 
IPZ-OH 186.0 
122.3 21 
128.2 17 
ORZ 220.0 
82.4 33 
128.2 17 
82.5 28 TRZ 186.0 
111.3 25 
118.2 13 
CRZ 245.0 
75.3 33 
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Figure 3-3: Chromatograms of Blank Bovine Plasma (the arrow points out the expected 
retention time of each compound). 
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Figure 3-4: Chromatograms for the ten nitroimidazole compounds fortified at 2.5ug mL-1 
 
3.3.5 Matrix-Matched Calibration 
Bovine matrix matched calibration curves were prepared and used for quantification. 
Control plasma was prepared as above (2.4). One control plasma sample was used 
for each calibration standard level. Plasma samples (5mL) were pipetted into 
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polypropylene tubes (50mL). Samples were fortified with mixed internal standard 
(50 L of 200 ng mL-1) at a level corresponding to 2 ng mL-1. Samples were fortified 
at 0, 2.5, 5, 7.5, 10 and 20ng mL-1 by adding mixed working standard solution (0, 25, 
50, 75, 100 and 200 l aliquots of a 500 ng mL-1). 
Six deuterated internal standards are used; d3-DMZ, d3-RNZ, d3-HMMNI, d2-
MNZ-OH, d3-IPZ and d3-IPZ-OH. For compounds with no deuterated form i.e. 
MNZ, TRZ, ORZ and CRZ, d3-HMMNI is used as internal standard. 
 
3.3.6 Method validation 
For estimation of accuracy, blank bovine plasma samples were fortified with each 
analyte at 3.0, 4.5 and 6.0ng mL-1. Six replicate test portions at each of the three 
fortification levels (18) were analysed on three separate days over a period of two 
weeks. To determine any matrix effects caused by biological variations arising from 
plasma from different species (bovine, ovine, porcine, avian and equine), a fourth 
day analysis was carried out. Two sets of ten plasma samples (two of each species) 
were analysed as in section 2.4. The first set was fortified with only internal standard, 
and the second set was fortified with both internal standard and with the analytes at a 
concentration equivalent to 4.5ng mL-1. The estimation of precision, intra-assay and 
inter-assay repeatability of the method were calculated along with CCand CC 
Absolute recovery was determined by analysing five replica plasma samples fortified 
at 3.0ng mL-1 prior to extraction and five replica plasma samples fortified at the 
equivalent concentration after extraction. 
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3.4 Results and Discussion 
3.4.1 Preliminary experiments 
The LC-MS/MS method was developed to provide confirmatory data for the analysis 
of 10 nitroimidazoles in plasma. The MS/MS fragmentation conditions were 
investigated and collision energies were optimised for each individual compound to 
give best response. For a method to be deemed confirmatory under CD 2002/657/EC 
it must yield 4 identification points. In this method a precursor ion (parent mass) and 
two daughter ions (corresponding to strong and weak ion) are monitored for each 
analyte (Table 3-1). This yields 4 identification points (1 for the parent ion and 1.5 
for each daughter ion) hence it can be deemed a confirmatory method. When the 
MS/MS fragmentation conditions for HMMNI were optimised it was seen that the 
background noise was very high in its strong daughter ion. This was investigated 
further and it was found that the use of the laboratory’s 18.2 MΩ water supply in the 
mobile phase was producing the high background. This problem was overcome by 
the use of LC-MS/MS grade water in the mobile phase.  
From previous work carried out on these compounds it was seen that acetonitrile can 
be used as a suitable extraction solvent [Mottier et al., 2006]. Various extraction 
procedures were examined. Double extractions are common practice in sample 
preparation but this in turn leads to an increased amount of solvent being used. Tests 
were carried out to see if this double extraction was necessary in the case of this 
procedure. Results were compared between a single and double extraction. These 
showed that recoveries were not significantly improved with the use of a double 
extraction therefore a single extraction of 10mL would suffice. 
Past work carried out on nitroimidazoles showed that the addition of NaCl helped to 
remove impurities [Mottier et al., 2006; Xia et al., 2006]. In order to investigate at 
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which stage the NaCl should be added to yield the cleanest extract various 
experiments were performed. It was found that the addition of NaCl (2g) directly 
after addition of acetonitrile allowed for greater purification and produced a cleaner 
sample for analysis.  
SPE is widely used as a sample clean-up method. Cartridges of extrelute NT20 
[Polzer et al., 2004], Oasis MCX [Xia et al., 2007], SCX [Sun et al., 2007] and HLB 
[Capitan-Vallvey et al., 2002], have been used in methods for the analysis of 
nitroimidazoles. With advances in LC-MSMS and its ability to perform Multi 
Reaction Monitoring (MRM) for compounds, which greatly reduces the effect of 
matrix interferences, the need for SPE is reduced. As a result it was found that 
addition of a quick liquid-liquid wash step was sufficient to remove an adequate 
amount of interferences and this in turn allows for quicker sample preparation times.  
Hexane was used in previous work carried out on these compounds [Mottier et al., 
2006; Xia et al., 2007] to help remove impurities, therefore the use of hexane as a 
liquid-liquid wash solvent was investigated in order to improve sample clean up.  
Hexane with varying amounts of ethyl acetate (0%, 2%, 5% and 10%) was used as 
the wash solvent. Ethyl acetate was added to help remove more polar impurities. 
Results concluded that the addition of this in any percentage gave poorer recoveries 
for some of the compounds due to the higher polarity of ethyl acetate. As a result 
hexane was chosen for the wash solvent. Samples were filtered before injection to 
remove any remaining impurities. Different types of syringe filters with varying pore 
sizes and various packing including PVDF, PTFE and Nylon filters were tested. 
Decreased analyte recovery was observed when using the PTFE and Nylon filters. 
Samples were cleaner when 0.25µm sized filters were used compared with 0.45µm. 
As a result 0.25µm PVDF syringe filters were chosen. 
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3.4.2 Validation study 
As part of the validation study, various experimental parameters were determined. 
These included specificity, linearity, accuracy, absolute recovery, repeatability, CC, 
CC and measurement of uncertainty. These parameters were determined in 
accordance with guidelines described in CD 2002/657/EC. In order to further 
demonstrate the applicability of the developed method analysis of incurred test 
material was also performed. 
 
Table 3-2: Validation results of % CV, Accuracy, Absolute Recovery, CCα, CCβ, Measure of 
Uncertainty and Linearity. 
Analytes 
CV 
% 
Accuracy
% 
Absolute 
Recovery % 
CCα 
µg L-1
CCβ 
µg L-1 
MU 
% 
Linearity
R2 
Metronidazole 4.9 106.6 50.4 0.52 0.89 50.4 >0.990 
MNZ-OH 6.3 105.8 61.8 0.53 0.91 24.0 >0.990 
Dimetridazole 6.1 101.8 61.4 0.58 0.99 22.8 >0.990 
Ronidazole 5.6 101.5 67.5 0.60 1.02 23.5 >0.990 
HMMNI 4.5 101.4 68.5 0.57 0.98 31.4 >0.990 
Ipronidazole 15.1 103.5 71.8 1.49 2.54 54.4 >0.990 
IPZ-OH 5.5 101.2 72.7 0.55 0.94 23.8 >0.990 
Ternidazole 5.8 106.5 71.1 0.57 0.97 36.8 >0.990 
Ornidazole 9.3 108.0 66.9 1.11 1.89 51.9 >0.990 
Carnidazole 13.2 108.8 60.5 1.52 2.60 67.8 >0.990 
  
3.4.2.1. Specificity 
The technique of LC-MS/MS itself offers a high degree of selectivity and specificity 
due to its ability to operate in multi reaction monitoring mode (MRM), which greatly 
reduces the effect of matrix interferences. On each of the four occasions when 
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validation was performed no interfering peaks were observed at the retention time for 
any of the transitions. This allowed for clear identification and quantification of all 
analytes. 
 
3.4.2.2. Linearity of the Response 
Calibration curves were prepared by plotting the response factor (analyte peak 
area/internal standard peak area) as a function of analyte concentration (0 to 20 ng 
mL-1). The regression coefficients (r2) for all the calibration curves used in this study 
were  0.990. This showed that these analytes have a good fit to linearity within this 
range. 
 
3.4.2.3. Absolute Recovery  
Absolute recovery was calculated by determining concentration of samples fortified 
before extraction and dividing by the concentration of samples fortified after 
extraction and expressing this result as a percentage. Absolute recoveries were in the 
range of 50.4-72.7% (Table 3-2). These values fall within acceptable ranges. 
 
3.4.2.4. Accuracy 
CD 2002/657 states that accuracy should be between 70-110%. The mean corrected 
accuracy (n = 6) of the analytes were found by experiment to lie between 101% and 
109 % for all analytes (Table 3-2) and therefore are acceptable. 
3.4.2.5. Repeatability 
99 
Inter assay precision (CV %) should be as low as reasonably possible as the method 
works in the ng mL-1 range. Values for CV % in range of 4.5-15.1% were achieved 
for all compounds (Table 3-2). The main reason for the excellent precision 
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demonstrated here can be attributed to the availability of six deuterated analogues of 
the compounds being examined. Deuterated internal analogues were not available for 
metronidazole, ternidazole, carnidazole, ornidazole. For these analytes d3-HMMNI 
was used as the corresponding internal standard and corrected well for any losses or 
matrix suppression. 
 
3.4.2.6. CC and CC 
CC is defined as the limit above which it can be concluded with an error probability 
of , that a sample contains the analyte. For prohibited substances an value equal 
to 1 % is applied. CC is the smallest content of the substance that may be detected, 
identified and quantified in a sample, with a statistical certainty of 1-, where 
 CC and CC were calculated using the calibration curve procedure 
according to ISO 11843. After identification, the signal is plotted against the added 
concentration. The corresponding concentration at the y-intercept plus 2.33 times the 
standard deviation of the within-laboratory reproducibility of the intercept equals the 
CC. CC values of for all 10 compounds are listed in Table 3-2 and are all below 
1.52 ng mL-1. CC is the concentration corresponding to the signal at CC + 1.64 
times the standard error of the intercept (i.e. the intercept + 3.97 times that standard 
error of the intercept). CC values for all 10 compounds are listed in Table 3-2 and 
are all below the RL of 3ng mL-1.  
3.4.2.7. Measurement of Uncertainty 
The  measurement  of  uncertainty  was  estimated  by  taking  into  account  the  
within laboratory reproducibility over days 1, 2 and 3 as well as considering the 
repeatability on day 4 due to matrix effects caused by different species. These two 
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variability’s were combined and multiplied by  a  coverage  factor  of  three  to  give  
an  overall  figure  for  the  MU. This approach of using the within laboratory 
reproducibility as a good estimator of measurement of uncertainty is taken from the  
SANCO/2004/2726rev4 document. It recommends using the within laboratory 
reproducibility and using a coverage factor of 2.33 to estimate expanded uncertainty, 
however as  it was  felt  that not all  the environmental and other  factors  that could 
be varied  over  the  course  of  the  validation were  examined,  hence  a  coverage 
factor of 2.33 may underestimate  the true uncertainty of the method. So a value of 3 
was  chosen instead  to  give  a  more  realistic  value  for  the  true  uncertainty. 
Values for MU are seen in Table 3-2 and lie between 20 and 70%. High MU values 
are seen for MNZ, CNZ and ORZ as they have no deuterated analogue to use as an 
internal standard. These values are increased further due to a high value for 
reproducibility due to matrix as a result of a high biological variation between 
species (day 4). A high value is also observed for IPZ especially in day 1 due to 
insufficient data points across its short peak width. The dwell time for this compound 
was altered and results improved on day 2 and 3.   

3.4.2.8. Evaluation  
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In order to evaluate this method two incurred samples were analysed. The samples 
were lyophilised plasma and were obtained from the CRL for nitroimidazoles in 
Berlin. One contained high levels of nitroimidazoles and the other contained lower 
levels. The results achieved from using the method are seen in Table 3-3 and when 
compared with the set values all but one lie well within the measurement uncertainty 
for each analyte. Exception is MNZ-OH in the V08G0247 sample where the result 
achieved was above the value stated by the CRL. Taken into consideration if the 
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CRL’s measurement uncertainty was placed on their result the ranges of both labs 
would overlap. 
Table 3-3:  Results achieved using method, of two incurred plasma samples. 
 
SAMPLE: V08G0246      
RANGE 
Compound 
Actual Amt 
(ng mL-1) 
Calculated Amt 
(ng mL-1) 
MU(%) MU of Cal 
Amt* 
Upper Lower 
MNZ-OH 4.55 4.643 24.04 1.116 5.759 3.527 
HMMNI 1.71 1.357 31.35 0.425 1.782 0.932 
Metronidazole 1.48 1.198 50.42 0.604 1.802 0.594 
Ronidazole 2.33 1.789 23.5 0.420 2.209 1.369 
IPZ-OH 1.69 1.435 23.78 0.341 1.776 1.094 
       
SAMPLE: V08G0247      
RANGE 
Compound 
Actual Amt 
(ng mL-1) 
Calculated Amt 
(ng mL-1) 
MU(%) 
MU of 
Cal 
Amt* 
Upper Lower 
MNZ-OH 2.02 2.707 24.04 0.651 3.358 2.056 
HMMNI 0.66 0.787 31.35 0.247 1.034 0.540 
Metronidazole 0.6 0.672 50.42 0.339 1.011 0.333 
Ronidazole 0.94 1.109 23.5 0.261 1.370 0.848 
IPZ-OH 0.66 0.551 23.78 0.131 0.682 0.420 
* MU calculated on result achieved by method. 
 
3.5 Conclusions 
A multi-residue confirmatory method has been developed that simultaneously 
identifies, confirms and quantifies ten nitroimidazole compounds in plasma by LC-
MS/MS. It can be considered as a rapid method, as the only clean-up step required is 
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a hexane wash. The method also has a short chromatographic run time of only 20 
minutes for each sample.  
The method includes 10 nitroimidazole compounds including seven that are 
suggested by the CRL in Berlin to be analysed. In addition other nitroimidazoles that 
haven’t been analysed previously such as Ornidazole and Carnidazole are included. 
The obtained data fulfils the requirements laid down in CD 2002/657/EC and allows 
the calculation of all relevant performance characteristics. This study shows that the 
developed method meets the required sensitivity of 3ng mL-1 which is the RL used 
for these compounds. The CC and CC values determined for each analyte are 
lower than this level. The method performs very well in terms of accuracy and 
repeatability for each of the analytes due to the utilisation of six different deuterated 
internal standards. The values achieved for % accuracy, CV % and MU all fall within 
acceptable ranges. The applicability of the method for use on different types of 
plasma was demonstrated by the satisfactory results obtained from the Day 4 analysis 
of different species. 
The reduced number of analytical steps within the method makes it very amenable 
for high through-put regulatory monitoring of these compounds. The objective of the 
work to develop a rapid confirmatory method capable of monitoring for these 
residues in plasma at ng mL-1 levels and validate according to the requirements in 
CD 2002/657/EC therefore has been achieved successfully. 
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4.1 Abstract 
A rapid confirmatory method has been developed and validated for the simultaneous 
identification, confirmation and quantitation of eleven nitroimidazoles in eggs by 
liquid chromatography tandem mass spectrometry (LC-MS/MS). The method is 
validated in accordance with Commission Decision 2002/657/EC and is capable of 
analysing Metronidazole (MNZ), Dimetridazole (DMZ), Ronidazole (RNZ), 
Ipronidazole (IPZ) and their hydroxy metabolites MNZ-OH, HMMNI 
(Hydroxymethyl, Methyl Nitroimidazole), IPZ-OH. The method is also capable of 
analysing Carnidazole (CRZ), Ornidazole (ORZ), Tinidazole (TNZ) and Ternidazole 
(TRZ). MNZ, DMZ and RNZ have been assigned a Recommended Level (RL) of 3 
µg kg-1 by the Community Reference Lab (CRL) in Berlin. The developed method 
described in this study is easily able to detect all the nitroimidazole compounds 
investigated at this level and below. Egg samples are extracted with acetonitrile, and 
NaCl is added to help remove matrix contaminants. The acetonitrile extract 
undergoes a liquid-liquid wash step with hexane; it is then evaporated and 
reconstituted in mobile phase. The reconstituted samples are analysed by liquid 
chromatography tandem mass spectrometry (LC-MS/MS). The decision limits (CC 
range from 0.33-1.26 µg kg-1 and the detection capabilities (CC, range from 0.56-
2.15 µg kg-1. The results of the inter-assay study, which was performed by fortifying 
hen egg samples (n = 18) on three separate days, show the accuracy calculated for 
the various analytes to range between 87.2-106.2%. The precision of the method, 
expressed as %CV values for the inter-assay variation of each analyte at the three 
levels of fortification (3, 4.5 and 6.0 µg kg-1), ranged between 3.7-11.3%. A Day 4 
analysis was carried out to examine species variances in eggs from different birds 
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such as duck and quail and investigating differences in various battery and free range 
hen eggs.  
Keywords: Nitroimidazoles; Method Validation; Liquid Chromatography- tandem 
Mass Spectrometry; Egg. 
 
4.2 Introduction 
Nitroimidazoles are imidazole heterocycles with a nitrogen group incorporated in the 
structure. Examples of these compounds are metronidazole (MNZ), dimetridazole 
(DMZ), ronidazole (RNZ), ipronidazole (IPZ), carnidazole (CNZ), ornidazole 
(ONZ), tinidazole (TNZ) and ternidazole (TRZ). These examples are known as 5-
nitroimidazoles as they contain a NO 2 group on the 5th position on its ring which can 
be seen in figures 4-1.  
Nitroimidazoles are extensively metabolised in avian, bovine and porcine species 
[Mottier et al., 2006]. The main metabolites of DMZ, IPZ and MNZ result from the 
oxidation of the side chain in the C-2 position of the imidazole ring to form hydroxy 
metabolites. RNZ has a different degradation pathway but results in an identical 
metabolite to that of DMZ [Mottier et al., 2006]. These metabolites are HMMNI, 
MNZ-OH and IPZ-OH. Structures of these metabolites are shown in figure 4-1. 
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Dimetridazole  (1, 2-dimethyl-5-nitroimidazole) 
 
HMMNI  (2-hydroxymethyl-1- 
methyl-5-nitroimidazole)  
 
 
 
Ronidazole 
(1-methyl-2-[(carbamoyloxy)  
methyl]-5-nitroimidazole) 
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Metronidazole MNZ-OH 
(1-(2-hydroxyethyl)-2-
hydroxymethyl-5-nitroimidazole)
(1-(2-hydroxyethyl)-2-methyl 
-5-nitroimidazole) 
 
 
 
Ipronidazole 
(2-isopropyl-1-methyl-5-
nitroimidazole) 
 
 
 
IPZ-OH 
(1-methy propyl)-l-2-(2′-hydroxyiso
5-nitroimidazole) 
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Carnidazole 
(1-(2-ethylcarbamothioic acid O-methyl ester) 
-2-methyl-5-nitroimidazole) 
Ornidazole 
(1-(3-chloro-2-hydroxypropyl)- 
2-methyl-5-nitroimidazole) 
Tinidazole 
1-(2-ethylsulfonylethyl)-2-
methyl-5-nitro-imidazole 
 
 
 
 
 
 
 
Ternidazole 
2-Methyl-5-nitroimidazole-1-
propanol; 3-(2-Methyl-5-
N
NO 2N
S O 2
Figure 4-1:  Chemical Structures of Nitroimidazole Compounds and Metabolites 
 
These 5-nitroimidazoles are very effective for the prophylactic and therapeutic 
treatments of diseases such as histominiasis and coocidiosis in poultry, genital 
tricchoniasis in cattle and hemorrhagic enteritis in pigs. However these compounds 
are now suspected to be carcinogenic and mutagenic to humans and as a consequence 
were banned for the use in food producing animals within the European Union under 
Regulation 2377/90. They are also banned for use in the U.S.A and China [Xia et al., 
2007]. The analysis of these compounds is required under Council Directive 
96/23/EC. 
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As the use of these substances are prohibited and food containing residues of these 
compounds may be dangerous to the consumer, there is a need for rapid multi residue 
analytical methods that have the capability of analysing a wide range of these 
analytes in order to ensure compliance with legislation. Previously, analysis of these 
compounds focused on liver and muscle [Xia et al., 2007; Polzer et al., 2001]. 
However studies on the stability and homogeneity of nitroimidazoles in incurred 
poultry muscle [Polzer et al., 2004; Polzer et al., 2005] show that there is not a 
homogenous distribution of the analyte(s) in turkey muscle and also there is a rapid 
degradation in analyte concentration in muscle stored for prolonged periods above 
4 °C. In contrast it was demonstrated that for egg, plasma and retina samples; the 
analytes are stable during storage under the same conditions as the muscle samples 
and as a result concentrations are stable allowing detection of these compounds for 
longer periods after medication had ceased. Therefore, egg, plasma and retina have 
been recommended as target matrices for the residue control of nitroimidazoles 
[Polzer et al., 2004; Polzer et al., 2005]. Current methods used for the analysis of 
nitroimidazoles in any matrix are limited to the analysis of at most seven 
nitroimidazole compounds [Mottier et al., 2006; Sun et al., 2007], but the majority 
analyse for fewer [Xia et al., 2006; Polzer et al., 2001; Fraselle et al., 2007 Wang, 
2001; Capitan-Vallvey et al., 2002; Hurtaud-Pessel et al., 2000; Ho et al., 2005; 
Ding et al., 2006; Mortier et al., 2003; Thompson et al., 2009]. These methods use, 
varied extraction protocols including the use of acetonitrile [Mottier et al., 2006] or 
ethyl acetate [Xia et al., 2006; Sun et al. 2007]. In some cases the samples are 
extracted using a buffer of NaCl/KH2PO4 with protease and adjusting the pH to 3 
with 25% HCl [Fraselle et al., 2007; Polzer et al., 2001]. This was performed as it 
was believed that nitroimidazole compounds may be protein bound.  
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The majority of these current methods then employ a solid phase extraction step 
(SPE) in order to purify the extract [Mottier et al., 2006; Xia et al., 2007; Xia et al., 
2006; Polzer et al., 2001; Polzer et al., 2004; Polzer et al., 2005; Fraselle et al., 2007; 
Sun et al. 2007] and of the methods that do not employ SPE [Ding et al., 2006; Xia 
et al., 2006] only one was used to analyse eggs [Xia et al., 2006]. Various techniques 
have been used for the determination of these compounds such as HPLC-UV [Sun et 
al. 2007] and GC-MS/MS [Polzer et al., 2001; Ho et al., 2005]. The use of GC-
MS/MS limits the number of analytes that can be analysed due to problems arising 
from derivatisation, such as the fact that HMMNI and RNZ form the same 
derivatization products [Xia et al., 2007]. Presently more methods are being 
developed for this analysis by LC-MS/MS which allow for a greater number of 
analytes to be analysed [Mottier et al., 2006; Xia et al., 2007; Xia et al., 2006; 
Capitan-Vallvey et al., 2002]. This overcomes the problem of derivatisation and 
allows for quicker analysis times. 
From the aforementioned papers it is clear that the analysis of egg as a target matrix 
for nitroimidazole [Polzer et al., 2004; Polzer et al., 2005] has been overlooked. 
From examining published literature, only three methods were found that were 
capable of analyzing nitroimidazoles in eggs. [Mottier et al., 2006; Xia et al., 2006; 
Mohamed et al., 2008]. These methods are limited to at most the analysis of seven 
analytes. The method described by Xia et al. while rapid only analyses four 
compounds while the methods by Mottier et al., 2006 and Mohamed et al., 2008 
analyse seven compounds but they incorporate time consuming SPE clean-ups in 
there methods. 
From examination of published literature no method was found that was capable of 
the thorough analysis of eleven nitroimidazoles listed in this paper. The sample 
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preparation described in this study is more efficient than previously published 
methods due to the absence of a SPE step. In previous studies a deconjugation step 
was utilised by addition of either a protease or an acid to deconjugate possible 
protein bound residues. Newer methods [Thompson et al., 2009] are now omitting 
this step and in this paper an incurred sample is tested to reinforce this theory.  
A rapid, sensitive and specific multi-residue method for the detection and 
confirmation of a wide variety of nitroimidazoles in egg has been developed and 
validated in accordance with Commission Decision 2002/657/EC. A recommended 
level (RL) for MNZ, DMZ and RNZ of 3 µg kg-1 has been proposed by the CRL 
hence this was used in validating these three compounds. This RL was also applied 
to the remaining eight compounds for which no RL has been proposed. During 
validation, all compounds were analysed in a single chromatographic run at 1, 1.5 
and 2 times the RL (3 µg kg-1) with six replicates at each level over three separate 
days. The validation parameters selectivity, linearity, recovery, accuracy, precision, 
measurements of uncertainty as well as decision limits (CCα) capabilities (CCβ) 
have been established. 
 
4.3 Experimental 
4.3.1 Materials and reagents 
MNZ, IPZ, CNZ, TNZ, TRZ, ORZ, IPZ-OH were provided by the CRL (BVL, 
Berlin, Germany). HMMNI, MNZ-OH, HMMNI-d3, MNZ-OH-d2, DMZ- d3 and 
RNZ -d3 (all from WITEGA Laboratorien Berlin), RNZ (Sigma) and DMZ (Reidel-
de-Haen). Water is of LC-MS grade quality (Reidel-de-Haen). All other solvents 
were of LC quality and purchased from Reagecon (Clare, Ireland). Sodium Chloride 
was AnalaR grade and purchased from VWR (Poole, England). Individual stock 
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standards at 1mg mL-1 in ethanol were prepared and stored at 4ºC for 1 year. 
Individual intermediate standard solutions (10 and 1 µg mL-1) in methanol were 
prepared and working standard solutions (mixture of nitroimidazoles) (500 ng mL-1) 
were prepared in methanol and stored at 4ºC for 3 months. Deuterated standards were 
prepared similarly except mixed standard was 200 ng mL-1.  
 
4.3.2 LC-MSMS Instrumentation 
The LC-MS/MS system is a TSQ Quantum Ultra EMR coupled to a Finnigan 
Surveyor LC system. The instrument is controlled by Xcalibur software (Version 
1.4). Separation was achieved using a (100  2) mm, 3 m particle size, Luna C18 
column (Part No. 00D-4251-B0) protected by a Security Guard guard cartridge 
system (202) mm, both supplied by Phenomenex. The oven temperature was set at 
40 ºC. The chromatographic separation performed on gradient mode using water 
acidified with 0.1% acetic acid (mobile phase A) and acetonitrile acidified with 0.1% 
acetic acid (mobile phase B), at a flow of 0.25 mL min-1. The initial conditions (0-4 
min) were 95% A. Then the conditions changed to 5% A (4-7 min) and these were 
maintained until 9 min, the conditions returned to 95% A in 3 min (9-12 min), and 
were maintained until the end of the run at 20 min. The ionisation mode used was 
positive electrospray ionisation (ESI) mode with a spray voltage of 4350 V. The 
individual MRMs with there respective collision energies are listed in Table 4-1.  
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Table 4-1: MS/MS parent daughter fragmentation and Collision energies. 
 
 
Nitroimidazole Parent/Daughter Collision Energies 
Compound 
Parent 
m/z 
Daughters 
m/z 
Collision Energies 
(eV) 
96.4 18 
DMZ 142.2 
81.4 28 
82.5 25 
MNZ 172.0 
128.2 15 
140.1 15 
RNZ 201.2 
55.7 20 
124.3 18 
IPZ 170.0 
109.4 25 
140.2 13 
HMMNI 158.2 
55.7 18 
123.2 16 
MNZ-OH 188.2 
126.2 17 
168.1 14 
IPZ-OH 186.0 
122.3 21 
128.2 17 
ORZ 220.0 
82.4 33 
128.2 17 
TRZ 186.0 
82.5 28 
118.2 13 
CRZ 245.0 
75.3 33 
121.2 18 
TNZ 248.0 
202.0 15 
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4.3.3 Egg samples 
Egg was obtained from local shops, homogenised and stored at –20 C in 
polypropylene centrifuge tubes (50 mL). Samples of theses egg were analysed and 
those found to contain no detectable residues of the analytes of interest were used as 
blank egg. Chromatograms of blank egg are seen in figure 4-2.  
 
4.3.4 Sample extraction and clean-up 
Egg (3 g) is weighed into a polypropylene centrifuge tubes (50 mL). These are 
fortified with mixed internal standard (30 µL) which correspond to 2 µg kg-1. 
Samples are fortified at levels corresponding to 3, 4.5 and 6 µg kg-1 by adding mix 
working standard containing each analyte (18, 27 and 36 L) and these are vortexed 
(20 s). To this acetonitrile (6 mL) is added and the tubes are vortexed. NaCl (1.2 g) is 
added to this slurry which is then hand shaken and centrifuged (4350 x g for 10min). 
The top organic layer is then transferred to a polypropylene tube (15 mL). Hexane 
(3.5 mL) is added and this is vortexed (30 s). The hexane layer is then removed and 
the extracts are evaporated to dryness at 60ºC under a nitrogen stream. They are then 
reconstituted in 95:5 Water:ACN (200 µL). These are finally filtered through 0.2 µm 
PVDF syringe filters. An aliquot (20 µL) is injected onto the LC column. 
Chromatogram of a 2.5 µg kg-1 fortified egg sample is shown in figure 4-2. 
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Figure 4-2: Chromatograms of all Nitroimidazole Compounds; (a) Fortified at 2.5µg kg-1 and 
(b) corresponding blank egg samples. 
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4.3.5 Matrix-Matched Calibration 
Matrix matched calibration curves were prepared and used for quantification. Blank 
egg previously tested and shown to contain no residues was prepared as above. One 
blank egg sample was used for each calibration standard level.  Samples were 
fortified at levels corresponding to 0, 2.5, 5, 7.5, 10 and 20µg kg-1 by adding mixed 
working standard solution (0, 15, 30, 45, 60 and 120 l). 
Calibration curves were prepared by plotting the response factor (peak area 
analyte/internal standard peak area) as a function of analyte concentration (0 to 20 µg 
kg-1). Six deuterated internal standards are used; d3-DMZ, d3-RNZ, d3-HMMNI, d2-
MNZ-OH, d3-IPZ and d3-IPZ-OH. For compounds with no deuterated form i.e. 
MNZ, TRZ, TNZ, ORZ and CRZ, d3-HMMNI is used as internal standard. 
 
4.3.6 Method validation 
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For estimation of accuracy, blank hen egg samples were fortified with each analyte at 
3.0, 4.5 and 6.0 µg kg-1. Six replicate test portions, at each of the three fortification 
levels, were analysed. Analysis of the 18 test portions was carried out on three 
separate occasions. On a fourth occasion in order to determine any effects caused by 
different birds and egg types, 10 different blank samples from various birds were 
analysed, these samples consisted of five different sample types i.e. duck eggs, quail 
eggs, battery hen eggs, free range hen eggs and eggs containing omega three fatty 
acids and vitamin E. The samples were analysed in duplicate, the first were fortified 
with only internal standard, and the second set was fortified with both internal 
standard and with analytes at a concentration equivalent to 4.5 µg kg-1. For the 
estimation of the precision of the method, intra and inter-assay repeatability was 
calculated.  
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4.4 Results and Discussion 
4.4.1 Preliminary experiments:- 
The method was developed from an existing method used in the laboratory for the 
analysis of nitroimidazoles in plasma [Cronly et al., 2009 (a)] to provide 
confirmatory data for the analysis of 11 nitroimidazoles in eggs. The MS/MS 
fragmentation conditions were investigated and collision energies were optimised for 
each individual compound to give best response. For a method to be deemed 
confirmatory under Commission Decision 2002/657/EC it must yield 4 identification 
points. In this method a precursor ion (parent mass) and two daughters 
(corresponding to strong and weak ion) are monitored for each analyte (Table 4-1). 
This yields 4 identification points (1 for the parent ion and 1.5 for each daughter ion) 
hence it can be deemed a confirmatory method. In addition to this relative retention 
times and ion ratios are tracked for each compound and ensured that they are within 
acceptable ranges stated in EC 2002/657.  
When the compound HMMNI was optimised it was seen that the background noise 
was very high in its strong daughter ion when tuning its standard solution. This was 
investigated further and it was found that the use of the laboratory’s 18.2 MΩ water 
supply in the mobile phase was producing the high background. This problem was 
overcome by the use of LC-MS grade water in the mobile phase.  
From previous work carried out on these compounds it was seen that acetonitrile is 
an effective extraction solvent [Mottier et al., 2006]. Various extraction procedures 
were examined. Double extractions are common practice in sample preparation but 
this in turn leads to an increased amount of solvent and time being used. Tests were 
carried out to see if this double extraction was necessary. Results were compared 
between a single and double extraction. Comparison of double and single extraction 
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recoveries only showed an improvement of between 5-7%. This combined with the 
fact that the lowest calibration level was easily distinguished above background noise 
allowed for a single extraction step of 6ml to be utilised.  
Past work carried out on these compounds showed that the addition of NaCl helped 
to remove impurities. [Mottier et al., 2006; Xia et al., 2006]. The position at which 
NaCl addition gave the cleanest sample was ascertained by investigating whether 
addition with or after extraction solvent gave better results. The addition of NaCl (2 
g) with extraction solvent allowed for greater impurities to be removed and produced 
a cleaner sample for analysis.  
SPE is widely used as a sample clean-up method. Cartridges of extrelute NT20 
[Polzer et al., 2004], Oasis MCX [Xia et al., 2007], SCX [Sun et al. 2007] and HLB 
[Capitan-Vallvey et al., 2002], have been used in methods for the analysis of 
nitroimidazoles. Advances in LC-MSMS and its ability to operate in Multi Reaction 
Monitoring greatly reduce the effect of matrix interferences hence the need for SPE 
is reduced in some applications. As a result it was found that addition of a quick 
liquid-liquid wash step was sufficient to remove an adequate amount of interferences 
and this in turn allows for quicker sample-preparation times.  
Hexane was employed as a wash solvent in prior work carried out on these 
compounds [Mottier et al., 2006; Xia et al., 2007] therefore the use of hexane as a 
liquid-liquid wash solvent was investigated.  Hexane with varying amounts of ethyl 
acetate (0%, 2%, 5% and 10%) was used as the wash solvent. Ethyl acetate was 
added to help remove more polar impurities but on examination of samples purified 
with hexane which contained various amounts of ethyl acetate it was that ethyl 
acetate in any percentage gave poorer recoveries for some of the compounds due to 
its higher polarity. As a result hexane with no additive was chosen for the wash 
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solvent. Samples are filtered before injection to further remove impurities. Various 
types and sizes of syringe filters were investigated including PVDF, PTFE and Nylon 
filters, losses were noted for some of the analytes with both the PTFE and Nylon 
filters. Filtering the samples through 0.25 µm PVDF syringe filters gave the best 
results and these were chosen for the study.  
 
4.4.2 Validation study 
Validation of the method was carried out according to procedures described in 
Commission Decision 2002/657/EC covering specificity, calibration curve linearity, 
accuracy, absolute recovery, repeatability, decision limit (CC), detection capability 
(CC) and measurement uncertainty. An evaluation of the method was also carried 
out by running an incurred sample from FAPAS. Ruggedness is demonstrated on an 
ongoing basis through the use of this method for the routine analysis of 
nitroimidazoles in eggs as part of the National Residue Control Plan in Ireland. 
Routine analysis has been carried out by various analysis and very similar results to 
those in validation have been observed. Nitroimidazole standards are stable over 
time. The peak areas of the analytes are monitored on an ongoing basis and the 
results achieved are consistent for standards stored 4 ºC. 
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Table 4-2: Results received from Validation; CV%, Accuracy, Absolute Recovery, CCα, CCβ, 
Measurement of Uncertainty and Linearity. 
 
Analytes 
CV 
% 
Accuracy
% 
Absolute 
Recovery 
% 
CCα 
µg kg-1 
CCβ 
µg kg-1 
MU 
% 
Linearity
R2 
Dimetridazole 4.2 98.0 69 0.43 0.73 28 >0.990 
Metronidazole 3.8 106.2 58 0.38 0.64 19 >0.990 
Ronidazole 5.6 104.5 72 0.59 1.01 34 >0.990 
Ipronidazole 4.7 100.3 70 0.53 0.90 27 >0.990 
HMMNI 4.3 99.2 74 0.45 0.78 18 >0.990 
MNZ-OH 3.7 102.5 67 0.33 0.56 22 >0.990 
IPZ-OH 4.4 100.4 77 0.43 0.73 26 >0.990 
Ornidazole 7.8 92.4 77 0.79 1.34 50 >0.990 
Ternidazole 4.5 99.6 67 0.41 0.71 19 >0.990 
Carnidazole 11.3 87.2 76 1.26 2.15 61 >0.990 
Tinidazole 5.1 97.2 72 0.45 0.77 24 >0.990 
  
4.4.2.1. Specificity 
The technique of LC-MS/MS itself offers a high degree of selectivity and specificity. 
To establish the selectivity/specificity of the method, egg samples were fortified with 
the eleven analytes and the internal standards and non-fortified samples were also 
analysed. On each of Days 1, 2 and 3 egg samples were examined and on Day 4, 5 
different types of egg samples were examined.  
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4.4.2.2. Linearity of the Response 
The linearity of the chromatographic response was tested with matrix matched curves 
using 6 calibration points in the concentration range of 0 to 20µg kg-1. The 
regression coefficients (r2) for all the calibration curves used in this study were  
0.990.  
 
4.4.2.3. Absolute Recovery  
Absolute recovery was determined by analysing five replica egg samples fortified at 
4.5 µg kg-1 before extraction and five replica egg samples fortified at 4.5 µg kg-1 after 
extraction and calculating the ratio as a % of one over the other. Results given in table 
4-2 lie between 58-77%.   
 
4.4.2.4. Accuracy 
The accuracy of the method was determined using egg samples fortified at 3.0, 4.5 
and 6.0 µg kg for each analyte. Mean corrected accuracy (n = 6) of the analytes, 
determined in four separate assays shown in Table 4-2 was between 87.2% and 
106.2% for the 11 analytes. 
 
4.4.2.5. Repeatability  
Quite low values for % CV (Table 4-2) were achieved for the majority of 
compounds, the main reason for this can be attributed to the availability of six 
deuterated analogues of the compounds being examined. For those compounds 
without a deuterated analogue namely metronidazole, ternidazole, carnidazole, 
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ornidazole and tinidazole; d3-HMMNI is used and corrects quite well for any losses 
or matrix suppression of the other compounds. 
 
4.4.2.6. CC and CC 
The decision limit (CC) of the method was calculated according to the calibration 
curve procedure using the intercept (value of the signal, y, where the concentration, x 
is equal to zero) and 2.33 times the standard error of the intercept for a set of data 
with 6 replicates at 3 levels (3, 4.5 and 6 µg kg-1). The detection capability (CC) 
was calculated by adding 1.64 times the standard error to the CC. Blank egg tissue 
was fortified at 1, 1.5 and 2 times the RL of 3µg kg-1 for each analyte; 3µg kg-1 for 
each compound has been used for the method validation in this work as this is the RL 
suggested by the Community Reference Laboratory (CRL) in Berlin for some of 
these analytes. CC is the concentration corresponding to the intercept + 2.33 times 
the standard error of the intercept. CC values of for all 11 compounds are listed in 
Table 4-2 and are all below 1.52 µg kg-1. CC is the concentration corresponding to 
the signal at CC + 1.64 times the standard error of the intercept (i.e. the intercept + 
3.97 times that standard error of the intercept). CC values for all 11 compounds are 
listed in Table 4-2 and are all below the RL of 3 µg kg-1. 
  
4.4.2.7. Measurement Uncertainty 
The  measurement  of  uncertainty  was  estimated  by  taking  into  account  the  
within laboratory reproducibility over days 1, 2 and 3 as well as considering the 
repeatability on day 4 due to matrix effects caused by different egg matrices These 
two variabilities were combined and multiplied by  a  coverage  factor  of  three  to  
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give  an  overall  figure  for  the  uncertainty  of  the measurement. This approach of 
using the within laboratory reproducibility as a good estimator of measurement of 
uncertainty is taken from the SANCO/2004/2726rev1 document (SANCO 
2004/2726rev1 2004). It recommends using the within laboratory reproducibility and 
using a coverage factor of 2.33 to estimate expanded uncertainty, however as  it was  
felt  that not all  the environmental and other  factors  that could be varied  over  the  
course  of  the  validation were  examined,  hence  a  coverage factor of 2.33 may 
underestimate  the true uncertainty of the method. So a value of 3 was  chosen 
instead  to  give  a  more  realistic  value  for  the  true  uncertainty,  this approach 
was acceptable to the ISO17025 (ISO/IEC 17025 2005) auditors as well. Values for 
MU are seen in Table 4-2 and lie between 18 and 61%. High MU values are seen for 
CNZ and ORZ as they have no deuterated analogue to use as an internal standard. 
These values are increased further due to a high value for reproducibility due to 
matrix as a result of a high biological variation between species (day 4 experiment). 
 
4.4.2.8. Evaluation 
Table 4-3: Results of FAPAS Proficiency Test 
 
SAMPLE: FAPAS  PT 02120 
RANGE 
Compound Actual Amt (µg kg-1) 
Calculated Amt 
(µg kg-1) MU(%) MU of 
Cal Amt Upper Lower 
 
Z-
Scores
MNZ 3.5 2.942 19.45 0.572 3.514 2.370 0.7 
MNZ-OH 2.67 3.085 22.23 0.686 3.771 2.399 -0.7 
 
In order to evaluate this method an incurred sample received as part of the Food 
Analysis Performance Assessment Scheme (FAPAS) was analysed. Figure 4-3 
shows chromatograms with both the strong and weak ions for MNZ-OH and MNZ 
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which were found to be present in these samples. These  samples were  tested  using  
the method  described  here  and found  to  yield  satisfactory  results. Z-scores 
achieved for both compounds were less than 1. As well as good z-scores when the 
method measurement of uncertainty is applied, the assigned values fall within the 
possible range of concentrations given by this method. Also the method found no 
peaks of analytes that were not present in the sample. Results of this proficiency test 
are seen in table 4-3. 
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Figure 4-3:  Chromatogram of FAPAS egg sample incurred with (1) MNZ-OH and (2) MNZ; (a) 
Strong Ion (b) Weak Ion (c) Internal Standard; (1) d2-MNZ-OH and (2) d3-HMMNI 
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4.5 Conclusions 
The objective of this work was to develop a rapid confirmatory method capable of 
identifying, confirming and quantifying eleven nitroimidazole compounds in egg at 
µg kg-1 levels and to validate according to the requirements in Commission Decision 
2002/657/EC and this was successfully completed.  
The method can be considered as rapid, as it utilises only a hexane wash and omits 
the use of the time consuming SPE step, it also utilises chromatography which 
separates all analytes in a total run time of only 20 minutes. The method includes 11 
nitroimidazole compounds including seven that are suggested by the CRL in Berlin 
to be analysed as well as other nitroimidazoles that are rarely if at all analysed such 
as tinidazole, ornidazole and carnidazole. 
The obtained data fulfills the requirements laid down in Commission Decision 
2002/657/EC and allows the calculation of all relevant performance characteristics. 
This study shows that the developed method meets the required sensitivity of 3 µg 
kg-1 which is the RL used for these compounds. The CC and CC values 
determined for each analyte are lower than this level. The method performs very well 
in terms of accuracy and repeatability for each of the analytes due to the utilisation of 
six different deuterated internal standards. The values achieved for accuracy, %CV 
and measurement of uncertainty all fall within acceptable ranges. The applicability of 
the method for use on different types of eggs was demonstrated by the satisfactory 
results obtained from the Day 4 analysis of different species.The reduced number of 
analytical steps within the method makes it very amenable for high through-put 
regulatory monitoring of these compounds. 
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5.1 Abstract 
A liquid chromatography tandem mass spectrometry method recently developed, 
validated and accredited was used to screen for the presence of metronidazole, 
ronidazole dimetridazole ipronidazole, ternidazole, tinidazole, ornidazole carnidazole 
and three hydroxy metabolites hydroxy-metronidazole, HMMNI and hydroxy-
ipronidazole in Irish retail egg samples . The method used had had decision limits 
(CCin the range 0.33-1.26 µg kg-1 and detection capabilities (CC, ranging from 
0.56-2.15 µg kg-1 for all analytes. The internal standard corrected recovery 
calculated for the various analytes range between 87.2-106.2% while the coefficient 
of variance expressed as %CV range between 3.7-11.3%. The method was applied to 
160 samples of caged, free range and organic hen and duck eggs available on the 
Irish Retail market as well as two incurred proficiency test egg samples. No 
nitroimidazole residues were detected in the survey samples above CCα and the 
results achieved for the two proficiency test samples were acceptable when compared 
with the assigned values.  
Keywords: Nitroimidazoles; eggs; retail survey; LC-MS/MS 
 
5.2 Introduction 
129 
Nitroimidazoles (NMZs) are imidazole heterocycles with a nitrogen group 
incorporated in the structure. Examples of these compounds are metronidazole 
(MNZ), dimetridazole (DMZ), ronidazole (RNZ), ipronidazole (IPZ), carnidazole 
(CNZ), ornidazole (ONZ), ternidazole (TRZ) and tinidazole (TNZ). These examples 
are known as 5-nitroimidazoles as they contain a NO2 group on the 5 ring position. 
The structures of these compounds can be seen in figure 5-1. 5-NMZs are active 
against most obligate anaerobic bacteria and a variety of protozoa; as a result they 
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are very effective in the prophylactic and therapeutic treatment of histominiasis and 
coccidiosis in poultry [Bishop, 2005]. 
 
 
                  HMMNI 
(2-hydroxymethyl-1-methyl-5-nitroimidazole) 
Dimetridazole 
(1, 2-dimethyl-5-nitroimidazole) 
Ronidazole 
(1-methyl-2-[(carbamoyloxy) methyl]-5-
nitroimidazole) 
Metronidazole 
(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole) 
MNZ-OH 
(1-(2-hydroxyethyl)-2-hydroxymethyl-5-
nitroimidazole) 
Ipronidazole 
(2-isopropyl-1-methyl-5-nitroimidazole) 
IPZ-OH 
(1-methyl-2-(2′-hydroxyisopropyl)-5-
nitroimidazole) 
Carnidazole 
(1-(2-ethylcarbamothioic acid 
O-methyl ester)-2-methyl-5-
nitroimidazole) 
Ornidazole 
(1-(3-chloro-2-
hydroxypropyl)-2-methyl-5-
nitroimidazole) 
Ternidazole 
2-Methyl-5-nitroimidazole-1-
propanol; 3-(2-Methyl-5-
nitroimidazol-1-yl)propan-1-ol 
N
NO 2N
S O 2
Tinidazole 
1-(2-ethylsulfonylethyl)-2-
methyl-5-nitro-imidazole 
 
Figure 5-1: Structures of eleven nitroimidazole residues that were analysed for as part of the 
survey. 
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Toxicological studies carried out on these compounds suggest that they are possibly 
carcinogenic and mutagenic in humans. The European Agency for the Evaluation of 
Veterinary Products (EMEA) have published summary reports on three 
nitroimidazole compounds; metronidazole [EMEA Report, Metronidazole], 
dimetridazole [EMEA Report, Dimetridazole] and ronidazole [EMEA Report, 
Ronidazole]. While the reports suggest the studies carried out on humans are 
insufficient and inconclusive to prove or disprove carcinogenicity of these 
compounds, results in animal studies are conclusive [IARC, 1987]. This in their 
opinion is enough to consider these compounds as carcinogenic and in the interest of 
human health they are prohibited for use in food producing animals.  
Due to these possible health risks associated with their use, nitroimidazole 
compounds previously used for treatment in animal husbandry, were prohibited 
originally by there inclusion in Annex IV of Commission Regulation 2377/90 but 
now by inclusion table 2 of Commision Regulation 37/2010. Compounds in this table 
are ones for which no Maximum Residue Level (MRL) can be fixed and therefore 
are prohibited for use in food producing animals. However because of concerns over 
these compounds no other 5-NMZ such as IPZ and TRZ has been issued a license for 
use in food producing animals and are therefore also prohibited. 
NMZ compounds are rapidly metabolised in bovine, porcine and avian species. The 
main metabolite of DMZ, IPZ and MNZ results from the oxidation of the side chain 
in the C-2 position of the imidazole ring to form hydroxy metabolites [EMEA 
Report, Metronidazole]. RNZ has a different degradation pathway but results in an 
identical metabolite to that of DMZ. These metabolites are 2-hydroxymethyl-1-
methyl-5-nitroimidazole (HMMNI), hydroxy-metronidazole (MNZ-OH) and 
hydroxy-ipronidazole (IPZ-OH). The structures of these compounds are seen in 
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figure 5-1. As these compounds still contain the imidazole ring their carcinogenicity 
cannot be overlooked. Also these metabolites can be an indication of potential 
misuse of prohibited nitroimidazoles compounds and therefore should also be 
examined. From studies carried out by Polzer et al., 2004 on the measurements of the 
parent drug and the corresponding main hydroxy-metabolite in various incurred 
materials it can be concluded that HMMNI should be chosen as target analyte to 
prove a treatment with DMZ. The metabolite IPZ-OH is recommended to detect an 
illegal medication with IPZ. To check for a treatment with RNZ or MNZ, the 
measurement of the parent drug is to be preferred. The studies also go on to state that 
the ratio of parent drug to metabolite was found to vary with the length of the 
withdrawal time in the case of a treatment with DMZ and respective data on the 
behaviour of the other nitroimidazoles are not available to date, it is recommended to 
monitor both, the parent drug and the respective metabolite, whenever possible in 
order to get more reliable results [Polzer et al., 2003]. 
The European Union Reference Laboratories (EURLs) published a Guidance 
Document in 2007 (CRL Guidance 2007) that outlined recommended 
concentration/levels (RC/RL) that laboratories should aspire to measure for 
prohibited substances with no legislative minimum required performance level 
(MRPL). The document also specified which matrices should be sampled and also 
what marker residue should be analysed (parent drug or metabolite). The information 
given in this document in relation to nitroimidazoles can be seen in table 5-1. 
Matrices that should be used for the analysis of nitroimidazoles are plasma, retina 
and eggs (Polzer at al., 2003). A level of 3 μg kg-1 has been assigned as the RL for 
NMZs and all methods used in the analysis of NMZ residues should be capable to 
detect to at least this level. 
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Table 5-1: EURL recommendations for nitroimidazoles adapted from CRL Guidance Document 
2007. 
Recommended 
Concentaration * 
Substances Matrix 
Poultry: 
Nitroimidazole: 
Dimetridazole, 
Ronidazole, 
Metronidazole 
Plasma, 
Serum, 
Eggs 
3ppb  
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Although these compounds have been prohibited for use in food producing animals 
since the mid 1990s their analysis in eggs has not always been carried out. This was 
the case in Ireland where their analysis in eggs was not carried out prior to 2007. 
From examination of non compliant findings in Europe, reported in the European 
Food Safety Authority (EFSA) annual report and on the Rapid Alert System for Food 
and Feed (RASFF) the abuse of these prohibited compounds cannot be overlooked. 
The 2009 report from EFSA states that there were 6 non compliant findings of 
nitroimidazole residues in 2007 and 5 in 2008. All positive findings were in poultry 
meat and egg products for metronidazole and ronidazole in two member states 
[EFSA Report, 2009]. From examination of the RASFF reports two positive results 
for poultry meat products also contained metronidazole and ronidazole. Hence taking 
into consideration these non compliant findings and the lack of analysis carried out 
on these compounds in eggs in Ireland prior to 2007, it was felt that an examination 
 
Pigs (and others species): 
hydroxy metabolites: 
MNZ-OH, 
Plasma, 
Serum, 
HMMNI 
Muscle 
* CCbeta for screening methods or CCalpha for confirmatory methods should be lower than the value 
expressed in this column 
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of eggs available in the Irish retail market for the presence of NMZ residues would 
be beneficial. It would firstly help ensure that the ban on these compounds is being 
observed and secondly it would give confidence to the consumer that the eggs that 
reach the table are free from these harmful residues. 
To the best of our knowledge, no data on the presence of NMZ residues in Irish Eggs 
has previously been published. Therefore the aim of this study was to examine 
occurrences of NMZ residues in eggs sold on the Irish retail market. The analysis of 
160 egg samples for eleven NMZ compounds was carried out with an in house 
validated and ISO 17025 accredited LC-MS/MS method (Cronly et al., 2009 (b)). 
 
5.3 Materials and methods 
5.3.1 Sample collection and preparation 
Table 5-2: Information on samples taken as part of the survey  
 
  Hen Eggs Duck Eggs 
Total Numbers 148 12 
Leinster 36 3 
Munster 62 5 
Connaght 30 2 
Purchased in 
Ulster 20 2 
Free Range 118 12 
Organic 14 0 
Caged 11 0 
Farming 
Practices 
Barn 5 0 
This survey was carried out in conjunction with Ashtown Food Research Centre 
(AFRC) and the collection of eggs was performed by them. Hen and duck eggs were 
purchased from farmer markets, small shops, convenience stores and large chain 
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supermarkets all over Ireland. To ensure representative samples 12 eggs were used 
for each one. Whole egg samples were homogenised, transferred into polypropylene 
tubes (50ml) and stored at -20ºC until transfer to our laboratory. These samples were 
delivered by courier in a frozen state and stored at -20ºC until analysis. A table of 
samples analysed and information related to them can be seen in table 5-2. 
 
5.3.2 Chemicals and materials 
CNZ, TNZ, TRZ, ORZ were provided by the EURL (BVL, Berlin, Germany). IPZ-
OH,  MNZ, IPZ, HMMNI, MNZ-OH, HMMNI-d3, MNZ-OH-d2, DMZ- d3 and 
RNZ -d3 (all from WITEGA Laboratorien Berlin), RNZ and DMZ (Sigma, St. Louis, 
MO). Water is of LC-MS grade quality (Fluka). All other solvents were of LC 
quality and purchased from Reagecon (Clare, Ireland). Sodium Chloride was AnalaR 
grade and purchased from VWR (Poole, England). Individual stock standards at 1mg 
mL-1 in ethanol were prepared and stored at 4ºC for 1 year. Individual intermediate 
standard solutions (10 and 1 µg mL-1) in methanol were prepared and working 
standard solutions (mixture of nitroimidazoles) (300 ng mL-1) were prepared in 
methanol and stored at 4ºC for 3 months. Deuterated standards were prepared 
similarly except mixed standard was 300 ng mL-1. 
 
5.3.3 Sample extraction 
Extraction method is one taken from Cronly et al., 2009 (b). In brief; egg samples (3 
g) are weighed into a polypropylene centrifuge tubes (50 mL). These are fortified 
with mixed internal standard. A calibration curve is run with each batch by fortifying 
blank egg at levels corresponding to 0, 2.5, 5, 7.5, 10 and 20 µg kg-1 by adding mix 
working standard containing each analyte (0, 25, 50, 75, 100 and 200µL) and these 
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are vortexed (20 s). To these samples acetonitrile (6 mL) is added and the tubes are 
vortexed. NaCl (1.2 g) is added and shaken vigorously by hand before centrifuging 
(4350 x g for 10min). The top organic layer is then transferred to a polypropylene 
tube (15 mL). Hexane (3.5 mL) is added and this is vortexed (30 s). The hexane layer 
is then removed and the extracts are evaporated to dryness at 50ºC under a nitrogen 
stream. They are then reconstituted in 95:5 Water: ACN (200 µL). Before injection 
the samples are filtered through 0.2 µm PVDF syringe filters. An aliquot (20 µL) is 
injected onto the LC column. A chromatogram of a 2.5 µg kg-1 fortified egg sample 
is presented in figure 5-2. 
 
5.3.4 Liquid chromatography tandem mass spectrometry conditions 
Two LC-MS/MS systems were used in the analysis of these samples, first was a TSQ 
Quantum Ultra EMR coupled to a Finnigan Surveyor LC system and controlled by 
Xcalibur software (Version 1.4) and the second one an AB Sciex Triple Quad 5500 
couple to Schimadzu UFLC XR LC system which is controlled by Analyst Software 
1.5. Separation was achieved using C18 column with an oven temperature was set at 
40 ºC. The chromatographic separation performed on gradient mode using water 
acidified with 0.1% acetic acid (mobile phase A) and acetonitrile acidified with 0.1% 
acetic acid (mobile phase B). As the two LC are different one being HPLC and the 
other UPLC the gradients and runs time are different. The gradients and mass 
spectrometer parameters for the respective instruments can be seen in table 5-3.  The 
ionisation mode used was positive electrospray ionisation (ESI) mode and the 
individual MRMs with there respective collision energies were optimised for both 
instruments and are listed in table 5-4. 
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Table 5-3: LC and MS/MS parameters for Instrument 1 (Thermo TSQ Quantum) and 
Instrument 2 (AB Sciex 5500) used in analytical method. 
 
Instrument 1 Instrument 2 
HPLC Gradient UHPLC Gradient 
Time (min) %A %B Flow mL min-1 Time (min) %A %B Flow mL min-1 
0 95 5 0.25 0 95 5 0.55 
4 95 5 0.25 1.5 95 5 0.55 
7 5 95 0.25 3 5 95 0.55 
9 5 95 0.25 5 5 95 0.55 
12 95 5 0.25 6 95 5 0.55 
20 95 5 0.25 9 95 5 0.55 
TSQ Quantum Mass Spectrometer 
Parameters AB Sciex 5500 Spectrometer Parameters 
Ionisation Mode: 
ESI (Positive 
Mode) Ionisation Mode: ESI (Positive Mode) 
Spray Voltage: 4350V Spray Voltage: 4500V 
Capiliary Temperature: 325ºC Source Temperature: 650ºC 
Source CID:  0 CAD Gas: 8 
Collision Pressure: 1.5 Torr Entrance Potential: 10V 
Tube Lens Offset: 75 Curtain Gas Pressure: 45psi 
Quad MS/MS Bias: -1 
Ion Source Gas1 
Pressure: 50psi 
Sheath Gas Pressure: 65 
Ion Source Gas2 
Pressure: 60psi 
Auxilary Gas Pressure: 35 Resolution Q1: unit 
Ion Sweep Gas Pressure: 0 Resolution Q3: unit 
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Table 5-4: Information on precursor ion, product ion, collision energies and retention times for 
each of the eleven nitroimidazole residues on both instruments. 
Collision Energy (eV) Retention Time (min) 
Compound Precursor(M/z) 
Product 
(M/z) Instrument 
2 
Instrument 
1 
Instrument 
2 
Instrument 
1 
123 17 16 
MNZ-OH    188 
126 23 17 
1.34 3.23 
110 20 18 
HMMNI     158 
140 17 13 
1.77 4.38 
82 33 25 
MNZ        172 
128 19 15 
2.11 5.02 
140 17 15 
RNZ        201 
55 29 20 
2.38 5.81 
96 21 18 
DMZ        142 
81 31 28 
3.05 7.35 
128 19 17 
TRZ        186 
82 37 28 
3.69 8.6 
121 23 18 
TNZ        248 
82 47 15 
3.97 11.71 
168 19 14 
IPZ-OH     186 
122 27 21 
4.09 12.12 
128 23 17 
ORZ        220 
82 39 33 
4.11 12.19 
118 21 13 
CRZ        245 
75 43 33 
4.27 12.57 
124 25 18 
IPZ         170 
109 33 25 
4.32 12.67 
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5.3.5 Validation studies 
The validation studies of this method can be seen in Cronly et al. 2009(b). The 
method was validated in accordance with Commission Decision 2002/657. The 
validation results associated with this method can be seen in table 5-5. To ensure the 
ongoing competency of the method proficiency test samples were analysed using the 
method. The results achieved from this scheme must meet requirements set out by 
both the organiser of the scheme in this case Food Analysis Performance Assessment 
Scheme (FAPAS) as well as in house laboratory requirements for performance in 
proficiency schemes. 
 
Table 5-5: Validation results of %CV, accuracy, absolute recovery, CCα, CCβ, MU and 
linearity. 
Analytes CV % 
Accuracy 
% 
Absolute 
Recovery 
% 
CCα 
µg kg-1 
CCβ 
µg kg-1 
MU 
% 
Linearity
R2 
Dimetridazole 4.2 98.0 69 0.43 0.73 28 >0.990 
Metronidazole 3.8 106.2 58 0.38 0.64 19 >0.990 
Ronidazole 5.6 104.5 72 0.59 1.01 34 >0.990 
Ipronidazole 4.7 100.3 70 0.53 0.90 27 >0.990 
HMMNI 4.3 99.2 74 0.45 0.78 18 >0.990 
MNZ-OH 3.7 102.5 67 0.33 0.56 22 >0.990 
IPZ-OH 4.4 100.4 77 0.43 0.73 26 >0.990 
Ornidazole 7.8 92.4 77 0.79 1.34 50 >0.990 
Ternidazole 4.5 99.6 67 0.41 0.71 19 >0.990 
Carnidazole 11.3 87.2 76 1.26 2.15 61 >0.990 
Tinidazole 5.1 97.2 72 0.45 0.77 24 >0.990 
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5.4 Results and discussions 
The LC–MS/MS method published in Cronly et al., 2009(b) was used to provide 
confirmatory data for the analysis of 11 nitroimidazole compounds in hen and duck 
eggs. The MS/MS fragmentation conditions were optimised in the method for each 
individual compound to give best response. For a method to be deemed confirmatory 
under Commission Decision 2002/657/EC it must yield 4 identification points. In this 
method a precursor ion (parent mass) and two product ions (corresponding to strong 
and weak ion) are monitored for each analyte (Table 5-4). This yields 4 identification 
points (1 for the precursor ion and 1.5 for each product ion) hence it can be deemed a 
confirmatory method. In addition to this relative retention times and ion ratios are 
monitored for each compound and evaluated to ensure that they are within acceptable 
ranges as stated in EC 2002/657. The developed extraction method assisted with the 
reduction of matrix associated ion suppression but did not eliminate it completely; 
this possible problem was overcome by the use matrix matched calibration curves 
and deuterated internal standards. The method was fully validated in accordance with 
Commission Decision 2002/657. The validation results associated with this method 
can be seen in table 5. The method has also received ISO 17025 accreditation. 
Table 2 lists the breakdown of samples analysed as part of this survey. The majority 
incorporated in this survey were hen eggs as they are the most widely available on 
the Irish market. The survey also analysed a number of duck egg samples. The 
samples are broken into these two categories and information associated to province 
of purchase and farming type is given. The samples were batched in numbers of ten 
to fifteen each month and analysed using the accredited method. They were analysed 
of the AB Sciex 5500 LC-MS/MS or Thermo Quantum LC-MS/MS. With each batch 
a calibration curve was run and certain parameters were examined to ensure the 
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extractions and instrumental analyses were successful. The 2.5 µg kg-1 matrix 
extracted standard was run at the start and the Signal to Noise (S:N) for the weakest 
transition for each analyte needed to be greater than 25. A chromatogram for each 
compound at the lowest calibration level 2.5 µg kg-1 with associated S:N can be seen 
in figure 5-2.  
 
M NZ-OH 
H M M NI
M NZ
R N Z
DM Z
TR Z 
TN Z 
IPZ-O H 
OR Z 
C R Z 
IPZ 
 
 
Figure 5-2: Chromatogram showing signal to noise of the eleven nitroimidazole residues in 2.5 
µg kg-1 fortified blank egg sample relating to the lowest calibration. 
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The calibration curve had to have a correlation coefficient of greater than 0.99 and an 
intercept smaller than ± 0.3. Finally the internal standard in each sample had to have 
a S:N greater than 25 to ensure that the extraction had worked for each sample. 
Example of internal standards in samples with their associated S:N values can be 
seen in figure 5-3. If these parameters were not met the sample would be repeated. 
 
 
D3-IPZ 
D3-IPZ-OH
D3-DM Z
D3-RNZ 
D3-HM M N I 
D3-M NZ-OH 
 
Figure 5-3: Chromatogram showing the signal to noise of the six internal standards in a survey 
sample. 
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In addition to these batch suitability tests, the method was tested on an ongoing basis 
by its use to analyse two proficiency test (PT) samples provided by FAPAS. These 
were run in the same way as the survey samples and the results achieved were 
compared to the assigned values. The chromatograms relating to the strong and weak 
ions and internal standard for the positive PT samples can be seen in figure 5-4. The 
results achieved gave very acceptable Z scores of less than +/- 2 and were well 
within the measurement uncertainty MU of the method. 
The samples analysed as part of the survey were collected all over the country over a 
two year period in 2009 and 2010. The samples were sourced from different retail 
outlets and markets from every province in Ireland to ensure that the egg samples 
analysed were representative of eggs that are available to the Irish consumer. From 
examination of the results of all 160 hen and duck egg samples no non compliant 
findings were observed for any of the 11 nitroimidazole residues investigated. 
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MNZ 
Strong 
Ion 
MNZ 
Strong 
Ion 
MNZ 
Weak 
Ion 
MNZ 
Weak 
Ion 
Int. Std. 
D3-HMNNI Int. Std. 
D3-HMNNI 
MNZ–OH 
Strong  MNZ–OH 
Strong  Ion 
Ion 
MNZ–OH 
Weak  MNZ–OH 
Weak  Ion 
Ion 
Int. Std. 
D2-MNZ-OH Int. Std. 
D2-MNZ-OH 
Figure 5-4: Chromatograms of strong and weak ions and internal standards relating to non 
compliant results associated with FAPAS proficiency test samples  
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5.5 Conclusions 
The results indicate a zero incidence of illegal or accidental use of nitroimidazoles in 
Irish poultry egg industry. The method used in the analysis of 160 hen and duck egg 
samples was one published by Cronly et al., 2009(b) and was validated in accordance 
with Commission Decision 2002/657/EC and has achieved ISO 17025 accreditation. 
Each batch analysed had to meet certain requirements for acceptance and in the case 
of all samples this was achieved. The method was further tested by its use in the 
analysis of PT samples and results achieved demonstrated the method was capable of 
the confirmation and quantitation of nitroimidazole residues in egg samples. Results 
achieved had Z scores less 2 and were within MU of the method. Confirmatory 
criteria of Ion ratios and RRT were within criteria set out in European legislation. 
When taking into consideration non compliant findings in eggs in Europe and the 
lack of analysis carried out on these compounds in eggs in Ireland prior to 2007, it 
was felt that an evaluation of eggs available in the Irish retail market for the presence 
of NMZ residues would be beneficial. Upon carrying out this survey which resulted 
in complaint findings for all samples analysed it is felt that this demonstrates that the 
ban on these compounds is being observed and secondly it gives confidence to the 
consumer that the eggs that reach the table are free from these harmful residues. 
Taking this into consideration it is felt that the monitoring of these compounds in 
eggs which is being carried out as part of the national monitoring plan is sufficient to 
ensure the continued enforcement of these prohibited compounds in eggs. In addition 
to this the results achieved for this study will be added to other research which is 
ongoing in AFRC in the hope of producing a dietary exposure assessment of food on 
the Irish market. 
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6.1. Abstract 
A confirmatory method was developed to allow for the analysis of eleven 
nitroimidazoles and also chloramphenicol in milk and honey samples. These 
compounds are classified as A6 compounds in Annex IV of Council Regulation 
2377/90 (European Commission 1990) and therefore prohibited for use in animal 
husbandry. Milk samples were extracted by acetonitrile with the addition of NaCl; 
honey samples were first dissolved in water before a similar extraction. Honey 
extracts underwent a hexane wash to remove impurities. Both milk and honey 
extracts were evaporated to dryness and reconstituted in initial mobile phase. These 
were then injected onto a liquid chromatography-tandem mass spectrometry (LC-
MS/MS) system and analysed in less than 9min. The MS/MS was operated in 
multiple reaction monitoring (MRM) mode with positive and negative electrospray 
ionization. The method was validated in accordance with Commission Decision 
2002/657/EC and is capable of analysing metronidazole, dimetridazole, ronidazole, 
ipronidazole and there hydroxy metabolites hydroxymetronidazole, 2-
hydroxymethyl-1-methyl-5-nitroimidazole, and hydroxyipronidazole. The method 
can also analyse for carnidazole, ornidazole, ternidazole, tinidazole, and 
chloramphenicol. A recommended level of 3 gL-1/gkg-1 for methods for 
metronidazole, dimetridazole, and ronidazole has been recommended by the 
Community Reference Laboratory (CRL) responsible for this substance group, and 
this method can easily detect all nitroimidazoles at this level. A minimum required 
performance level of 0.3 gL-1/gkg-1is in place for chloramphenicol which the 
method can also easily detect. For nitroimidazoles, the decision limits (CCα) and 
detection capabilities (CCβ) ranged from 0.41 to 1.55 gL-1 and from 0.70 to 2.64 
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gL-1, respectively, in milk; and from 0.38 to 1.16 gkg-1 and from 0.66 to 1.98 
gkg-1, respectively, in honey. For chloramphenicol, the values are 0.07 and 0.11 
gL-1 in milk and 0.08 and 0.13 gkg-1 in honey. Validation criteria of accuracy, 
precision, repeatability, and reproducibility along with measurement uncertainty 
were calculated for all analytes in both matrices. 
Keywords: Nitroimidazoles; chloramphenicol; milk; honey; lc-ms/ms; validation 
 
6.2. Introduction 
6.2.1. Nitroimidzoles 
5-Nitroimidazoles are primarily used for the prophylactic and therapeutic treatments 
of diseases such as histominiasis and coocidiosis in poultry, hemorrhagic enteritis in 
pigs and genital trichomoniasis in cattle. Recently, reports from China suggest that 
the use of nitroimidazoles in beekeeping is being practiced [Zhou et al., 2007]. 
Nitroimidazoles may be used to prevent and control Nosema apis in hives. Nosema 
Apis is a microsporidian pathogen that is commonly found in Apis mellifera 
throughout the beekeeping world [Official Method (2003)].  
Nitroimidazoles(NMZs) are believed to be carcinogenic and mutagenic to humans 
and as a consequence are placed in the group A6 (prohibited) substances and their 
use in food producing animals within the European Union is not permitted under 
Regulation 2377/90. They are also prohibited for use in the U.S.A and China. The 
analysis of these compounds is required under Council Directive 96/23/EC. The CRL 
has also established a recommended level (RL) of 3 gL-1/gkg-1 for these 
compounds. There is a need for rapid multi residue analytical methods that have the 
capability to include a wide rage of these analytes in all matrices where abuse may be 
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found. The structure of these 5-nitroimidazoles and their metabolites are seen in table 
6-1. 
The Community Reference Laboratory (CRL) in Berlin has carried out homogeneity 
and stability studies on NMZs in various matrices [Polzer et al., 2004, Polzer et al., 
2005]. These studies showed that there is not a homogenous distribution of these 
analytes in turkey muscle and they also observed a rapid degradation in analyte 
concentration stored for prolonged periods above 4 °C. In contrast it was discovered 
that for plasma, retina and egg samples; the analytes were stable during storage under 
the same conditions which resulted in stable concentrations and allowed detection of 
these compounds for longer periods after medication had been halted. Therefore, it is 
advised that plasma, retina and eggs be used as target matrices for the residue control 
of NMZs [Polzer et al., 2004, Polzer et al., 2005]. 
As a result of these published studies there has been an increase in the methods being 
developed for the analysis of these compounds in matrices such as egg [Mottier et al. 
2006, Mohammed et al., 2008, Xia et al., 2006, Daeseleire et al., 2000, Cronly et al., 
2009(b)] and plasma [Aerts et al., 1991, Fraselle et al., 2007, Thompson et al., 2009, 
Cronly et al., 2009(a)]. The majority of methods published for the analysis of eggs 
involve extraction with acetonitrile and the addition of NaCl. Purification 
methodologies of these extracts varied. Solid Phase Extraction (SPE) such as 
Hydrophilic Lypophilic Balance (HLB) catridges [Mottier et al., 2006] or Molecular 
imprinted (MIPs) SPE cartridges [Mohamed et al., 2008] were used. In some 
methods the samples were just filtered before injection and satisfactory results were 
still achieved [Xia et al., 2006, Daeseleire et al., 2000, Cronly et al., 2009(a), (b)]. 
Methods for the analysis of these compounds in plasma are varied in their extraction 
protocols. Extraction solutions such as aqueous buffer [Aerts et al., 1991], 
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NaCl/Potassium phosphate buffer (Fraselle et al., 2007) and acetonitrile [Thompson 
et al., 2009, Cronly et al., 2009 (b)] have been used in the extraction of NMZs from 
plasma. SPE catridges of Extrelut [Aerts et al., 1991] and Chromabond kieselguhr 
[Fraselle et al., 2007] have been used in the sample purification in this matrix. 
Cronly et al., 2009 (a) omits the use of SPE and clean up is achieved by purifying 
samples with the use of a hexane wash step and filtering before injection.  
While suitable methods now exist for monitoring these analytes, no suitable methods 
in matrices such as milk and honey exist for the comprehensive confirmatory 
analysis of NMZs. The CRL for NMZs has suggested that honey be tested to 
ascertain any possible misuse and if non-compliant results are found then this matrix 
should be included in monitoring plans. They also state that countries with high milk 
production should also analyse for these analytes in milk as their possible misuse in 
this matrix cannot be discounted. From investigation of literature only two method 
could be found that allows for the analysis of NMZs in honey. Zhou et al., 2007 
published a method for the analysis of 5 NMZs in honey by HPLC-UV. Samples 
were extracted with ethyl acetate and evaporated. The residue containing the NMZs 
was dissolved in ethyl acetate–hexane and subjected to solid-phase extraction 
cleanup by amino extraction columns. The eluent was evaporated, reconstituted and 
injected onto the column. The second by Mol et al., 2008, was a multi-class 
multiresidue method for the analysis of veterinary residues in honey. While the 
method was confirmatory for eight nitroimidazole compounds it could only analyse 
to 10 g kg-1 which is three times higher the RL for these compounds. 
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[Thompson et al., 2009] or time of flight mass spectrometers [Ortelli et al., 2009; 
Stolker et al., 2008]. From investigation of literature there are no methods for the 
confirmatory analysis of NMZs in milk at the levels desired. 
 
6.2.2. Chloramphenicol 
Chloramphenicol (CAP) is a broad spectrum bacteriostatic antibiotic that exerts its 
effect by inhibiting bacterial protein synthesis. The structure of CAP is seen in table 
6-1.  Research carried out on CAP has shown that it has adverse toxicological affects 
in human such as aplastic anaemia or grey-syndrome. Due to these health concerns it 
has been classified as an A6 compound in annex IV of council regulation 2377/90 
which means it is prohibited for use in food producing species. CAP has been issued 
a minimum required performance limit (MRPL) of 0.3 ng mL-1 which means all 
methods should be able to at least see to this level. As a result of this low level; CAP 
is often analysed in single analyte methods [Rejtharova et al., 2009; Ronning et al., 
2006] although some multi amphenicol methods do exist [Zhang et al., 2008; Shen et 
al., 2009]. In addition to this there are two other multiclass methods which include 
the analysis of CAP [Lopez et al., 2008 and Sheridan et al., 2008.] These analyse for 
CAP with compounds that are not prohibited for use such as sulfonamides and 
tetracyclines. 
A common trend in analysis of CAP in any matrix is the use of an SPE clean-up. 
Common cartridge chemistries used in the analysis of CAP are Oasis HLB [Shen et 
al., 2009], Mixed Cation Exchange (MCX) [Zhang et al., 2008] and the selective 
technique of Molecular Imprinted Polymers (MIPs) [Rejtharova et al., 2009; Boyd et 
al., 2007] An investigation into the methods used to analyse for CAP found that it is 
often analysed singly in several matrices including milk and honey. Ronning et al., 
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2006 developed a method that anaylse for CAP residues in meat, seafood, egg, 
honey, milk, plasma and urine with liquid chromatography–tandem mass 
spectrometry. Samples were extracted with acetonitrile and chloroform was added to 
remove water. Extracts were then evaporated to dryness, reconstituted and filtered 
before injection.  Rejtharova et al., 2009 described a method for the analysis of CAP 
in urine, feed water, milk and honey samples by GC-MS-NCI using molecular 
imprinted polymer clean-up. 
On examining published literature it is quite clear that the confirmatory analysis of 
NMZs in milk and honey has not been examined to date. No confirmatory methods 
could be found for the analysis of these analytes in the matrices of honey and milk. 
With growing concerns from China about the use of NMZs in honey the CRL having 
recommended that this matrix be examined. The CRL have also recommended that 
countries with high milk production should analyse for these compounds in milk. 
Therefore there is a need for a comprehensive method to allow for the confirmatory 
analysis of both these matrices. In addition to this, while the analysis of CAP in all 
matrices is being performed it is often performed using single analyte methods which 
contain time consuming SPE clean-up steps. From literature investigation no method 
was found that was capable of analysing for CAP and the eleven NMZs listed in this 
paper. The sample preparation described in this study is less time consuming than 
previously published methods. The milk method has a sample size of 1ml which 
allows for fast extraction times. The majority of methods for the analysis of CAP 
incorporate the use of an SPE clean up. The method presented here omits this step 
and still achieves satisfactory results. 
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Table 6-1: Structures, Retention time (Rt), Precursor and Product ions and typical ion ratios for 
all 12 analytes 
 
124
109
23
39
21
43
-16
-12
25
128
82
118
75
122 27
     0.50 
Compound Structure Rt Collision Energy
82 47
168
128 19
19
82 37
121 23
96 21
81 31
140 17
55 29
Typical 
Ion Ratio
123
126
17
23
Precursor(
M/z) Product (M/z)
110 20
140 17
82
IPZ-OH                     
1-methyl-2-(2′-hydroxyisopropyl)-
5-nitroimidazole
4.09 186
33
128 19
Chloramphenicol (CAP)       
2,2-dichloro-N-[(1R,2R)-2-
hydroxy-1-(hydroxymethyl)-2-(4-
nitrophenyl)ethyl]acetamide
4.25 321
257
33
152
     0.90 
Ipronidazole (IPZ)            
2-isopropyl-1-methyl-5-
nitroimidazole
4.32 170      0.65 
     0.58 
Carnidazole (CNZ)            
1-(2-ethylcarbamothioic acid O-
methyl ester)-2-methyl-5-
nitroimidazole
4.27 245      0.17 
Ornidazole (ORZ)             
1-(3-chloro-2-hydroxypropyl)-2-
methyl-5-nitroimidazole
4.11 220
     0.46 
Tinidazole (TNZ)             
1-(2-ethylsulfonylethyl)-2-methyl-
5-nitroimidazole
3.97 248      0.19 
Ternidazole (TRZ)            
2-Methyl-5-nitroimidazole-1-
propanol; 3-(2-Methyl-5-
nitroimidazol-1-yl)propan-1-ol
3.69 186
     0.33 
Dimetridazole (DMZ)          
1, 2-dimethyl-5-nitroimidazole 3.05 142      0.30 
Ronidazole (RNZ)            
1-methyl-2-[(carbamoyloxy) 
methyl]-5-nitroimidazole
2.38 201
     0.73 
Metronidazole (MNZ)          
1-(2-hydroxyethyl)-2-methyl-5-
nitroimidazole
2.11 172      0.70 
HMMNI                     
2-hydroxymethyl-1-methyl-5-
nitroimidazole
1.77 158
MNZ-OH                    
1-(2-hydroxyethyl)-2-
hydroxymethyl-5-nitroimidazole
     0.71 1.34 188
N
NO 2N
S O 2
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Materials and Methods 
6.3.1. Materials and Reagents  
CAP and CAP-d5 were purchased from Sigma (St. Louis, MO) and Dr. Ehrenstorfer 
GmbH(Germany) respectively. CNZ, TNZ, TRZ, ORZ were provided by the CRL 
(BVL, Berlin, Germany). RNZ and DMZ were purchased from Sigma (St. Louis, 
MO) and MNZ, IPZ, IPZ-OH, HMMNI, MNZ-OH, HMMNI-d3, MNZ-OH-d2, 
DMZ-d3, RNZ-d3 were purchased from WITEGA Laboratorien (Berlin, Germany). 
Water is of LC-MS grade (Fluka). All other solvents were of LC grade and 
purchased from Reagecon (Clare, Ireland). Sodium chloride was AnalaR grade and 
purchased from VWR (Poole, England). Individual stock standards of each analyte at 
1mg ml-1 in ethanol were prepared and stored at 4˚C for 1 year. Individual 
intermediate standard solutions (10,000 and 100 ng ml-1) in methanol were prepared. 
Two working standards solutions (mixture of analytes) were prepared in methanol 
containing all NMZs at levels of 300ng ml-1 and 100ng ml-1 respectively (for honey) 
and CAP at levels of 30ng ml-1 and 10ng ml-1 respectively (for milk). Deuterated 
standards were prepared similarly except the mixed standard contained 200ng ml-1 
deuterated NMZs and 20ng ml-1 deuterated CAP. 
 
6.3.2. LC-MS/MS Instrumentation 
The LC-MS/MS system is an AB Sciex Triple Quad 5500 couple to Shimadzu UFLC 
XR LC system. The instrument is controlled by Analyst Software 1.5 and operated in 
positive and negative electrospray ionisation (ESI +/-).  
Separation was achieved using a 100x2mm, 1.8 micron particle size Zorbax Eclipse 
Plus C18 column supplied by Agilent Technologies (Santa Clara, CA). The column 
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oven temperature was set at 45 ºC. The chromatographic separation was achieved 
using gradient mode consisting of water acidified with 0.1% acetic acid (mobile 
phase A) and acetonitrile acidified with 0.1% acetic acid at flow rate 0.5ml min-1. 
The gradient is as follows; 95% A for the first 1.5 min. Then this changes to 5% A 
from 1.5-3.0 min and maintained for 2.0 min. The conditions then return to the initial 
95% A in 1.0 min (5-6min) and remain the same till the end of the run of 9.0 min. A 
divert valve is utilised to help remove any matrix impurities from entering the 
MS/MS. The LC flow is diverted for the first minute and the last three minutes of the 
method. The ionisation mode used was positive electrospray ionisation for the NMZs 
and negative electrospray ionisation for CAP. The MS/MS method was segmented in 
order to obtain enough data points on each peak. The first three minutes is run in 
positive mode and from then on it is run with positive and negative switching. A 
source temperature of 650ºC with a spray voltage of 4500V was used to produce 
parent to product ions. The individual precursor and products ions for each analyte 
with their respective collision energies are listed in table 6-1. 
 
6.3.3. Milk and Honey Samples 
Milk and honey were obtained and stored at -20 ºC. Portions of these samples were 
analysed and those found to contain no detectable residues of the analytes of interest 
were used as blanks for the validation study. Chromatograms of blank milk and 
honey samples can be seen in figure 6-1 and 6-2. For the day four validation studies 
of variability due to matrix variances a wide range of milk and honey samples were 
obtained. Milk samples comprised of high fat, low fat, organic milk and also milk 
with added extra calcium, folic acid and vitamins A, B, D and E, a sample of goat's 
milk was also examined. Honey samples comprised of the following types 
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Kapetanios Pure Greek; Rowse Australian Eucalyptus; Capilano Australian Organic 
Blended; Tropical Forest Ltd. Ethiopian Forest; Marks and Spencer’s New Zealand 
Clover; Famille Michaud-Lavender Honey, Provence, France; New Zealand Manuka 
Honey, Irish Honey ; Irish Honeycomb, Dublin; De Rit Blended Flower, Holland. 
 
6.3.4. Methods 
6.3.4.1. Milk Extraction 
Milk (1mL) was pipetted into polypropylene centrifuge tubes (15mL). These were 
fortified with mixed internal standard (30 µL) which corresponded to 6 ng mL-1 of 
deuterated NMZs and 0.6 ng mL-1 deuterated CAP. Acetonitrile (2mL) was added 
and vortexed. NaCl (0.5g) was added to this slurry which was shaken (30 secs) and 
then centrifuged (4350 x g for 10min). The top organic layer from each sample was 
then transferred to amber vials (5mL) and evaporated (50ºC) to dryness under a 
stream of nitrogen. The extracts were reconstituted in Water: Acetonitrile (95:5, 
200µL) and filtered through 0.2µm PVDF syringe filters. An aliquot (10µL) was 
injected onto the LC column. 
 
6.3.4.2. Honey Extraction 
Honey (3 g) was weighed into polypropylene centrifuge tubes (50 mL). These were 
then placed in an oven at 50 ºC for 30 min to soften. The samples were then fortified 
with mixed internal standard (50 µL) which correspond to 2 µg kg-1 of deuterated 
NMZs and 0.2 µg kg-1 deuterated CAP. Water (5ml) was then added to each sample 
and these are then placed back in the oven for a further 10 min. The samples were 
then thoroughly vortexed until the honey was fully dissolved in the water. To this 
acetonitrile (10 mL) was added and the tubes were vortexed (20secs). NaCl (2 g) was 
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added to this slurry which was then shaken (30secs) and centrifuged (4350 x g for 
10min). The top organic layers were then transferred to polypropylene tubes (15 mL) 
and evaporated (50ºC) to 6mL under nitrogen. Hexane (5 mL) was added and this 
was vortexed (30secs). The hexane layer was then discarded and the extracts were 
evaporated to dryness at 50ºC under a nitrogen stream. They were then reconstituted 
in Water:ACN (200 µL of 95:5 and filtered through 0.2 µm PVDF syringe filters. An 
aliquot (10 µL) was injected onto the LC column. 
 
6.3.5. Matrix Matched Calibration Curves 
Quantitation was carried out using matrix-matched calibration curves. Blank honey 
and milk samples were used. These samples were fortified with mixed working 
standard and submitted to the full extraction procedure of the method. A matrix 
matched calibration curve is performed with every batch. Six samples are fortified 
with internal standard and mixed working standard for a calibration range of 0 to 20 
ng mL-1 (µg kg-1 Honey) for the NMZs and a range of 0-2 ng mL-1 (µg kg-1 Honey) 
for CAP. Calibration curves were prepared by plotting the response factor (the ratio 
of peak area analyte over peak area of internal standard) against analyte 
concentration.  Seven deuterated internal standards are used; d3- DMZ, d3-RNZ, d3-
HMMNI, d2-MNZ-OH, d3-IPZ, d3-IPZ-OH and d5-CAP. For those compounds with 
no deuterated analogues; MNZ, TRZ, TNZ, ORZ and CRZ, d3-HMMNI is used as 
an internal standard. For each analyte calibration curves were linear in the given 
range with a correlation coefficient of at least 0.99. 
 
157 
 
Chapter 6                    Analysis of Honey and Milk for NMZs and CAP 
6.3.6. Method Validation 
The LC–MS/MS method was validated according to 2002/657/EC guidelines. The 
same validation protocol was used for both the honey and milk matrix. LC–MS/MS 
identification criteria were verified throughout the validation study by monitoring 
relative retention times, ion detection (signal-to-noise ratio (S/N)) and relative ion 
intensities. LC-MS/MS identification criteria as set out in the legislation were 
verified throughout the validation of the method.  
Several method validation parameters were determined including linearity, 
specificity, recovery, precision (repeatability and within-laboratory reproducibility) 
and analytical limits (decision limit CC and detection capability CC). Specificity 
was determined by analysing 10 different blank milk and honey samples sourced 
from different suppliers. No interfering peaks were observed at the retention time for 
any of the transitions. This allows for clear identification and quantification of all 
analytes. To investigate the linearity of the method, matrix-matched calibration 
curves were prepared and run with each of the validation batches to give 6 point 
calibration curves ranging from 0 to 20g L-1 / g kg-1 for the NMZs and 0 to 2g L-
1 / g kg-1 for CAP.  
Since no certified reference materials were available for the analytes and matrices of 
interest, the recovery from fortified negative samples was measured as an alternative 
to trueness. The recovery and precision were determined through the analysis of 
negative milk and honey samples fortified in six replicates at 1, 1.5 and 2 times the 
RL and the MRPL of 3 and 0.3 g L-1 / g kg-1 for NMZs and CAP respectively. Six 
replicate test portions at each of the three fortification levels (n = 18) were analysed 
on three separate days over a period of two weeks. Samples were fortified with 
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NMZs at 3, 4.5 and 6 g L-1 / g kg-1and with CAP at 0.3, 0.45 and 0.6 g L-1 / g 
kg-1 by adding mix working standard solution (30, 45 and 60 µL) and analysed. To 
determine any matrix effects caused by biological variations arising from various 
milk and honey samples a fourth day analysis was carried out. For each matrix two 
sets of ten different samples were analysed. The first set was fortified with only 
internal standard, and the second set was fortified with both internal standard and 
with the analytes at a concentration equivalent to 4.5g L-1 / g kg-1of NMZs and 
0.45g L-1 / g kg-1 of CAP. From these four separate validation days an estimation 
of recovery, precision (repeatability and within-laboratory reproducibility) and 
analytical limits (decision limit CC, and detection capability CC) were 
determined. 
 
6.4. Results and Discussion 
6.4.1. Method Optimisation 
The method was developed to provide confirmatory data for the analysis of CAP and 
11 NMZs in milk and honey. The method was developed from an existing method 
used in the lab to analyse for NMZs in plasma and eggs [Cronly et al., 2009(a), (b)]. 
The LC-MS/MS instrument used for this method was different than the one used 
previously so fragmentation conditions were investigated and collision energies were 
optimised for each individual compound to give best response. For a method to be 
deemed confirmatory under Commission Decision 2002/657/EC it must yield 4 
identification points. In this method a precursor ion (parent mass) and two product 
ions (corresponding to quantifier and qualifier ion) are monitored for each analyte 
(Table 6-1). This yields 4 identification points (1 for the precursor ion and 1.5 for 
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each product ion) hence it can be deemed a confirmatory method. In addition to this 
relative retention times and ion ratios are tracked for each compound and ensured 
that they are within acceptable ranges stated in EC 2002/657. The LC gradient was 
also optimised in order to have a quick run time but also have enough data points for 
each peak. For a method to achieve reliable quantitation each analyte peak should 
have at least 10-12 data points. As this method involved positive and negative 
ionisation switching the MS/MS method had to be segmented. This along with 
altering the LC gradient allowed for the analysis of all 12 analytes in a complete run 
time of less than 9 minutes. 
In developing the milk method; the sample size was reduced to as low as possible to 
allow for a more efficient extraction method with reduced extraction costs as 1ml of 
milk was extracted with 2ml of acetonitrile with the addition of 0.5g of NaCl. The 
extract was then evaporated to dryness and reconstituted in initial mobile phase. The 
samples were filtered and run on the LC-MS/MS. The instrument was sensitive 
enough to see all the analytes at low concentrations with a sample size of only 1ml. 
The matrix of honey is more complex and not much work had been carried out 
previously on it. The majority of methods use a SPE clean-up and this was overcome 
by adapting the previous methods used for aqueous based matrices (eggs and 
plasma). The honey sample was first diluted in water before extraction with 
acetonitrile and the addition of NaCl. Initial studies saw that the honey was quite 
difficult to dissolve in the water so the honey was first softened in an oven before the 
addition of water and this allowed the honey to dissolve fully. It was also seen that 
when acetonitrile was added to this solution that two layers formed after shaking. It 
was decided to take top organic layer and investigate if the analytes had been 
extracted into this layer. It was clear upon evaporation of this layer that some honey 
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had been taken into the layer and therefore could not be reconstituted. This did not 
occur when NaCl (2g) was added to the mixture and shaken. The extract was hexane 
washed and evaporated to dryness. The samples were reconstituted and filtered 
before been run on the LC-MS/MS. This is a much less involved extraction than used 
previously with these analytes in honey but results achieved were still satisfactory. 
 
6.4.2. Validation 
Validation is carried out in accordance with the procedures outlined in Commission 
Decision 2002/657/EC covering specificity, calibration curve linearity, accuracy, 
precision, decision limits (CCα), decision capability (CCβ) and measurement 
uncertainty. Results are seen in table 6-2 for these criteria. The ruggedness of the 
method is demonstrated on an ongoing basis through the use of it to analyse National 
Residue Control Plan milk and honey samples in Ireland. The criteria of relative 
retention times (RRT) and ion ratios were monitored for all analytes in the four 
validations days. The values identified for these were all within European 
requirements. The RRT tolerance of 2.5% was adhered to when standards were 
compared to samples in the validation runs. Two transition ions were monitored for 
each of the twelve analytes. The most intense was used for quantitation. All ion 
ratios of samples were within tolerances as set out by European criteria when 
compared with standards used during validation. 
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Table 6-2: Validation Results for Milk and Honey; Coefficient of Variance (%CV), Accuracy, 
Decision Limits (CCα) and Detection Capabilities (CCβ), Measurement Uncertainty (MU) and 
Correlation Coefficients (R2). 
 
 
CV% 
Accuracy
% 
CCα 
g L-1 / g kg-1 
CCβ 
g L-1 / g kg-1
MU  
% Analytes 
Milk Honey Milk Honey Milk Honey Milk Honey Milk Honey 
 R2 Value
MNZ-OH 4.5 4.1 92.0 103.8 0.43 0.39 0.73 0.67 27 25 >0.99 
HMMNI 4.1 4.6 94.5 104.2 0.42 0.42 0.71 0.71 27 29 >0.99 
MNZ 7.8 6.7 92.6 108.9 0.65 0.72 1.10 1.22 30 51 >0.99 
RNZ 4.3 3.5 94.3 102.4 0.41 0.38 0.70 0.66 23 24 >0.99 
DMZ 9.2 9.4 96.2 94.7 1.08 0.73 1.83 1.24 40 42 >0.99 
TRZ 5.4 9.0 93.9 102.0 0.53 0.78 0.91 1.34 23 56 >0.99 
TNZ 15.3 12.4 90.5 104.4 1.55 1.16 2.64 1.98 61 64 >0.99 
IPZ-OH 4.8 6.2 94.2 100.8 0.46 0.64 0.78 1.10 20 39 >0.99 
ORZ 11.4 11.3 90.8 100.7 1.08 1.00 1.85 1.71 69 81 >0.99 
CRZ 10.8 10.7 91.7 101.0 1.23 0.95 2.09 1.62 40 90 >0.99 
CAP 7.5 8.0 95.1 100.7 0.07 0.08 0.11 0.13 32 31 >0.99 
IPZ 4.7 4.3 95 97.8 0.52 0.40 0.88 0.68 25 35 >0.99 
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6.4.2.1. Specificity 
The technique of LC-MS/MS itself offers a great deal of specificity and selectivity. 
To establish the specificity and selectivity of the method blank milk and honey 
samples and samples fortified with all 12 analytes were analysed over the 3 
validation days. On the fourth day 10 different types of milk and honey samples were 
also analysed. Blank samples showed no interfering peaks in the area of interest for 
any of the analytes. Chromatograms of blank milk and honey and milk and honey 
fortified at the RL and MRPL for each of the analytes are seen in figure 6-1 and 6-2. 
 
6.4.2.2. Linearity 
The linearity of the chromatographic response was tested with matrix matched 
calibration curves using six calibration points in the range of 0-20 g L-1 / g kg-1 
NMZs and 0-2.0 g L-1 / g kg-1for CAP. The regression coefficients for all the 
analytes on each of the validation days in both matrices were greater than 0.99. 
 
6.4.2.3. Accuracy/Trueness 
The accuracy (trueness) of the method was determined by fortifying 6 replicate milk 
and honey samples at 1, 1.5 and 2 times the analytes respective RL or MRPL on 
three separate days. Mean corrected recovery (n=6) of the analytes, determined in the 
three separate validation batches are shown in table 6-2 range between 90.8 and 
108.9% for the twelve analytes in both matrices. No absolute recovery was 
determined as the use of internal standards means that each sample is individually 
corrected for. 
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Compound                            A                                                                          B 
 
MNZ-OH 
 
 
HMMNI 
 
 
MNZ 
 
RNZ 
 
 
DMZ 
 
 
 
CAP 
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TRZ 
 
 
TNZ 
 
 
IPZ-OH 
 
 
ORZ 
 
 
CRZ 
 
 
IPZ 
  
Figure 6-1. Chromatogram of blank milk (A) and milk (1ml) fortified at 2.5g L-1 for NMZs and 
0.25g L-1 for CAP (B). 
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Compound                 A    B 
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TRZ 
 
 
TNZ 
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Figure 6-2: Chromatogram of blank honey (A) and honey (3g) fortified at 2.5g kg-1 for NMZs 
and 0.25 g kg-1for CAP (B) 
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6.4.2.4. Precision 
Satisfactory values for inter-assay precision expressed as %CV values for the within 
lab reproducibility (table 6-2) were achieved for all analytes in both matrices. 
According to Commission Decision 2002/657/EC this coefficient of variance for the 
repeated analysis of fortified material under reproducible conditions shall not exceed 
the level calculated by the Horwitz equation. For a concentration of 100 g L-1 / g 
kg-1 this equation gives a value of 23%. However when concentrations go under this 
value the equation gives unacceptably high results. Therefore its stated in 
Commission Decision 2002/657/EC that %CV should be kept as low as possible. 
Results achieved range from 3.5 to 15.3% for all analytes in both matrices. These 
acceptable results can be attributed to the availability of 7 deuterated analogues to 
use as internal standards. HMMNI-d3 was used as an internal standard and worked 
well for compounds with no deuterated internal standards such as CNZ, ORZ, TRZ 
and TNZ. 
 
 CC and CC
CC is defined as the limit above which it can be concluded with an error probability 
of , that a sample contains the analyte. For prohibited substances an value equal 
to 1 % is applied. CC is the smallest content of the substance that may be detected, 
identified and quantified in a sample, with a statistical certainty of 1-, where 
CC and CC were calculated using the calibration curve procedure in 
accordance with ISO 11843. After identification, the signal is plotted against the 
added concentration. The corresponding concentration at the y-intercept plus 2.33 
times the standard deviation of the within-laboratory reproducibility of the intercept 
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equals the CC. CC values of for the 12 compounds in honey and milk are listed in 
Table 6-2 and are all below 1.55 g L-1 / g kg-1for the NMZs and below 0.08 g L-1 
/ g kg-1 for CAP. CC is the concentration corresponding to the signal at CC + 
1.64 times the standard error of the intercept (i.e. the intercept + 3.97 times the 
standard error of the intercept). CC values for all compounds in honey and milk are 
listed in table 6-2 and are all below the RL of 3ng mL-1and MRPL of 0.3g kg-1 for 
NMZs and CAP respectively. 
 
6.4.2.6. Measurement Uncertainty 
The  measurement uncertainty (MU)  was  estimated  by  taking  into  account  the  
within laboratory reproducibility over days 1, 2 and 3 as well as considering the 
repeatability on day 4 due to matrix effects caused by various honey and milk 
samples. These two variability’s were combined and multiplied by  a  coverage  
factor  of  three  to  give  an  overall  figure  for  the  MU. This approach of using the 
within laboratory reproducibility as a good estimator of measurement of uncertainty 
is taken from the SANCO/2004/2726rev4 document. It recommends using the within 
laboratory reproducibility and using a coverage factor of 2.33 to estimate expanded 
uncertainty, however it was felt that not all the environmental factors that could be 
varied over the course of the validation were  examined. Therefore  a  coverage 
factor of 2.33 may underestimate  the true uncertainty of the method and instead a 
value of 3 was  chosen to  give  a  more  realistic  value  for  the  true  uncertainty. 
Values for MU are seen in Table 6-2 and lie between 23 and 69% for all compounds 
in milk and between 24 and 90% for all analytes in honey. 
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Higher MUs are seen in milk for some compounds with no deuterated analogues to 
use as internal standards which is expected. Honey results in general display higher 
MUs. High MU estimates are again seen for some of the compounds with no 
deuterated analogues to use as internal standards in particular ORZ (81%) and CRZ 
(90%). Their MU estimates in honey are the highest due to large values for 
reproducibility due to matrix as a result of a variation between matrices used in the 
day 4 experiment and the lack of suitable internal standards.  
 
6.5. Conclusions 
The objective of this work was to develop a rapid multi-class multi-residue 
confirmatory method capable of identifying, confirming and quantifying eleven 
NMZ compounds and CAP in milk and honey at µg L-1 and µg kg-1 levels and to 
validate according to the requirements in Commission Decision 2002/657/EC.  This 
was successfully completed. 
The method can be considered as rapid, as it utilises an efficient extraction protocol 
without the use of SPE. It also utilises chromatography which separates all analytes 
in a total run time of only 9 minutes. The method includes the confirmatory analysis 
of CAP and 11 NMZs in milk and honey which has not been seen before.  
The obtained data fulfils the requirements laid down in Commission Decision 
2002/657/EC and allows the calculation of all relevant performance characteristics. 
This study shows that the developed method meets the required sensitivities of 3 g 
L-1 / g kg-1 for NMZs and 0.3g L-1 / g kg-1for CAP which are the RL and MRPL 
used for these compounds. The CC and CC values determined for each analyte are 
lower than this level. The method performs very well in terms of accuracy and 
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repeatability for each of the analytes due to the utilisation of seven different 
deuterated internal standards. The values achieved for accuracy, %CV and 
measurement of uncertainty all fall within acceptable ranges. The applicability of the 
method for use on various types of milk and honey samples was demonstrated by the 
satisfactory results obtained from the Day 4 analysis of different species. The 
reduced number of analytical steps within the method makes it very amenable for 
high through-put regulatory monitoring of these compounds.  
From examination of published literature, no method was found that was capable of 
the sensitive confirmatory analysis of CAP and eleven NMZs in milk and honey. 
Methods published on these matrices analysed at most seven analytes and in the case 
of CAP often analysed as a single analyte method. The method developed in this 
study allows for improvement on any existing method as it allows for the analysis of 
an increased number of analytes in matrices that have been previously overlooked. It 
also allows for reduced sample preparation times as SPE clean-up has been omitted. 
In the case of the extraction protocol for milk time and solvent usage is greatly 
reduced compared to other published methods as a result of reduced sample size of 
1mL. 
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7.1 Abstract 
A confirmatory method has been developed to allow for the analysis of fourteen 
prohibited medicinal additives in pig and poultry compound feed. These compounds 
are prohibited for use as feed additives although some are still authorised for use in 
medicated feed. Feed samples are extracted by acetonitrile with addition of sodium 
sulphate. The extracts undergo a hexane wash to aid with sample purification. The 
extracts are then evaporated to dryness and reconstituted in initial mobile phase. The 
samples undergo an ultracentrifugation step prior to injection onto the LC-MS/MS 
system and are analysed in a run time of 26 minutes. The LC-MS/MS system is run 
in MRM mode with both positive and negative electrospray ionisation. The method 
was validated over three days and is capable of quantitatively analysing for 
metronidazole, dimetridazole, ronidazole, ipronidazole, chloramphenicol, 
sulfadiazine, sulfamethazine, dinitolimide, ethopabate, carbadox and clopidol. The 
method is also capable of qualitatively analysing for tylosin, virginiamycin and 
avilamycin. A level of 100 µg kg-1 was used for validation purposes and the method 
is capable of analysing to this level for all the compounds. Validation criteria of 
trueness, precision, repeatability and reproducibility along with measurement 
uncertainty are calculated for all analytes. 
 
Keywords: Antibiotics; pig and poultry compound feed; lc-ms/ms; validation. 
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7.2 Introduction 
The use of many antibiotics, coccidiostats and antibacterial growth promoters as feed 
additives has been prohibited in Europe since 2006 by Commission 
Recommendation 2005/925/EC. This recommendation lists medicinal substances that 
should be monitored and the substances are divided into two groups; medicinal 
substances authorised as feed additives for certain animal species or categories and 
medicinal substances no longer authorised as feed additives. This paper focuses on 
the analysis of the second group of medicinal substances specifically antibacterial 
growth promoters (AGPs) which are no longer authorised as feed additives; this 
group consists of various different types of compounds. Nitroimidazoles and 
chloramphenicol are banned for use in food producing animals. Other AGPs which 
include virginiamycin and tylosin are prohibited for use as feed additives. Finally 
some compounds such as sulfonamides are only permitted for use in medicated feed.  
The structures for all fourteen analytes are presented in Tables 7-1a and 7-1b. 
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Table 7-1a. Molecular Structures, Retention time (Rt), Precursor and Product ions and typical 
ion ratios for all 11 analytes 
 
Compound Molecular Structure Rt Precursor 
Ion (M/z) 
Product 
Ions 
Collision 
Energy
124 18 Ipronidazole (IPZ)         
2-isopropyl-1-methyl-5-
nitroimidazole 
 
 
 9.90 170 109 25 
96 18 Dimetridazole (DMZ)       
1, 2-dimethyl-5-nitroimidazole  2.83 142 81 28 
82 25 Metronidazole (MNZ)       
1-(2-hydroxyethyl)-2-methyl-5-
nitroimidazole 
 1.95 172 
128 15 
140 15 Ronidazole (RNZ)         
1-methyl-2-[(carbamoyloxy) 
methyl]-5-nitroimidazole 
 2.21 201 
110 18 
257 18 Chloramphenicol (CAP)    
2,2-dichloro-N-[(1R,2R)-2-
hydroxy-1-(hydroxymethyl)-2-(4-
nitrophenyl)ethyl]acetamide 
 13.46 321 
152 12 
110 23 Sulfadiazine (SDZ)        
4-amino-N-pyrimidin- 2-yl-
benzenesulfonamide 
 2.39 251 
156 17 
186 17 Sulfamethazine (SMZ)      
2-(p-Aminobenzenesulfonamido)-
4,6-dimethylpyrimidine 
 4.29 279 
156 19 
136 32 Ethopabate (EPB)         
methyl 4-(acetylamino)-2-
ethoxybenzoate 
 
14.16 238 
206 13 
128 24 Clopidol (CLOP)          
3,5-Dichloro-2,6-dimethyl-pyridin-
4-ol 
 2.00 192 
101 26 
175 19 Carbadox (CAR)          
methyl (2E)-2-[(1,4-
dioxidoquinoxalin-2-yl) 
methylene]hydrazinecarboxylate 
 2.65 263 
130 22 
151 18 
Dinitolmide (DINIT)        
2-Methyl-3,5-dinitrobenzamide  7.68 224 
181 12 
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Table 7-1b: Molecular Structures, Retention time (Rt), Precursor and Product ions and collision 
energies for all 3 analytes. 
 
Compound Molecular Structure Rt Precursor Ion (M/z) 
Product 
Ions (M/z) 
Collision 
Energy 
772 29 
Tylosin (TYL)  
 
 
14.03 917 
174 37 
355 20 
Viginiamycin (VIR)  
  
16.12 526 
508 15 
373 45 
Avilamycin (AVIL)     
  
14.89 791 
391 48 
Nitroimidazoles and chloramphenicol are classified as prohibited substances in table 
2 of Commission Regulation 2010/37/EC and therefore prohibited for the use in 
animal husbandry. As a result these should not be found in animal feeds. While there 
are single class methods for the analysis of some of compounds [Vincent et al., 2008; 
Galarini et al., 2009; Pecorelli et al., 2003; Barbosa et al., 2007; van Holthoon et al., 
2010] there are very few published methods for nitroimidazoles and chloramphenicol 
in animal feed. Capitan-Vallvey et al., 2007 describes a method for the analysis of 
nitroimidazoles in feed by LC-MS and Vinas et al., 2006 describes a method for 
chloramphenicol in feed by LC-photo diode array detector. 
The use of 5 AGPs including tylosin and virginiamycin were prohibited for this use 
in Council Regulation 2821/98. As a result there are some published methods for the 
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analysis of these compounds. Van Poucke et al. described a method for the analysis 
of tylosin and virginiamycin in feed by LC-MS/MS [Van Poucke et al., 2003 Van 
Poucke et al., 2005] and Civitareale et al., 2004 describes a method for the analysis 
of tylosin by LC-UV/DAD. Other medicinal additives listed in 2005/925/EC also 
have LC methods for their analysis such as clopidol/nicarbazin [Dusi et al., 2000], 
amprolium/ethopabate [Tan et al., 1996] and carbadox [Kesiunaite et al., 2008; 
Hutchinson et al., 2005] while for compounds such as dinitrolimide no published 
methods exist for their analysis. The majority of methods published for the list of 
compounds specified in 2005/925/EC allow for the analysis of these compounds at 
levels relating to therapeutic level or in the mg kg-1  range while only a few allow for 
the analysis in the µg kg-1  range. Also, from examination of literature the majority 
of methods are single or dual analyte methods while very few are capable of 
analysing for a particular class of compounds.  
From a review of the literature it would seem there is a lack of published methods 
available that would help with the enforcement of Commission Recommendation 
2005/925/EC. In addition to this, methods available are for single analytes/classes at 
mg kg-1 range; often utilising large sample sizes which in turn need large amounts of 
solvent for extraction which can prove expensive and time consuming. Reports from 
the Screening and Identification Methods for official control of Banned Antibiotics 
and Growth promoters in Feedingstuffs study (SIMBAG-FEED study) suggested that 
methods be able to identify compounds to at least 5 times lower than the lowest 
contents formerly described in the Directive 70/524/CEE. In many cases this was 
around the 1ppm range [de Jong, 2005]. To aid compliance with Commission 
Recommendation 2005/925/EC there is a need for an efficient sensitive multi-class 
method to analyse for as many of the analytes listed in this recommendation as 
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possible. To this end; this paper describes the analysis of 14 of these prohibited 
medicinal additives at 100 µg kg-1 levels in pig and poultry compound feed by LC-
MS/MS utilising a small sample size of 2 g and an efficient sample extraction 
procedure. 
 
7.3 Materials and Methods 
7.3.1 Chemicals and Reagents 
Dimetridazole (DMZ), ronidazole (RNZ), chloramphenicol (CAP), sulfadiazine 
(SDZ), sulfamethazine (SMZ), dinitolimide (DINIT), ethopabate (ETB), carbadox 
(CAR), clopidol (CLOP) and sulfaphenazole (SPZ) were purchased from Sigma (St. 
Louis, MO, USA), metronidazole (MNZ), ipronidazole(IPZ), d3-IPZ, d3-DMZ, d3-
RNZ were purchased from WITEGA Laboratorien (Berlin, Germany), d5-
chloramphenicol were purchased from Dr Ehrenstorfer (Augsborg, Germany) and 
tylosin, virginiamycin and avilamycin were received from RIKILT (Wageningen, The 
Netherlands). Water was of LC-MS grade from Fluka (Germany). All other solvents 
were of LC grade and purchased from Reagecon (Clare, Ireland). Anhydrous Sodium 
sulphate was AnalaR grade and purchased from Acros (Geel, Belgium). Individual 
stock standards of each analyte ranging between 0.25-1.00 mg ml-1 in ethanol were 
prepared and stored at 4˚C. A working standard solution (mixture of analytes) (10 ug 
mL-1) was prepared in acetonitrile and stored at 4º. Internal standards were prepared 
similarly. 
 
7.3.2 Instrumentation 
 The LC-MS/MS system was a TSQ Quantum Ultra EMR coupled to a Finnigan 
Surveyor LC system. The instrument was controlled by Xcalibur software (Version 
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1.5). Separation was achieved using a (100  2)mm, 3m particle size, Luna C18 
column (Part No. 00D-4251-B0) protected by a Security Guard guard cartridge 
system (202)mm, both supplied by Phenomenex. The oven temperature was set at 
40ºC. The chromatographic separation was performed in gradient mode using water 
acidified with 0.2% acetic acid (mobile phase A) and acetonitrile acidified with 0.2% 
acetic acid (mobile phase B), at a flow rate of 0.25mL min-1. The initial conditions 
from 0-6min were 85% A. This was changed to 50% A over  2 minutes from 6-8min 
and was maintained until 10 min. The conditions were changed again to 10% A over 
2 minutes from 10-12 min and these were maintained until 15.20 min. Finally the 
conditions returned to 85% A over 2.8 minutes from 15.20-18min and were 
maintained until the end of the run at 26min. Electrospray ionisation (ESI) was used 
in the MS with both positive and negative ionisation mode, with a spray voltage of 
4350V and a cone temperature of 325 ºC. The individual precursor and products ions 
for each analyte with their respective collision energies are listed in Tables 7-1a and 
7-1b.  
 
7.3.3 Pig and Poultry Compound Feed Samples 
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Different varieties of pig and poultry compound feed were sourced from various feed 
mills. These were milled upon receipt to 1mm using a Retsch SM 100 mill and stored 
in amber jars at 4ºC. Portions of these samples were analysed and those found to 
contain no detectable residues of the analytes of interest except for residues of 
sulfadiazine were used as blanks for the validation study. To ensure true robustness of 
the method a high number of different feed samples were used in validation. These 
included 18 different pig feeds and 18 different poultry feeds. Chromatograms of 
blank feed can be seen in Figure 7-1b. 
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7.3.4 Extraction 
Feed (2 g) was weighed into polypropylene centrifuge tubes (50 mL). The sample 
was fortified with mixed internal standard (50 µL) which corresponds to a 
concentration of 250 µg kg-1 of internal standard in the feed material. To this 
acetonitrile (12 mL) was added and the tubes were vortexed (20 secs). Anhydrous 
sodium sulphate (3.5 g) was added to this slurry which was shaken (30 mins) and 
centrifuged (5100rpm for 20 min). The organic layer was transferred to a clean 
polypropylene tube (15 mL) and evaporated at 50ºC to 6 mL under nitrogen. Hexane 
(5 mL) was added and the tubes contents were vortexed (30 secs) and centrifuged 
(3750 rpm for 20 min). The hexane layer was discarded and the extracts were 
evaporated to dryness at 50ºC under a nitrogen stream. The extract was reconstituted 
in water: acetonitrile (85:15, 800 µL) and vortexed thoroughly for 45 secs. The 
sample underwent an ultra-centrifugation step at 13750 rpm for 30 mins. This 
centrifugation step separated the sample into two distinct layers. 200 µL of the clear 
lower layer (containing the analytes) was transferred into an LC-MS vial. An aliquot 
(20 µL) was injected onto the LC column.  
 
7.3.5 Matrix Extracted Calibration Curves 
Quantitation was carried out using matrix extracted calibration curves. Blank pig and 
poultry feed samples were used. These samples were fortified with mixed working 
standard and submitted to the full extraction procedure. Matrix extracted calibration 
curves were performed with every batch. Six different feed samples are fortified with 
internal standard and mixed working standard yielding a calibration range of 0 to 
1000 µg kg-1 for all the 11 quantitation analytes. Calibration curves were prepared by 
plotting the response factor (the ratio of peak area analyte over peak area of internal 
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standard) against analyte concentration.  Five internal standards were used; d3- DMZ, 
d3-RNZ, d3-IPZ, d5-CAP and Sulfaphenazole. For those compounds for which no 
suitable deuterated internal standard could be acquired; MNZ, CLOP, DIN, ETB and 
CAR, d3-DMZ was used as an internal standard. For each analyte; calibration curves 
were linear in the given range with a correlation coefficient of at least 0.98. In the 
case of the 3 qualitative analytes, TYL, VIR and OLA no suitable internal standard 
could be found. This resulted in poor linearity as matrix effects could not be corrected 
for in a repeatable manner. For these analytes six different feed samples were 
fortified; one at 0 µg kg-1 and five at the 100 µg kg-1. d3-DMZ was used as an internal 
standard for these in order to compensate for any extraction errors. 
 
7.3.6 Method Validation 
LC–MS/MS identification criteria were verified throughout the validation study by 
monitoring relative retention times and relative ion intensities. LC-MS/MS 
identification criteria as set out in the Commission Decision 2002/657 were verified 
throughout the validation of the method. 
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Several method validation parameters were determined including linearity, 
specificity, trueness, precision (repeatability and within-laboratory reproducibility). 
Specificity was determined by analysing a number of different blank animal feed 
samples sourced from different mills. To investigate the linearity of the method, 
matrix-extracted calibration curves were prepared and run with each of the validation 
batches to give 6 point calibration curves in the range of 0 to 1000 g kg-1 for all 
eleven quantitation analytes. To ensure linearity across the range of different feed 
samples that could be encountered for these species a different type of feed 
alternating between pig and poultry was used for each calibration point.   
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Since no certified reference materials were available for the analytes and matrices of 
interest, the trueness from fortified negative samples was measured as an alternative 
to trueness. The trueness and precision of the method were determined through the 
analysis of negative pig and poultry compound feed fortified in six replicates at 100 
µg kg-1, 500 µg kg-1 and 1000 µg kg-1 with the eleven quantifiable analytes for a total 
of 18 samples. This was repeated on three separate days. For the three qualititative 
analytes all 18 samples were fortified at 100 µg kg-1. The type of feed was varied for 
each of the six replicates in ordered to ensure that the method was fully fit for 
purpose. From these three separate validation days an estimation of trueness, 
precision (repeatability and within-laboratory reproducibility) and LC-MS/MS 
confirmatory criteria were all evaluated. 
 
7.4 Results and Discussion 
7.4.1 LC-MS/MS Optimisation 
The LC-MS/MS method was developed to provide confirmatory data for the analysis 
of 14 antibiotics in pig and poultry compound feed. The MS/MS fragmentation 
conditions were investigated and collision energies were optimised for each 
individual compound to give best response. For a method to be deemed confirmatory 
under Commission Decision 2002/657/EC it must yield 4 identification points. In 
this method a precursor ion (parent mass) and two product ions (corresponding to 
strong and weak ion) were monitored for each analyte (Tables 7-1a and 7-1b). This 
yielded 4 identification points (1 for the precursor ion and 1.5 for each product ion) 
hence it can be deemed a confirmatory method. In addition to this relative retention 
times and ion ratios were monitored for each compound and evaluated to ensure that 
they are within acceptable ranges as stated in CD 2002/657/EC. As this method 
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involved positive and negative ionisation switching the MS/MS method had to be 
segmented. The LC gradient was optimised in order to have as an efficient run time 
as possible in order to allow successful segmentation of the MS/MS method. Only 
when the positive and negative ionisation switching was isolated to one segment was 
there enough data points for each peak. Lowering scan time and dwell time of the 
instrument was not sufficient to achieve this. For a method to achieve reliable 
quantitation each analyte peak should have at least 10-12 data points. The LC 
gradient along with segmentation permitted for the analysis of all 14 analytes in a 
complete run time of 26 minutes with each peak having a minimum of 12 data 
points. 
 
7.4.2 Sample Extraction Development 
The development of the extraction method faced two major obstacles; one the need 
to extract a wide variety of analytes with a single extraction and the other the need to 
purify the sample sufficiently without losing the analytes in question. A variety of 
extraction solutions including water, acetonitrile and methanol and various mixtures 
of the three were tested. Immediately it was visibly evident that methanol and water 
extracted far more matrix contaminants than acetonitrile and this resulted in lower 
recoveries for the analytes using these extraction solvents. It was also observed that 
acetonitrile consistently extracted the broad range of analytes therefore acetonitrile 
was chosen as the extraction solvent. The next stage was to sufficiently clean up the 
acetonitrile extract in order to determine down to the levels of interest. The use of 
anhydrous sodium sulphate in sample clean up when extracting these analytes has 
been previously seen. [Stubbings et al., 2009]. Hence the use of anhydrous sodium 
sulphate was investigated followed by addition of a hexane wash step. This 
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purification procedure sufficiently removed background interferences resulting in the 
fact that a SPE clean-up step was not needed. The purification was completed when 
the reconstituted extract underwent an ultracentrifugation step. This removed further 
interferences and also allowed all analytes to be determined at levels in the µg kg-1 
range. 
 
7.4.3 Internal Standard Selection 
While the extraction method allowed all analytes to be seen in the µg kg-1 range the 
variability in sample recovery was noticeable from feed sample to feed sample. To 
overcome this problem the sourcing of suitable internal standards was pursued. In 
some cases deuterated analogues were available for the analytes such as d3-DMZ, 
d3-IPZ, d3-RNZ and d5-CAP. These corrected well for all variabilities encountered 
in extraction. Sulfaphenazole is a sulphonamide and it has been used as an internal 
standard for sulfonamides in previous work [McDonald et al., 2009]. This was used 
for SDZ and SMZ compounds and corrected sufficiently for them. Erythromycin was 
tried for use with VIR, TYL and AVIL but did not correct consistently well for them. 
As a last attempt the internal standards used for other compounds were used for the 
remaining compounds without internal standards. It was observed that d3-DMZ 
extracted consistently and as a result could be used as an internal standard for CLOP, 
CAR, DIN and ETH. This allowed for eleven compounds to be analysed 
quantitatively. For the remaining three compounds VIR, TYL and AVIL no suitable 
internal standard could be identified. Therefore the method could only be used as a 
qualitative extraction method for these compounds. 
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7.4.4 Validation Approach Selection 
As of yet no official EU validation protocol exists for the analysis of veterinary drugs 
in animal feed. Therefore a validation protocol was designed in order to best show 
that the method was fit for purpose. It was seen in development the variability due to 
the matrix feed is significant. In order to prove that the method would extract all 
analytes in a wide range of pig and poultry compound feed it was decided that feed 
samples would be varied as much as possible. For each of the calibration curve 
points a different feed would be used on each validation day to ensure linearity held 
through for all feeds. Eighteen samples were analysed on each day of the three 
validation days containing six different types of animal. A level of 100µg kg-1 was 
chosen as a reporting level and this is significantly lower for the majority of the 
analytes presented in this paper than observed in previous methods. SIMBAG study 
suggested levels around 1000 µg kg-1 but it was felt that as these compounds are 
banned they should not be present at any level. These compounds are prohibited for 
use as feed additives and therefore these compounds should not be present at any 
level and therefore the ALARA (as low as reasonably achievable) principle was 
adopted. Work carried out prior to validation indicated that a level of 100µg kg-1 
was achievable. This was chosen as it was felt that the method could be used to 
determine this level on a routine basis for all analytes. For the three qualitative 
analytes TYL, VIR, OLA it was decided that all eighteen samples on the three 
different days would be fortified at the reporting level of 100 µg kg-1. The 
measurement of uncertainty for each analyte would be calculated and added onto the 
100 µg kg-1level and give us a value above which would result in a positive. For the 
eleven quantitative analytes a different approach was taken. The eighteen samples on 
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the three days would be made up of six replicates of 100, 500 and 1000g kg-1. This 
was done in order to validate the method over the complete calibration range for 
which positive results might be obtained. Specificity, trueness, precision 
(repeatability and within-laboratory reproducibility); along with confirmatory criteria 
laid out Commission Decision 2002/657 were determined during validation. 
 
7.4.5 Specificity 
The technique of LC-MS/MS itself offers a great deal of specificity and selectivity. 
To establish the specificity and selectivity of the method 18 blank pig and poultry 
compound feed samples and samples fortified with all 14 analytes were analysed 
over the 3 validation days. All blank samples showed no interfering peaks in the area 
of interest for any of the analytes except for sulfadiazine. This is as a result of low 
levels of sulfadiazine found in the majority of feed samples available. Sulfadiazine is 
still permitted to be used in medicated feed and this might possibly be the reason for 
low levels been found in the feed. In order to correct for this, the feed samples were 
analysed prior to validation and the response observed for SDZ was subtracted from 
the results achieved during the validation procedure. Although this corrected the 
results somewhat, the variability in the background sulfadiazine resulted in worse 
validation results for this compound than the others. Chromatograms of blank feed 
and feed fortified at 100 µg kg-1 for each of the fourteen analytes are seen in Figure 
7-1a and 7-1b. 
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Figure 7-1a: Chromatograms of Feed Fortified at a level equal to 100 g kg-1 for all 14 
compounds. 
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Figure 7-1b: Chromatograms of Blank Feed 
 
7.4.6 Linearity of Response 
The linearity of the chromatographic response was tested with matrix extracted 
calibration curves using six calibration points in the range of 0-1000g kg-1 for all 
eleven quantitative analytes on each of the validation days. The regression 
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coefficients for all the analytes on each of the validation days in were greater than 
0.98. 
Table 7-2: Validation results for Accuracy, Repeatability, Reproducibility and Measurement 
Uncertainty (MU) and Confirmatory data of typical ion ratios and relative retention 
times(RRT) for all 14 analytes. 
 
Analyte 
Internal 
Standard 
Accuracy 
(%) 
Repeat 
%RSD 
Reprod 
%RSD 
MU 
(%) 
Typical 
RRT 
Typical 
Ion Ratio 
Cut-Off 
Level 
µg/kg 
DMZ DMZ-d3 98.9 4.5 8.9 27 1.0100 0.2344 100 
RNZ RNZ-d3 99.1 6.3 9.0 27 1.0053 0.0395 100 
MNZ DMZ-d3 102.5 5.8 9.3 28 0.6911 0.2964 100 
IPZ IPZ-d3 99.4 4.3 7.2 24 1.0164 0.8382 100 
SDZ SPZ 101.4 23.3 28.0 84 0.1666 0.4667 100 
SMZ SPZ 101.4 16.8 20.6 55 0.2987 0.2815 100 
CAR DMZ-d3 99.9 12.6 13.9 42 0.9466 0.1610 100 
CAP CAP-d5 101.2 11.4 12.0 36 1.0082 0.8108 100 
CLOP DMZ-d3 103.3 10.8 16.0 48 0.7125 0.3653 100 
DINIT DMZ-d3 96.3 7.7 14.8 44 2.7345 0.1880 100 
ETB DMZ-d3 99.4 9.1 16.3 49 5.0406 0.5094 100 
TYL DMZ-d3 95.6 16.8 21.8 69 5.0000 0.7275 169 
VIR DMZ-d3 100.0 22.7 22.9 65 5.7381 0.3777 165 
AVIL DMZ-d3 89.2 21.1 22.0 66 5.2961 0.4851 166 
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7.4.7 Ion Ratios 
Two transition ions were monitored for each of the fourteen analytes. The most 
intense was used for quantitation. Ion ratios were calculated for all analytes. The ion 
ratio is a ratio of ion responses. The ratios of weak ion responses/strong ion 
responses are presented in Table 7-2. All ion ratios of samples were within tolerances 
as set out by European criteria when compared with standards used during validation. 
Control charts were used to ensure all ion ratios were acceptable. The example of 
metronidazole is seen in Figure 7-2. 
  
7.4.8 Relative Retention Times (RRT) 
RRTs were calculated for all fourteen analytes in this method by calculating the ratio 
of the retention time of the analyte over the retention time of its corresponding 
internal standards. The RRTs tolerance for LC-MS/MS of 2.5% was adhered to when 
standards were compared to samples in the validation runs. Control charts were again 
used to ensure all ion ratios were acceptable. The example of metronidazole is seen 
in Figure 7-3. The typical RRT for all the analytes are shown in Table 7-2. 
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Ion Ratios Control Chart
0.2000
0.2200
0.2400
0.2600
0.2800
0.3000
0.3200
0.3400
0.3600
0.3800
std 2
std 3
std 4
std 5
std 6
Le vel 1 A
Level 1 B
Level 1 C
Level 1 D
Level 1 E
Level 1 F
Level 2 A
Level 2 B
Level 2 C
Level 2 D
Level 2 E
Level 2 F
Level 3 A
Level 3 B
Level 3 C
Level 3 D
Level 3 E
Le vel 3 F
Sample No.
Io
n 
R
at
io
s
Metronidazole
20%+
20%-
Metronidazole 
Sample 
Strong Ion 
Peak Area 
Weak Ion 
Peak Area  Ion Ratio 20%+ 20%- 
Std 100 g kg-1 15194729 4752084 0.3127 0.3556 0.2371
Std 250 g kg-1 42333522 12107683 0.2860 0.3556 0.2371
Std 500 g kg-1 72310544 20962631 0.2899 0.3556 0.2371
Std 750 g kg-1 111573188 33615028 0.3013 0.3556 0.2371
Std 1000 g kg-1 141124965 41197657 0.2919 0.3556 0.2371
Level 1 A 15930883 4802808 0.3015 0.3556 0.2371
Level 1 B 13779107 4100715 0.2976 0.3556 0.2371
Level 1 C 15060999 4687121 0.3112 0.3556 0.2371
Level 1 D 14015787 4045653 0.2886 0.3556 0.2371
Level 1 E 14936729 4494700 0.3009 0.3556 0.2371
Level 1 F 15109412 4330588 0.2866 0.3556 0.2371
Level 2 A 82300381 23812667 0.2893 0.3556 0.2371
Level 2 B 55668164 16886535 0.3033 0.3556 0.2371
Level 2 C 98201444 27970852 0.2848 0.3556 0.2371
Level 2 D 86217956 24778305 0.2874 0.3556 0.2371
Level 2 E 88044794 25699990 0.2919 0.3556 0.2371
Level 2 F 88971771 27257657 0.3064 0.3556 0.2371
Level 3 A 183983033 50847934 0.2764 0.3556 0.2371
Level 3 B 157024199 45227252 0.2880 0.3556 0.2371
Level 3 C 170214626 50069929 0.2942 0.3556 0.2371
Level 3 D 170597905 48706960 0.2855 0.3556 0.2371
Level 3 E 177451858 50805992 0.2863 0.3556 0.2371
Level 3 F 163816078 47947886 0.2927 0.3556 0.2371
 
Average Std Ion Ratio: 0.2964 
Average + 20%   : 0.3556 
Average – 20%   : 0.2371  
 
 
 
Figure 7-2: Control Chart for Ion Ratio of Metronidazole 
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Average RRT: 0.6911 
 
Average + 2.5%: 0.7081 
Average – 2.5%: 0.6738 
Relative Retention Times Control Charts
0.6500
0.6600
0.6700
0.6800
0.6900
0.7000
0.7100
0.7200
Std2
Std3
Std4
Std5
Std6
Level 1 A
Level 1 B
Level 1 C
Level 1 D
Level 1 E
Level 1 F
Level 2 A
Level 2 B
Level 2 C
Level 2 D
Level 2 E
Level 2 F
Level 3 A
Level 3 B
Level 3 C
Level 3 D
Level 3 E
Level 3 F
Sample number
R
R
T
Metronidazole
2.5%+
2.5%-
  
Metronidazole 
  
  Sample 
Retention 
Time  
Retention Time 
of Internal 
Standard 
Relative 
Retention Time 
(RRT) 2.5%+ 2.5%- 
Std2 Std 100 1.94 2.82 0.6879 0.7084 0.6738 
Std3 Std 250 1.95 2.80 0.6964 0.7084 0.6738 
Std4 Std 500 1.94 2.82 0.6879 0.7084 0.6738 
Std5 Std 750 1.94 2.80 0.6929 0.7084 0.6738 
Std6 Std 1000 1.94 2.81 0.6904 0.7084 0.6738 
  Level 1 A 1.95 2.82 0.6915 0.7084 0.6738 
  Level 1 B 1.94 2.82 0.6879 0.7084 0.6738 
  Level 1 C 1.94 2.80 0.6929 0.7084 0.6738 
  Level 1 D 1.93 2.80 0.6893 0.7084 0.6738 
  Level 1 E 1.95 2.80 0.6964 0.7084 0.6738 
  Level 1 F 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 A 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 B 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 C 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 D 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 E 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 F 1.94 2.82 0.6879 0.7084 0.6738 
  Level 3 A 1.96 2.82 0.6950 0.7084 0.6738 
  Level 3 B 1.94 2.80 0.6929 0.7084 0.6738 
  Level 3 C 1.94 2.80 0.6929 0.7084 0.6738 
  Level 3 D 1.94 2.80 0.6929 0.7084 0.6738 
  Level 3 E 1.95 2.82 0.6915 0.7084 0.6738 
  Level 3 F 1.95 2.82 0.6915 0.7084 0.6738 
 
 Figure 7-3: RRT Control Chart for Metronidazole 
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7.4.9 Trueness 
The trueness of the method was determined by fortifying 18 replicate feed samples 
on three separate days. For the eleven quantitative analytes six replicates were 
fortified at 100, 500, 1000g kg-1 while the three qualitative analytes were all spiked 
at 100g kg-1 for the 18 replicates. Mean corrected trueness (n=6) of the analytes, 
determined in the three separate validation batches, are shown in Table 7-2 ranging 
between 89.2 and 103.3 for the fourteen analytes in pig and poultry feed. No 
recovery was determined as the use of internal standards means that each sample is 
individually corrected for. 
 
7.4.10 Precision (Repeatability and within-lab Reproducibility) 
Repeatability (within-day) and within-laboratory reproducibility (different days and 
operators) were determined by calculating relative standard deviations (RSD, %) for 
the repeated measurements. Overall repeatability (RSD, %) and within-laboratory 
reproducibility (RSD, %) ranged from 4.3 to 23.3% and from 7.2 to 28.0%, 
respectively, for all analytes (Table 7-2). 
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The usefulness of suitable deuterated internal standards is demonstrated in the 
acceptable results for repeatability and within-laboratory reproducibility obtained for 
DMZ, RNZ, IPZ and CAP. Although deuterated analogues could not be obtained by 
our laboratory for use as internal standards for over half of the analytes investigated, 
acceptable repeatability and within-laboratory reproducibility is obtained by using 
the d3-DMZ for MNZ, CLOP, DINIT, ETH, CAR and using sulfaphenazole for 
SMZ. Less favorable is the situation for SDZ. Rather high RSD values were obtained 
for both the repeatability and within-laboratory reproducibility of SDZ (between 20 
and 28%), even when applying correction by means of an internal standard 
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(sulfaphenazole). This is as a result of the variability for the feed sample due to the 
low levels of SDZ present in the feed. 
 
7.4.11 Measurement of Uncertainty 
The measurement uncertainty (MU) was estimated by taking into account the within 
laboratory reproducibility over days 1, 2 and 3. This value was multiplied by  a  
coverage  factor  of  three  to  give  an  overall  figure  for  the  MU. This approach of 
using the within laboratory reproducibility as a good estimator of measurement of 
uncertainty is taken from the SANCO/2004/2726rev4 document. It recommends 
using the within laboratory reproducibility and using a coverage factor of 2.33 to 
estimate expanded uncertainty, however it was felt that not all the environmental 
factors that could be varied over the course of the validation were  examined. 
Therefore  a  coverage factor of 2.33 may underestimate  the true uncertainty of the 
method and instead a value of 3 was  chosen to  give  a  more  realistic  value  for  
the  true  uncertainty. Values for MU are seen in Table 7-2 and lie between 24 and 
84% for all the analytes. 
Higher MUs are seen in some compounds with no deuterated analogues for use as 
internal standards which is expected. In particular the MU for SDZ (84%) is the 
highest observed for any of the analytes investigated due to problems with low levels 
of SDZ observed in the majority of feed used. This resulted in greater variability in 
results achieved for SDZ and in turn increased its MU. 
 
7.5 Conclusions 
The objective of this work was to develop a rapid multi-class confirmatory method 
capable of analysing for fourteen prohibited medicinal additives in pig and poultry 
194 
 
Chapter 7                                Prohibitted Medicinal Additives in Feed 
compound feed at 100 g kg-1 and to validate in such a way as to best show the 
method as fit for purpose. This was successfully completed to allow for the 
quantification of 10 analytes and qualitative analysis of 4 analytes. 
The method can be considered as rapid, as it utilises an efficient extraction protocol 
without the use of large sample sizes, extraction volumes and SPE. It also utilises 
chromatography which separates all analytes in a total run time of only 26 minutes. 
The method permits the analysis of 14 medicinal additives in pig and poultry 
compound feed which has not been seen in literature before. 
The obtained confirmatory criteria of ion ratios and relative retention times fulfill the 
requirements laid down in Commission Decision 2002/657/EC. The calculation of all 
relevant performance characteristics was performed during validation. This study 
shows that the developed method meets the desired sensitivity of 100 µg kg-1 for all 
the compounds. The method performs satisfactorily in terms of trueness and 
repeatability for each of the analytes investigated with the exception of sulfadiazine 
due to the utilisation of five different internal standards. The values achieved for 
trueness, %RSD and measurement of uncertainty all fall within acceptable ranges 
except for sulfadiazine. The applicability of the method for use on various types of 
pig and poultry compound feed was demonstrated by the satisfactory results obtained 
from the validation. The validation data shows that the method allows for the 
quantitation of 10 analytes and the qualitative analysis of 3 analytes. While 
sulfadiazine was validated in order to be quantified the validation results achieved 
were not acceptable. This is as a result of varying background sulfadiazine in the 
feeds that were used in validation. That said, the reduced number of analytical steps 
within the method makes it very amenable for high through-put regulatory 
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monitoring of these compounds and enforcing Commission Recommendation 
2005/925/EC.  
The method developed in this study is an improvement on existing methods as it 
allows for the analysis of an increased number of analytes in this matrix. It also 
allows for reduced sample preparation times and solvent usage than other published 
methods. 
 
7.6 Acknowledgements 
This work was funded by the Dublin Institute of Technology (DIT). The author 
would like to thank DIT for the opportunity to carry out this work and also the staff 
at The State Laboratory, Co. Kildare for their practical assistance. 
 
 
 
 
 
 
 
 
Chapter 8                             Coccidiostats at carry-over level in feed 
 
 
 
 
 
 
 
CHAPTER 8: DETERMINATION OF ELEVEN 
COCCIDIOSTATS IN ANIMAL FEED BY LIQUID 
CHROMATOGRAPHY-TANDEM MASS 
SPECTROMETRY AT CROSS CONTAMINATION 
LEVELS 
 
 
 
Accepted Manuscript for publication in Analytica Chimica Acta; Article in Press, Corrected Proof. 
 
 
 
 
197 
 
Chapter 8                             Coccidiostats at carry-over level in feed 
8.1 Abstract 
A confirmatory multi-residue method has been developed to allow for the detection, 
confirmation and quantification of eleven coccidiostats in animal feed by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS). The method can be used 
to determine halofuginone, robenidine, nicarbazin, diclazuril, decoquinate, 
semduramicin, lasalocid, monensin, salinomycin, narasin, maduramicin at levels 
relating to unavoidable carry over as stated in Regulation 2009/8/EC. Feed samples 
are extracted with water and acetonitrile with the addition of anhydrous magnesium 
sulphate and sodium chloride. The extract then undergoes a freezing out step before 
being diluted and injected onto the LC-MS/MS system. The LC-MS/MS system is 
run in MRM mode with both positive and negative electrospray ionisation and can 
confirm all eleven analytes in a run time of 19 minutes. The sensitivity of the method 
allows quantification and confirmation for all coccidiostats at a 0.5% carry over 
level. The method was validated over three days in accordance with of European 
legislation; Commission Decision 2002/657/EC. Validation criteria of accuracy, 
precision, decision limit (CC, and detection capability (CCalong with 
measurement uncertainty are calculated for all analytes. The method was then 
successfully used to analyse a number of feed samples that contained various 
coccidiostat substances. 
 
Keywords: Coccidiostats; Regulation 2009/8/EC; LC-MS/MS; Animal Feed; 
Validation. 
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8.2 Introduction 
The use of many antibiotics, coccidiostats and antibacterial growth promoters as feed 
additives has been prohibited in Europe since 2006 by Commission 
Recommendation 2005/925/EC. This recommendation lists medicinal substances that 
should be monitored and the substances are divided into two groups; medicinal 
substances authorised as feed additives for certain animal species or categories and 
medicinal substances no longer authorised as feed additives. Following this ban of 
antibiotics such as tylosin, virginiamycin and spiramycin as feed additives no 
antibiotics other than coccidiostats and histomonostats can be marketed and used as 
feed additives within the European Union. Coccidiostats constitute the main choice 
to fight against coccidiosis. Coccidiosis is a parasitic disease of the intestinal tract 
caused by unicellular organisms. The disease is highly contagious and spreads from 
one animal to another by contact with infected faeces. Coccidiosis is a major disease 
in poultry as well as in many other hosts. [Matabudul et al., 1999] 
During the production of feed containing coccidiostats as feed additives, unavoidable 
carry-over of the coccidiostats from target to non target feed occur from the use of 
the same production lines. This may lead to high concentrations of coccidiostats in 
non-target feed; which could harm certain species and also accumulation of 
coccidiostats may be a risk to human health. As a result of these concerns and in 
order to avoid coccidiostat carry-over, Regulation 2005/183/EC sets specific 
requirements for companies using coccidiostats in the production of feed, pertaining 
particularly to facilities and equipment, production, storage and transport, to avoid 
any cross-contamination. In addition to this EU legislation was published in the form 
of Regulation 2009/8/EC and this established maximum limits for unavoidable carry 
over of coccidiostats and histomonostats. Taking into account the application of good 
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manufacturing practices, carry-over rates of approximately 1 and 3% of the 
authorised maximum content should be considered for sensitive and less sensitive 
non-target animal species, respectively. A carry-over rate of 1% should also be 
considered for feed used during the period before slaughter, for other target species 
feed to which no coccidiostats are added, and for non-target feed for ‘continuous 
food producing animals’ (dairy cows or laying hens). The structures and the 1% and 
3% carry over levels of all the coccidiostats covered by this legislation are seen in 
table 8-1.  
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As a result of this legislation there is a need for reliable multi-residue methods to 
help enforce it. From examination of literature it was observed that there is a limited 
amount of methods available to carry out this work. There are number of methods for 
the analysis of these substances in various biological matrices such as liver, muscle 
and eggs [Dubois et al., 2004; Olejnik et al., 2009; Mortier et al., 2005(a)]. Methods 
for the analysis of feed for some of these compounds are varied; from the analysis of 
one analyte [de la Huebra et al., 2010; Mortier et al., 2005(b); Kot-Wasik et al., 
2005] up to the analysis of several [Vincent et al., 2008; Mortier et al., 2005(a)]. A 
method by Vincent et al., 2008 allowed for the analysis of the six ionophore 
coccidiostats by LC-MS/MS. Purification was by solid phase extraction and 
quantification was by matrix matched standards or by standard addition. A method 
published by Mortier et al., 2005(a) allowed for the analysis of four substances of 
interest; HAL, ROB, DNC and DIC in feed by LC-MS/MS. Samples were extracted 
with methanol and concentrated up before filtering through a 0.22m filter. 
Quantification was performed with the use of internal standards and calibration 
curves. To the laboratory’s knowledge only one method has been published in 
literature to allow for the analysis of all eleven coccidiostats in feed. Delahaut et al., 
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2010 published a method for the analysis of eleven coccidiostats in feed by LC-
MS/MS. Samples were extracted with 10% Na2CO3 and double extraction 
acetonitrile. No purification was performed and quantitation was performed by the 
use of internal standards and quadratic regression model [Delahaut et al., 2010]. 
From previous work carried out on the analysis of feed in our laboratory it is clear 
that feed is a very complex matrix [Cronly et al., 2010 (b)]. Each feed sample can 
almost be unique at time therefore developing a method to allow for its analysis can 
prove difficult. None of the methods available in literature could be applied 
successfully to allow for the analysis of all eleven coccidiostats in the feed that is 
encountered in our laboratory. As a consequence a method had to be optimised in our 
laboratory that would allow for the extraction of all eleven analytes but would also 
overcome the issue of feed variability that would be encountered on a routine basis. 
To this end; this paper describes the analysis of eleven coccidiostats in pig and 
poultry feed at unavoidable carry-over levels described in Regulation 2009/8/EC by 
LC-MS/MS utilising an efficient extraction protocol. 
 
8.3 Materials and Methods 
8.3.1 Chemicals and Reagents 
Robenidine (ROB), nicarbazin (NIC), diclazuril (DIC), decoquinate (DEC), lasalocid 
(LAS), monensin (MON), salinomycin (SAL), narasin (NAR), maduramicin (MAD), 
nigericin (NIG), d8-Robenidine (d8-ROB), d8-4,4'-dinitrocarbanilide (d8-DNC) and 
d5-decoquinate (d5-DEC) were all purchased from Sigma (St. Louis, MO, USA). 
Halofuginone (HAL) was purchased WITEGA Laboratorien (Berlin, Germany) , bis-
diclazuril (bis-DIC) from Janssen (Beerse, Belgium) and semduramicin (SEM) from 
Phibro (Pittsburgh, PA, USA). Water is of LC-MS grade from Fluka (Berlin, 
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Germany). All other solvents are of LC grade and purchased from Reagecon (Clare, 
Ireland). Anhydrous magnesium sulphate is AnalaR grade and purchased from Sigma 
(St. Louis, MO, USA). Individual stock standards of each analyte ranging between 
0.50-1.00 mg ml-1 were prepared in methanol for all compounds except for 
halofuginone (water) and nicarbazin (dimethylsulfoxide) and stored at 4˚C. Working 
standard solution (mixture of analytes) was prepared in acetonitrile by diluting stock 
standard into a range that equated to the carryover levels in 2.5g of feed and stored at 
4ºC for. Internal standards were prepared similarly. 
 
8.3.2 Instrumentation 
202 
 The LC-MS/MS system is a TSQ Quantum Ultra EMR coupled to a Finnigan 
Surveyor LC system. The instrument is controlled by Xcalibur software (Version 
1.5). Separation was achieved using a (100 x 3)mm, 3.5m particle size, Symmetry 
C8 column protected by a Security Guard guard cartridge system (20 x 2)mm, 
supplied by Waters and Phenomenex respectively. The oven temperature was set at 
40ºC. The chromatographic separation was performed in gradient mode using water 
acidified with 0.1% formic acid (mobile phase A) and acetonitrile acidified with 0.1% 
formic acid (mobile phase B), at a flow rate of 0.6mL min-1. The initial conditions 
(from 0-1min) were 100% A. Then the conditions were changed to 2% A over 4 
minutes from 1-5min and this were maintained until 11.50 min. Finally the conditions 
returned to 85% A over 0.5 minutes from 11.5-12min, and were maintained until the 
end of the run at 19min. Electrospray ionisation (ESI) was used in the MS with both 
positive and negative ionisation utilised with a spray voltage of 4500V and a cone 
temperature of 350 ºC. The individual precursor and products ions for each analyte 
with their respective collision energies are listed in Table 8-1. 
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Table 8-1: Molecular Structures, 1% and 3% Carry-over, Electrospray Ionisation (ESI) 
Retention time(Rt), Precursor and Product ions for all 11 analytes. 
 
100.4*
Halofuginone 0.030 416positive
Nicarbazin 0.500 3011.500 7.30 negative
Robenidine 0.700 333.92.100 6.02 positive
Decoquinate 0.400 4181.200 8.21 positive
7.56 negative
405
407
Diclazuril 0.001 0.003
Lasalocid 1.250 613.33.750 9.38 positive
Semduramicin 0.250 895.40.750 9.08 positive
Narasin 0.700 787.42.100 10.08
Salinomycin 0.700 773.52.100 9.69
877.7*
65
35
Maduramicin 0.050 935.90.150 10.30
42
372.1
719.5
41
577.2 32
461.5
29
833.3*
377.2*
29
21
120.0
Monensin 1.250 693.43.750 9.76
203.9*
333.9 20
31138.0
335.9* 22
155.0*
0.090 5.48
38
136.9* 18
18
107.2
Compound Structure
1% Carry 
Over 
(mg/kg)
Collision 
Energy
3% Carry 
Over 
(mg/kg)
Rt Precursor (M/z)
Product 
(M/z)ESI
431.0*
531.4
32
39
851.3
50
45
50
45
55
431.4*
531.4
675.3* 41
positive
positive
positive
positive
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8.3.3 Pig and Poultry Compound Feed Samples 
A variety of pig and poultry compound feed samples were sourced from various feed 
mills. These were milled upon receipt to 1mm using a Retsch SM 100 mill and stored 
in amber jars at 4ºC. Portions of these samples were analysed and those found to 
contain no detectable residues of the analytes of interest were used as blanks for the 
validation study. To ensure robustness of the method a high number of different feed 
samples were used in validation. These included 12 different pig feeds and 12 
different poultry feeds. Chromatograms of blank feed can be seen in Figure 8-1a. 
 
8.3.4 Extraction 
Feed (2.5 g) was weighed into polypropylene centrifuge tubes (50 mL). The sample 
was fortified with mixed internal standard (25 µL). To this deionised water (12 mL) 
was added and the tubes were shaken (15 min). To this acetonitrile (25mL) was 
added and the tubes were shaken (15min). Anhydrous MgSO4 (4.0 g) and NaCl (2g) 
was added to this slurry which was then shaken (15 min) and centrifuged (5100rpm 
for 20 min). The organic layer was then transferred to a clean polypropylene tube (50 
mL) and placed in a -80 ºC freezer for 15mins to allow for freezing out of matrix 
components. The samples were then removed from the freezer. 10mL of the extract 
is then transferred to a clean polypropylene tube (15mL) and centrifuged at 4500rpm 
for 10min. The extract is then run twice. The first was a straight extract and the 
second was the extract diluted 15 times in mobile phase B. An aliquot (20 µL) of 
each is injected onto the LC-MS/MS. 
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8.3.5 Matrix Extracted Calibration Curves 
Quantitation was carried out using matrix extracted calibration curves. Blank pig and 
poultry feed samples were used. These samples were fortified with mixed working 
standard and submitted to the full extraction procedure. A matrix extracted 
calibration curve was performed with every batch. Feed samples were fortified with 
internal standard and mixed working standard yielding a calibration range relating 0 
to 4% carryover of each of the eleven analytes. Calibration curves were prepared by 
plotting the response factor (the ratio of peak area analyte over peak area of internal 
standard) against analyte concentration for the four compounds with internal 
standard.  Four internal standards were used; d8- DNC, d8-ROB, d5-DEC and bis-
DIC. For compounds for which no suitable internal standard could be acquired; HAL 
and the six ionophore coccidiostats SEM, LAS, SAL, MON, NAR and MAD; 
calibration curves were prepared by plotting the peak area of the analyte against 
analyte concentration.  
 
8.3.6 Method Validation 
The LC–MS/MS method was validated according to Commission Decision 
2002/657/EC guidelines. LC–MS/MS identification criteria were verified through-
out the validation study by monitoring relative retention times, ion recognition 
(signal-to-noise ratio (S/N)) and relative ion intensities. LC-MS/MS identification 
criteria as set out in the legislation were verified throughout the validation of the 
method.  
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Several method validation parameters were determined including linearity, 
specificity, recovery, precision and analytical limits (decision limit CC, and 
detection capability CC). Specificity was determined by analysing 28 different 
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blank pig and poultry samples sourced from different mills. To investigate the 
linearity of the method, matrix-matched calibration curves were prepared and run 
with each of the validation batches to give 6 point calibration curves ranging from 0 
to 4% carryover for each of the analytes.  
Since no certified reference materials were available for all the analytes and matrices 
of interest, the recovery from fortified blank samples was measured as an alternative 
to trueness. The accuracy and precision were determined through the analysis of wide 
variety of blank pig and poultry feed samples fortified in seven replicates relating to 
0.5%, 1% and 3% carryover of each of the analytes. Seven replicate test portions at 
each of the three fortification levels (n = 21) were analysed on three separate days 
over a period of two weeks. Samples were fortified by adding mix working standard 
solution (12.5, 25 and 75 µL) and analysed. From these three separate validation days 
the estimation of recovery, precision and analytical limits (decision limit CC, and 
detection capability CC) were determined along with the methods measurement 
uncertainty. 
 
8.4 Results and Discussion 
8.4.1 LC-MS/MS Optimisation 
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The LC-MS/MS method was developed to provide confirmatory data for the analysis 
of 11 coccidiostats in pig and poultry compound feed. The MS/MS fragmentation 
conditions were investigated and collision energies were optimised for each 
individual compound to give best response. For a method to be deemed confirmatory 
under Commission Decision 2002/657/EC it must yield 4 identification points. In 
this method a precursor ion (parent mass) and two product ions (corresponding to 
strong and weak ion) are monitored for each analyte (Table 8-1). This yields 4 
 
Chapter 8                             Coccidiostats at carry-over level in feed 
identification points (1 for the parent ion and 1.5 for each daughter ion) hence it can 
be deemed a confirmatory method. In addition to this relative retention times and ion 
ratios are monitored for each compound and evaluated to ensure that they are within 
acceptable ranges as stated in EC 2002/657. 
 Previous work carried out on coccidiostats in various matrices used a range of 
different columns and gradients. A popular choice with many methods is C18 with 
acidified water and acetonitrile gradient [Mortier et al., 2005 (a); Dubois et al., 2004; 
Delahaut et al., 2010]. Other methods used phenylhexyl [Olejnik et al., 2009] and C8 
[Dubreil-Chéneau et al., 2009] columns with three mobile phases. During the 
development of this method it was found that a combination of C8 column with a 
mobile phase of water and acetonitrile acidified with 0.1% formic acid gave the best 
retention, peak shape and separation for all compounds in an acceptable run time. As 
this method involved positive and negative ionisation switching, the MS/MS method 
had to be segmented. The LC gradient was optimised in order to have the negative 
ionisation in one segment. Only when the positive and negative ionisations were 
isolated to separate segments was there enough data points for each peak. For a 
method to achieve reliable quantitation each analyte peak should have at least 12 -15 
data points. The LC Gradient along with segmentation allowed for the analysis of all 
11 analytes in a complete run time of 19 minutes with each peak having a minimum 
of at least 12 data points. 
 
8.4.2 Extraction Optimisation 
The aim of the development work was to develop a quick efficient extraction 
protocol for the analysis of eleven coccidiostats in a wide variety of feed. From 
investigation of literature it was found that acetonitrile is commonly used as an 
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extraction solvent for these compounds in various matrices [Olejnik et al., 2009; 
Dubois et al., 2004; Delahaut et al., 2005]. From initial tests it was clear that 
although acetonitrile extracted all the analytes of interest it also extracted a lot of 
matrix interferences as feed is a very complex matrix. Previous research carried out 
in our lab has demonstrated difficulties with this matrix [Cronly et al., 2010 (b)]. 
Feed is not a standardised formula and is a lot more variable than other biological 
matrices such as plasma and milk. Even one batch of feed to the next can vary and 
therefore each feed can be considered a unique sample.  
Taking this into consideration there is a need for a suitable sample clean up 
procedure. A number of procedures were investigated; the extraction of analytes by 
water and acetonitrile with addition of NaCl [Cronly et al., 2009 (a)], extraction by 
acetonitrile with the addition of anhydrous sodium sulphate [Cronly et al., 2010(b)] 
and the extraction by water and acetonitrile with addition of NaCl and magnesium 
sulphate [Walorczyk, 2008] in order to reduce the amount of interferences extracted 
from the matrix. While all these helped to improve the recovery of the analytes and 
the ion suppression in the LC-MS/MS the addition of NaCl and magnesium sulphate 
with an extraction of water and acetonitrile gave the best results.  
To help improve the method further the addition of a dispersive SPE step was added. 
This improved the method repeatability but on investigation of literature it was found 
that this step could be replaced by a freezing out step which can remove many of the 
same matrix components as the dispersive SPE [Walorczyk, 2008; Mastovska et al., 
2010]. This step was performed by placing the extract into a -80ºC freezer for fifteen 
minutes. Upon removal from the freezer a visible amount of particles had fallen to 
the bottom of the extract. The addition of this step improved repeatability in different 
feeds.  
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The next step in the development was the selection of suitable internal standards. 
From investigation of literature it was observed that some deuterated internal 
standards were available [Dubreil-Chéneau et al., 2009]. Deuterated standards 
available were ROB-d8, DNC-d8 and DEC-d5. Other internal standards used were 
bis-DIC for diclazuril and nigericin for the ionophore coccidiostats [Mortier et al., 
2005; Vincent et al., 2008]. These were obtained and used as internal standards for 
the various analytes. It was seen that while the deuterated standards and bis-DIC 
corrected satisfactorily for their respective analogues, nigericin did not correct the 
ionophore coccidiostats adequately. It was observed that in calibration curves of the 
six ionophore coccidiostats the curve started levelling off near the top. Recent work 
published [Delahaut et al., 2010] suggested the use of quadratic instead of linear 
calibration curves. While in single feeds this gave coefficient of determination (R2) 
values of 0.99, the use of this curve for calculating fortified samples gave very 
variable results in various different types of feed. Therefore in order to use this 
approach the selection of feed for matrix matched curves had to be very similar to the 
feed being analysed. As feed can vary greatly it was felt that this approach would not 
be fit for purpose in our laboratory where a wide range of feed samples would be 
received for analysis. 
In order to overcome this problem it was decided that diluting the extract would 
allow for less matrix interference while still having enough analyte signal. Various 
dilutions were tested and it was found that a 1 in 15 dilution gave linear curves in a 
single feed with R2 of 0.99 using nigericin as an internal standard for the ionophore 
coccidiostats. When this was used for calculating the levels in fortified feed samples 
it was seen that while in some feeds, results were satisfactory, there were cases in 
which the results were not acceptable in relation to accuracy. Upon further 
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investigation it was seen that this was due to the unsuitability of nigericin as an 
internal standard for these compounds in feed. Results showed that when peak areas 
for the analyte increased, the results for nigericin decreased and vice versa. This 
resulted in larger errors in the results for these feeds. It was seen that repeatability 
and accuracy were greatly improved when no internal standard was used for these 
compounds. The only drawback to this was that each extract would have to be run 
twice, once as a straight extract and once diluted 15 times. This was as a result of the 
levels and low responses for DIC and HAL in the diluted samples.  
In order to ensure that this procedure would hold true in the wide variety of feed 
samples likely to be encountered in the laboratory on a routine basis a validation 
procedure was developed in accordance with Commission Decision 2002/657. In 
each validation a single feed would be used for the six point matrix extracted 
calibration curve and seven different feeds would be used for the replicates at the 
three validation levels. This would allow the validation to fully cover the various 
feeds likely to be encountered. 
 
8.4.3 Validation 
Validation was carried out in accordance with the procedures outlined in 
Commission Decision 2002/657/EC covering specificity, calibration curve linearity, 
accuracy, precision, decision limits (CCα), decision capability (CCβ) and 
measurement uncertainty. Results are seen in table 8-2 for these criteria. The criteria 
of relative retention times and ion ratios were monitored for all analytes in the three 
validations days. The values identified for these were all within European 
requirements. 
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Table 8-2: Validation results for accuracy, precision (%CV), decision limit (CC)  detection 
capability (CC)and measurement uncertainty (MU) and confirmatory data of typical ion 
ratios and relative retention times (RRT) for all 11 analytes. 
 
Analyte 
Internal 
Standard 
Accuracy 
(%) 
CV 
(%) 
CC (mg/kg) 
1%       3% 
CC (mg/kg) 
1%          3% 
Typical 
RRT 
Typical 
Ion Ratio 
MU 
(%) 
HAL None 88.8 8.8 0.029 0.092 0.033 0.109 0.912 0.334 25 
ROB ROB-d8 95.0 6.1 0.786 2.370 0.871 2.639 1.000 0.863 19 
DNC DNC-d8 97.3 4.4 0.532 1.669 0.564 1.837 1.000 0.069 12 
DIC bis-DIC 96.3 8.0 0.011 0.035 0.013 0.040 0.990 0.849 17 
DEC DEC-d5 95.0 7.0 0.439 1.333 0.478 1.466 1.000 0.589 15 
SEM None 99.9 7.6 0.294 0.863 0.338 0.976 1.511 0.129 21 
LAS None 98.1 8.6 1.570 4.524 1.890 5.298 1.561 0.455 31 
SAL None 92.3 9.1 0.821 2.418 0.942 2.737 1.612 0.548 22 
MON None 96.6 6.3 1.388 4.178 1.527 4.606 1.624 0.354 21 
NAR None 101.7 7.0 0.775 2.380 0.850 2.660 1.677 0.463 19 
MAD None 104.5 8.4 0.057 0.168 0.064 0.187 1.714 0.037 24 
8.4.3.1 Specificity 
The technique of LC-MS/MS itself offers a great deal of specificity and selectivity. 
To establish the specificity and selectivity of the method 24 blank pig and poultry 
compound feed samples and samples fortified with all 11 analytes were analysed 
over the 3 validation days. All blank samples showed no interfering peaks in the area 
of interest for any of the analytes. Chromatograms of blank feed and feed fortified at 
0.5% carryover of each analyte are seen in Figure 8-1a and 8-1b. 
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Figure 8-1a: Chromatogram of feed fortified at 0.5% Carry-Over  
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Figure 8-1b: Chromatogram of blank feed 
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8.4.3.2 Linearity of Response 
The linearity of the chromatographic response was tested with matrix extracted 
calibration curves using six calibration points in the range of 0-4% carryover for all 
eleven analytes on each of the validation days. For each analyte; calibration curves 
were linear in the given range with a coefficient of determination (R2) of at least 0.99 
for all compounds except for LAS and MAD which were at least 0.98. 
 
8.4.3.3 Ion Ratios 
Two transition ions were monitored for each of the fourteen analytes. The most 
intense was used for quantitation. Ion ratios were calculated for all analytes by 
calculating the ratio of the strong ion over the weak ion. All ion ratios of samples 
were within tolerances as set out by European criteria when compared with standards 
used during validation. Control charts were used to ensure all ion ratios were 
acceptable. The typical ion ratios for all the analytes are shown in Table 8-2. 
 
8.4.3.4 Relative Retention Times (RRT) 
RRTs were calculated for all analytes in this method by calculating the ratio of the 
retention time of the analyte over the retention time of its corresponding internal 
standards. For the seven compounds that do not use an internal standard, ROB-d8 
was used for their RRT calculations. The RRT tolerance for LC-MS/MS of 2.5% was 
adhered to when standards were compared to samples in the validation runs. Control 
charts were again used to ensure all ratios were acceptable. The typical RRT for all 
the analytes are shown in Table 8-2.  
 
214 
 
Chapter 8                             Coccidiostats at carry-over level in feed 
8.4.3.5 Accuracy/Trueness 
The accuracy (trueness) of the method was determined by fortifying 21 replicate feed 
samples on three separate days. For the eleven coccidiostat analytes seven replicates 
were fortified at 0.5%, 1% and 3% carryover. Mean corrected accuracy (n=7) of the 
analytes, determined in the three separate validation batches are shown in Table 8-2 
range between 88.8% and 104.5%  for the eleven analytes in pig and poultry feed. 
These are within acceptable limits set out in European legislation. 
 
8.4.3.6 Precision 
Satisfactory values for inter-assay precision expressed as %CV values for the within 
lab reproducibility (table 8-2) were achieved for all analytes. According to 
Commission Decision 2002/657/EC this coefficient of variance for the repeated 
analysis of fortified material under reproducible conditions shall not exceed the level 
calculated by the Horwitz equation. For a concentration of 1 mg kg -1 this equation 
gives a value of 16%. Results achieved range from 4.4 to 9.1% for all analytes and 
this is less the desired 16%. These acceptable results can be attributed to the 
availability of 4 suitable internal standards. For compounds without suitable internal 
standards the optimisation of the extraction protocol can be attributed to the 
acceptable values. 
 
8.4.3.7 CC and CC 
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In the case of substances with an established permitted limit, the decision limit (CCα) 
means the limit at and above which it can be concluded with an error probability of α 
that a sample is non-compliant and the detection capability (CCis the 
concentration at which the method is able to detect permitted limit concentrations 
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with a statistical certainty of 1 – β. CC and CC values were determined in 
accordance with sections 3.1.2.5 and 3.1.2.6 of commission decision 2002/657/EC 
by fortifying seven samples at the 1% and 3% allowed carry over levels on three 
different days (n=21) and calculating standard deviations. The concentrations at the 
1% and 3% plus 1.64 times the calculated standard deviation was used to yield CC, 
CCwas determined by addition of another factor of 1.64 times the standard 
deviation. Values of CC and CC for each of the eleven analytes for the 1% and 
3% carryover are shown in Table 8-2.  
  
8.4.3.8 Measurement Uncertainty 
The measurement uncertainty (MU) was estimated by taking into account the within 
laboratory reproducibility over days 1, 2 and 3. This value was multiplied by  a  
coverage  factor  of  two  to  give  an  overall  figure  for  the  MU. This approach of 
using the within laboratory reproducibility as a good estimator of measurement of 
uncertainty is taken from the SANCO/2004/2726rev4 document. It recommends 
using the within laboratory reproducibility and using a coverage factor of 1.64 to 
estimate expanded uncertainty for permitted substances, however it was felt that not 
all the environmental factors that could be varied over the course of the validation 
were  examined. Therefore  a  coverage factor of 1.64 may underestimate  the true 
uncertainty of the method and instead a value of 2 was  chosen to  give  a  more  
realistic  value  for  the  expanded  uncertainty. Values for MU are seen in Table 8-2 
and lie between 12 and 31% for all the analytes. 
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8.4.3.9 Method Evaluation 
 
Figure 8-2: Chromatogram containing strong and weak ions of non compliant samples 
 
In order to evaluate this method non compliant feed samples that were received from 
Rikilt (Netherlands) at levels relating to carry over issues were analysed. Figure 8-2 
shows chromatograms with both the strong and weak ions for robenidine, 
salinomycin and monensin which were found to be present in these samples. These 
samples were tested using the method described here and found to yield satisfactory 
results. When the methods measurement uncertainty is applied, the assigned values 
fall within the possible range of concentrations given by this method. Also the 
method found no peaks of analytes that were not present in the sample. Results of all 
non compliant samples tested are seen in table 8-3.  
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Table 8-3: Results of non compliant sample received from Rikilt 
 
RESULTS 
Feed 
Sample No. Compound MU (%) 
Calculated 
 (mg kg -1) 
Result + MU 
 (mg kg -1) 
Result -MU 
 (mg kg -1) 
Actual  
(mg kg -1) 
12 ROB 19 3.24 3.86 2.62 2.9 
7 SAL 22 2.24 2.73 1.75 2.3 
14 MON 21 1.61 1.95 1.27 1.3 
8.5 Conclusions 
The objective of this work was to develop a rapid confirmatory method capable of 
identifying, confirming and quantifying eleven coccidiostats at levels relating to 
unavoidable carry-over in a variety of feed samples that the laboratory might 
encounter on a routine basis and to validate in accordance with the requirements set 
out in Commission Decision 2002/657/EC. This was successfully completed.  
The method can be considered as rapid, as it utilises an efficient extraction protocol 
without the use of large sample sizes, extraction volumes and SPE. It also utilises 
chromatography which separates all analytes in a total run time of 19 minutes. The 
method includes the analysis of 11 coccidiostats in a wide variety pig and poultry 
compound feed. 
The obtained confirmatory criteria of ion ratios and relative retention times fulfill the 
requirements laid down in Commission Decision 2002/657/EC. The calculation of all 
relevant performance characteristics was performed during validation. This study 
shows that the developed method meets the desired sensitivity of 0.5% carry-over for 
all the compounds. The method performs satisfactorily in terms of accuracy and 
precision (%CV) for each of the analytes investigated and all fall within acceptable 
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ranges. The analytical limits in terms of decision limit (CC, and detection 
capability (CCof the method were calculatedfor all eleven coccidiostats.Therefore 
applicability of the method for use on various types of pig and poultry compound 
feed was demonstrated by the satisfactory results obtained from the validation. The 
validation data shows that the method allows for the quantitation of 11 analytes. The 
method was further evaluated by using it to analyse for these compounds in non 
compliant samples. The reduced number of analytical steps within the method makes 
it very amenable for high through-put regulatory monitoring of these compounds and 
enforcing Commission Directive 2009/8/EC. 
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9.1 Conclusions 
The main areas on which this research focused was the development of analytical 
methodologies for the detection of nitroimidazole residues in various biological 
matrices. These included plasma, eggs, milk and honey [Cronly et al., 2009(a); 
2009(b); 2010(a)]. By using generic extraction protocols the work also demonstrated 
that different classes of drugs could be analysed together such as chloramphenicol 
and nitroimidazoles. The developed method was then used to carry out a survey for 
the presence of nitroimidazole residues in Irish retail egg samples [Cronly et al., 
2011(a)]. The second area of research focused on the analysis of medicinal additives 
in animal feed. New legislation has been introduced in this area by the EU which 
prohibits the use of wide number of these compounds [Commission Recommendation 
2005/925/EC]. As a result there is a requirement for multi-class methods that can 
analyse for a wide variety of these additives in feed. The remaining authorised 
additives are only permitted for use in target species. Levels for allowed unavoidable 
carryover of these additives in non target feed were set by the EU [Commission 
Directive 2009/8/EC] and hence a need existed for an analytical method capable of 
measuring all these substances at these carry over levels. Therefore as part of this 
research two methods were developed for the analysis of animal feed, firstly for the 
presence of 14 prohibited medicinal additives [Cronly et al., 2010(b)] and secondly 
for the coccidiostats at levels relating to unavoidable carry over [Cronly et al., 
2011(a)]. The conclusions resulting from these two areas of research are discussed 
fully in the following two sections. 
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9.1.1 Analytical methodologies for detection of nitroimidazoles and 
chloramphenicol residues in biological matrices 
When initiated the main focus of this research was on the development of multi-
residue analytical methods for the analysis of nitroimidazole residues in plasma and 
eggs by LC-MS/MS. There were a number of reasons for this; 
 Nitroimidazole compounds are believed to be carcinogenic and mutagenic to 
humans. 
 They are prohibited for use in food producing animals by their inclusion in Table 
2 of Council Directive 37/2010/EC. 
 Matrices of plasma and egg are recommended as target matrices for these 
compounds by the EURL. 
 Finally their monitoring as part of the national residue control plan in Ireland 
was limited to the analysis of two residues in one matrix. 
 LC-MS/MS offered a selective and sensitive confirmatory technique that could 
overcome problems associated with derivatisation of these analytes for analysis 
by GC-MS/MS. 
From examination of literature it was apparent that there was a shift from traditional 
labour intensive extraction and purification techniques such as SPE to more efficient 
generic extraction protocols which resulted in significant economic and time 
benefits.  
The approach to method development taken as part of this research was to try to 
incorporate as many nitroimidazole analytes as possible and develop a rapid and 
efficient method. Initially a method published by Xia et al., 2006 for the analysis of 
nitroimidazoles in muscle and eggs was used as the basis for the developed 
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extraction protocol. Xia et al., 2006 method was limited to the analysis of four NMZ 
residues so needed to be adapted to incorporate increased number of analytes. This 
paper described the use of a fast LLE using acetonitrile. The miscible aqueous and 
organic phases were separated by the addition of salt. The salt used was NaCl and 
this resulted in the phases separating into two layers. The NMZ residues were 
extracted into the acetonitrile phase which resulted in a cleaner extract. 
Using this protocol as a basis for method development; methods were developed for 
the analysis of NMZ residues in plasma and eggs. This was achieved by making the 
following adaptations to the original method; 
 The samples were extracted with a single extraction rather than a double 
extraction. 
 The samples were purified by the addition of a hexane wash step which removed 
any further non polar impurities 
 Two centrifuge steps were incorporated, one to ensure complete phase 
separation and another to remove any particulates prior to evaporation. 
 The sample was evaporated to dryness and reconstituted in a small volume to 
increase sensitivity. 
 Finally after testing numerous filters, samples were filtered through 0.25 µm 
PVDF filters which resulted in a clean extract for injection. 
These adaptations allowed for rapid, multi-residue, confirmatory methods to be 
developed that simultaneously identifies, confirms and quantifies ten NMZ residues 
in plasma [Cronly et al., 2009(a)] and eleven NMZ residues in eggs [Cronly et al., 
2009(b)] by LC-MS/MS.  
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The developed methods were an improvement on existing methodologies and the 
benefits of the analytical methods are as follows; 
 An increased number of analytes are incorporated both in plasma and egg than 
previously published in the literature. The method is capable of analysing for the 
seven NMZ residues that are recommended for analysis by the EURL as well as 
other nitroimidazoles that haven’t been analysed previously such as ornidazole 
and carnidazole 
 The method can be considered as rapid, as it utilises an efficient extraction 
protocol with purification by hexane wash and filtering. 
 The method is validated and the obtained data fulfils the requirements laid down 
in CD 2002/657/EC and allows the calculation of accuracy, repeatability, 
reproducibility and MU. These parameters fall within acceptable ranges for each 
analytes.  
 The required sensitivity of the method is demonstrated by the values for CC 
and CCThese values are lower than the RL for NMZ residues of 3 µg kg-1/ng 
mL-1. 
 The developed methods were capable of analysing for plasma and eggs from a 
variety of species. These include bovine, avian, porcine, ovine and equine 
plasma and caged, free range and organic hen eggs along with duck and quail 
eggs. 
 Finally both methods performed satisfactorily in evaluation tests carried out on 
incurred plasma and egg samples where results achieved were within MUs when 
compared to assigned values. 
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Upon completion of validation of the developed method for the analysis of 
nitroimidazoles in eggs, a survey of retail egg samples commenced [Cronly et al., 
2011(b)]. The two main reasons for undertaking this survey were that non compliant 
findings of NMZ residues in eggs had been recorded in Europe [EFSA Report, 2009] 
and also there was no analysis carried out on these compounds in eggs in Ireland prior 
to 2007. Therefore it was felt that an evaluation of eggs available in the Irish retail 
market for the presence of NMZ residues would be beneficial. The survey was carried 
out throughout the course of the research with retail samples taken every month over 
two years. Upon completion of this survey; 160 hen and duck egg samples were 
analysed and no non-compliant samples were identified. It is felt that this 
demonstrates that the ban on these compounds is being observed and it gives 
confidence to the consumer that the eggs that reach the table are free from these 
harmful residues. It is felt that the continued monitoring of these compounds in eggs 
which is being carried out as part of the national monitoring plan is sufficient to 
ensure the continued enforcement of these prohibited compounds in eggs. 
Carrying on from the development of the methods for plasma and eggs other matrices 
were examined. In order to ensure continued consumer protection the EURLs are, on 
an ongoing basis, suggesting that a wider variety of residues and matrices be 
examined. Two such matrices suggested by the EURL for nitroimidazoles were milk 
and honey. Honey bees and dairy cows were originally not target species for 
nitroimidazole drugs but abuse in them now cannot be overlooked. The EURL 
suggest that countries with high milk production should test for NMZ residues in this 
matrix. Reports from China about the potential use of nitroimidazoles in beekeeping 
suggest that honey should also be investigated [Zhou et al., 2007]. Examination of 
literature found that there was a lack of methods for these matrices with regards to the 
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analysis of nitoimidazoles with only one confirmatory method for the analysis of 
NMZ residues in milk and none in honey. Therefore it was felt that the previously 
developed method could be adapted to include the analysis of milk and honey. 
Due to the generic nature of the extraction procedure it was envisaged that it may be 
possible to include other classes of compounds. From examination of literature and 
legislation it was felt that it would be beneficial to include chloramphenicol. The 
main reasons for this were that it is also listed in Table 2 of Commission 37/2010/EC 
(prohibited substances), it is commonly analysed in single analyte labour intensive 
methods which are time consuming and target matrices for this compound include 
milk and honey. Therefore it was decided to adapt the method for the analysis of 11 
NMZ residues and CAP in milk and honey by LC-MS/MS. 
The main benefits of this method over existing published methods are as follows; 
 The method includes the confirmatory analysis of CAP and 11 NMZs in milk 
and honey which has not been seen before. 
 The method can be considered as rapid, as it utilises an efficient extraction 
protocol without the use of SPE and utilises rapid chromatography with a total 
run time of only 9 minutes. 
 Methods previously published on these matrices analysed at most seven NMZ 
analytes and in the case of CAP it was often analysed as a single analyte method. 
 This study shows that as the developed method uses a newer sensitive 
instrument that even with reduced sample sizes required sensitivities of 3 g L-1 / 
g kg-1 for NMZs and 0.3g L-1 / g kg-1for CAP which are the RL and MRPL 
used for these compounds are easily achieved. 
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 The method performs very well in terms of accuracy and repeatability for each 
of the analytes due to the utilisation of seven different deuterated internal 
standards. 
 In the case of the extraction protocol for milk; time and solvent usage is greatly 
reduced compared to other published methods as a result of reduced sample size 
of 1mL. 
This concluded the research on the analysis of nitroimidazole residues in biological 
matrices. The main aim of this research was to help improve the surveillance 
capabilities of The State Laboratory with regards to the analysis of nitroimidazoles. 
To this end, a number of novel, rapid, confirmatory, multi residue methods using 
liquid chromatography tandem mass spectrometry in a variety of biological matrices 
were successfully developed. Other aims including determining the potential misuse 
of nitroimidazole compounds in eggs in the Irish poultry industry by the analysis of 
retail survey samples and the implementation of these methods in the National 
Reference Laboratory designated for nitroimidazoles in Ireland were also 
successfully completed. 
 
9.1.2 Analytical methodologies for the detection of medicinal additives in animal 
feed. 
The second phase of the research was concerned with the development of multi-class 
analytical methods for the analysis of medicinal additives in animal feed. This 
included methods for the analysis of 14 prohibited medicinal additives and the 
analysis of 11 coccidiostats at levels relating to unavoidable carryover. The reasons 
for researching this area are; 
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 Contaminated feed has the potential to result in possibly harmful levels of 
residues in any animal fed such feed.  
 Recent legislation; Commission Recommendation 2005/925/EC; has prohibited 
all previously used feed additives except for one class of compounds 
coccidiostats and histomonostats. 
 Further legislation, Commission Directive 2009/8/EC established maximum 
limits for unavoidable carry over of coccidiostats and histomonostats into 
sensitive and less sensitive non target species. 
 Previously used single analyte HPLC methods used for the analysis of additives 
at medicated level are not sensitive or selective enough to enforce levels set out 
in the new legislation. 
 No multi-class multi-residue analytical methods were available for analysis of 
these compounds and prior to this legislation, LC-MS/MS was not utilised in this 
area. 
It was felt that the best analytical tool for analysing these various feed additives and 
enforcing new legislation was LC-MS/MS. However the use of LC-MS/MS in 
medicinal additive analysis in animal feed is not routinely used and therefore this 
research focused on the development and implementation of LC-MS/MS methods for 
this purpose. Upon carrying out literature review it was decided that two methods 
would be developed; one for the analysis of as many prohibited medicinal feed 
additives as possible and one for the analysis of all allowed coccidiostat additives at 
levels set out in legislation. 
The first of these methods was developed to allow for the analysis of 14 prohibited 
medicinal additives in pig and poultry compound feed. The method was one of the 
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first multi-class feed additive methods to be published and it had significant benefits 
over previously published articles. These included; 
 It is a rapid multi-class confirmatory method that allowed for the quantitative 
analysis of 10 analytes and qualitative analysis of 4 analytes in pig and poultry 
compound feed which had not been seen in literature before. 
 The method was capable of analysing all these compounds to a level of at least 
100 µg kg-1. 
 The method developed in this study is an improvement on existing methods as it 
allows for the analysis of an increased number of analytes in this matrix with 
reduced sample preparation times and solvent usage. 
 The applicability of the method for use on the various different types of pig and 
poultry compound feed was demonstrated by the satisfactory results obtained 
from the validation. 
 The values achieved for accuracy, repeatability, reproducibility and MU all fall 
within acceptable ranges. 
 The obtained confirmatory criteria of ion ratios and relative retention times for 
all analytes fulfil the requirements laid down in Commission Decision 
2002/657/EC. 
The development of this method had great economical benefits as well as improved 
analytical capabilities for monitoring laboratories. Previous methods were often 
single analyte methods that needed large samples sizes and large volumes of 
extraction solvents for analysis. As well as this a number of analytes such as 
dinitolimide did not have methods for their analysis. This method allowed for all 
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samples to be analysed for 14 analytes in a single run with less sample and solvent 
required. 
The final LC-MS/MS method to be developed as part of this research was a method 
for the analysis of all eleven authorised coccidiostat feed additives at levels related to 
unavoidable carry over in non target feed. Methods routinely used in monitoring 
laboratories and many of the published methods in lliterature could only analyse for a 
select number of these compounds. The allowed levels in non target feed for these 
compounds ranged from the 5 mg kg-1 down to 10 µg kg-1 and some existing methods 
had difficulty reaching the required sensitivity. The method developed as part of this 
research could identify, confirm and quantify eleven coccidiostats at levels relating to 
unavoidable carry-over in a variety of feed samples that the laboratory might 
encounter on a routine basis and was validated in accordance with the requirements 
set out in Commission Decision 2002/657/EC. The benefits of this method are as 
follows; 
 The method can be considered as rapid, as it utilises an efficient extraction 
protocol without the use of large sample sizes, extraction volumes or SPE. It also 
utilises chromatography which allows for the analysis of all analytes in a total 
run time of 19 minutes. 
 This study shows that the developed method meets the desired sensitivity of 
0.5% carry-over of the medicated level for all the compounds. 
 The method performs satisfactorily in terms of accuracy and precision (%CV) 
for each of the analytes investigated and all fall within acceptable ranges. Levels 
for CCand CC were calculated for all compounds. 
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 The method was further evaluated by using it to analyse for these compounds in 
non compliant samples. Results achieved were within MU for all analytes when 
compared to the assigned values. 
 The reduced number of analytical steps within the method makes it very 
amenable to high throughput regulatory monitoring of these compounds and as a 
result enforcing Commission Directive 2009/8/EC. 
The primary aim of this research; meeting the requirements of new EU legislation 
with regard to medicinal feed additives was achieved by developing two new liquid 
chromatography tandem mass spectrometry methods for the analysis of prohibited 
medicinal feed additives in pig and poultry feed and eleven coccidiostats at 
unavoidable carry over levels in animal feed. Both methods used efficient extraction 
protocols with reduced usage of extraction solvents and decrease in sample 
preparation time which will result in economical benefits for monitoring laboratories. 
This work will contribute greatly to the research that is ongoing in this area as it has 
shown improvements on many existing methods published in literature. 
 
9.2 Future Work 
9.2.1 Generic extractions for multi-class methods. 
This research has demonstrated that in some cases the use of highly selective and 
sensitive mass spectrometry techniques reduces the need for complex extraction 
protocols utilising labour intensive purification steps. Leading on from this research it 
is envisaged that future work in this area will be focused on the use of generic 
extraction protocols for the analysis of multiple residues from multiple classes of 
compounds in multiple matrices in a single method. An example of this is the 
extraction method utilised in this study for nitroimidazoles. This was used for the 
231 
 
Chapter 9                                             Conclusions and Future Work 
analysis of nitroimidazoles and chloramphenicol in milk and honey. From 
examination of literature similar extraction protocols with acetonitrile and phase 
separation with NaCl has been used for the analysis of non steroidal anti 
inflammatory drugs (NSAIDs) and corticosteroids in milk [Malone et al., 2009; 
Malone et al., 2010]. Taken this into consideration this extraction procedure has the 
capabilities of analysing for at least four classes of veterinary residues that routinely 
monitored for as part of a European wide monitoring program.  
Although there has been some work in the development of generic extraction methods 
for the analysis of veterinary residues in biological matrices it is still somewhat in it’s 
infancy. However the use of such extraction protocols has, for some time now, been 
utilised in the analysis of pesticides. The most commonly used extraction method 
utilised in this area is known as QuEChERS which stands for Quick, Easy, Cheap, 
Effective, Rugged, and Safe. There is a wide range of these type of methods used in 
pesticide residue analysis but they have the same core elements involved in their 
extraction with some minor adaptations for specific analytes. Anastassiadiades et al., 
2003 and Lehotay et al., 2005 were some of the first to publish methods utilising this 
type of generic method in pesticide analysis. Samples are extracted with acidified 
acetonitrile. LLE is induced by addition of MgSO4 and NaCl to remove water. The 
sample then undergoes purification with what is known as dispersive solid phase 
extraction (d-SPE) by the addition of primary secondary amine (PSA), C18 sorbents 
and MgSO4. The extract is centrifuged before injection and initially allowed for the 
analysis of 80 different pesticides in a single extraction but has been further 
developed to allow up to 229 pesticides to be incorporated [Lehotay et al., 2005]. 
There are a number of benefits to this type of approach in pesticide analysis which 
might be beneficial in veterinary residue analysis [Lehotay et al., 2005]. These are; 
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 High recoveries (>85%) are achieved for a wide range of polarity and volatility. 
 Very accurate results are achieved because an IS is used to correct for 
commodity to commodity water content differences and volume fluctuations. 
 High sample through-put of 10-20 preweighed samples in 30-40min. 
 A single person can perform the extraction without much training or technical 
skill. 
 Despite ease of method the procedure is still quite rugged. 
This type of generic extraction if adapted for the analysis of veterinary residues could 
greatly improve the analytical capabilities of monitoring laboratories. To date there 
has been only one published method for the analysis of veterinary residues attempting 
to use QuEChERS protocol. Stubbings et al., 2009 published results of their research 
for the analysis of 11 different classes of verteinary residues in animal tissue. The 
published method was capable of screening for near 50 different residues but was 
limited by there use of LC-MS/MS system. They needed to run samples several times 
in order to achieve a complete screen.  
This is where problems with the use of LC-MS/MS in this type of multi-class multi-
analyte work arise. This analytical instrument while it gives unequivocal confirmation 
it can only analyse for a finite amount of analytes. The number of analytes it can 
analyse for is governed by a number of factors such as scanning speed, dwell time, 
need for pos/neg switching as well as column separation in order to allow for 
segmentation of the MS/MS program. Therefore while a large number of analytes 
could be determined using this instrument it might be a limiting factor. With the 
advent of UHPLC-MS/MS more analytes can be incorporated due to increased 
separation of analyte in shorter run times. However it is felt that future work in this 
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area will lead to use of these type of generic extraction procedures in combination 
with liquid chromatography coupled to high resolution mass spectrometry (LC-
HRMS). The benefits of this instrument technique are discussed fully in the next 
section.      
 
9.2.2 Screening for veterinary residues by High Resolution Mass Spectrometry 
(HRMS). 
Many analytical methods currently employed in monitoring laboratories throughout 
Europe for the analysis of veterinary residues are performed using LC-MS/MS. The 
major drawback of this technique is that it only offers targeted analysis i.e. only 
compounds that the instrument is tuned may be detected. However, with the advent of 
HRMS combined with recent advances in extraction procedures, the possibility exists 
to monitor for potentially 100’s of harmful substances in one assay. Hence there will 
be increased confidence that the food that reaches the consumer will be free from 
harmful residues. From examination of published literature it has become apparent 
that the capabilities of HRMS may be applied to the area of veterinary residue 
analysis and offers many exciting opportunities [Kaufmann et al., 2011; Peters et al., 
2009]. The relatively few articles published to date in this area have shown the 
impressive capabilities and possibilities of this technique. 
To date this instrument is not considered a confirmatory instrument but never the less 
its screening capability is vast and when applied to veterinary residues analysis has 
the ability to improve analytical capability immensely. It is felt that future work in 
this area will look at the possible combination of generic extraction procedures and 
HRMS for the analysis of large numbers of residues in a single run. Two common 
instruments that work on the basis of HRMS are Orbitrap and Time of Flight 
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instruments. These instruments work on the basis of accurate mass calculations with 
high resolution that allow for molecular weight determination to 4 decimal places. 
This allows for compounds to be distinguished from each other. These instruments 
can provide full scan targeted/untargeted screening and this approach offers a 
number of advantages: 
 Using these instruments in untargeted full scan with a generic extraction 
protocol allows samples of edible matrices (milk, eggs, meat etc.) containing 
possibly dangerous levels of veterinary residues to be identified that may be 
otherwise declared compliant. 
 It also allows for the re-interrogation of the data at a future date to examine for 
the presence of possible residues which laboratories may not have been aware 
of at the time of analysis. 
 The chemical formula of unknown residues can be determined which may allow 
for identification of previously unknown compounds that are potentially being 
abused. 
It is anticipated that with decreasing cost of these instruments over time they will be 
introduced more for performing targeted and untargeted screening assays of 
veterinary residues in monitoring laboratories. It is believed the combination of this 
powerful screening tool with generic extraction protocols such as QuEChERS will 
lead to an improved monitoring program throughout EU member states for veterinary 
residues. 
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9.2.3 Development of a “risk based” approach to the monitoring of veterinary 
residues. 
The overall goal for this research was to improve the veterinary residue surveillance 
capabilities of monitoring laboratories by the development of novel, efficient multi-
residue analytical methods. As previously stated the use of veterinary drugs is 
becoming a critical component of food production which has resulted in an increased 
demand for veterinary residue surveillance systems. The current approach adopted 
throughout the EU member states involves the analysis of a percentage of animals 
slaughtered in the previous year as directed by Council Directive 96/23/EC. An 
example of this approach is given below for bovine species taken from the legislation; 
“The minimum number of animals to be controlled each year for all kinds of residues 
and substances must at least equal 0.4 % of bovine animals slaughtered the previous 
year, with the following breakdown: 
Group A: 0.25 % divided as follows: 
- one half of the samples are to be taken from live animals on the holding; 
- one half of the samples are to be taken at the slaughterhouse. 
Each sub-group in Group A must be checked each year using a minimum of 5 % of 
the total number of samples to be collected for Group A. The balance must be 
allocated according to the experience and background information of the Member 
State. 
Group B: 0.15 % 
30 % of the samples must be checked for Group B 1 substances. 
30 % of the samples must be checked for Group B 2 substances. 
10 % of the samples must be checked for Group B 3 substances. 
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The balance must be allocated according to the situation of the Member State species 
for each class of compound every year.” 
Key concerns over this type of approach are the economic viability of such 
surveillance programmes when the prevalence of a residue approaches zero. 
As human and financial resources available to support government monitoring of 
veterinary residues are becoming more limited in many countries world-wide a search 
to find a more efficient monitoring protocol is being considered. Hence the concept of 
“risk based” monitoring programs has become an area of interest in veterinary residue 
analysis. The main tenet of this approach focuses on the analysis of compounds in 
particular species that pose a higher risk to human health. It is felt, issues that present 
higher risks merit higher priority for residue surveillance resources as investments 
will yield higher benefit-cost ratios. 
As part of this research a survey of retail egg samples available on the Irish market 
for the presence of nitroimidazole residues was performed. The results of this found 
no noncompliant results in 160 samples. Therefore the assumption could be made that 
the risk posed by nitroimidazole residues in eggs is relatively small. However more 
factors need to be taken into consideration when developing risk based assessments. 
This is where problems have arisen in implementing a risk based approach to residue 
analysis. It is difficult to clarify the meaning of risk. Factors such as toxicity of 
residues, overall occurrence of residues, species in which residues typically occur, the 
intake of residues into humans from food and the deterioration of residues after 
traditional cooking processes need to be taken into consideration when developing 
risk based monitoring programs. 
As a result of this, a lot of future work should go into assessing the risk associated 
with these factors. Further toxicological studies should be carried out to assess the 
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risk of residues to humans. Surveys like the one carried out in this research for 
nitroimidazole residues in eggs, in addition to current monitoring plans, should be 
carried out throughout Europe in a wide range of matrices to assess the occurrences of 
different residues and the species they typically occur in. This information along with 
values of Average Daily Intake (ADI) of certain foods for humans should be used in 
determining the risk associated with certain residues. This associated risk will then be 
used to determine what residues in what species should be given higher priority when 
drafting residue plans. 
 
9.2.4 Future work on contaminants in animal feed  
Following an investigation into the Irish Dioxin crisis resulting from contaminated 
feed fed to pigs in 2008 it was noted that there is too much emphasis placed on the 
analysis of the quality of feed rather than on the monitoring for the presence of 
undesirable substances in the feed. Therefore it was suggested that more samples 
should be taken for the analysis of undesirables in animal feed. Hence as part of this 
research, methods for the analysis of medicinal feed additives were developed. These 
included detecting medicinal substances in feed that are no longer authorized as feed 
additives as listed in Annex II of Commission Recommendation 2005/925/EC and 
monitoring of unavoidable carryover of coccidiostats in non-targeted feed as per 
Commission Directive 2009/8/EC. 
Future work in this area will continue and should focus on the development of multi-
analyte methods for the analysis of contaminants in animal feed such as mycotoxins 
and dioxins. Another area that should possibly be examined is the setting of 
unavoidable carryover levels for medicines such as sulfadiazine and chlortetracycline 
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in non medicated feed similar to what is set in legislation for cocciodisats in non 
target feed. This work would be beneficial for a number of reasons; 
 Analytical methods for analysis of mycotoxins in animal feed: Fungal growths 
and moulds on crops and animal feed can produce various mycotoxins. These 
mycotoxins can pose a threat to animal health, consumer safety and food 
processing activities if they occur at unacceptable limits. There are a number of 
different parent classes of mycotoxins such as fusarium, aspergillus and 
penicillium mycotoxins all with numerous sub components. Commission 
Regulation (EC) No. 1881/2006 sets out maximum levels for contaminants in 
foodstuffs. Levels are set for a number of mycotoxins including aflatoxins, 
ochratoxin and deoxynivalenol. With the advent of newer, more selective and 
sensitive analytical techniques emphasis should be place on the development 
confirmatory multi analytes method for the analysis of a wide range of these 
analytes in animal feedingstuffs in order to ensure these harmful contaminants 
are below permitted levels. 
 Analytical methods for analysis of dioxins in animal feed: The general term 
"dioxin" collectively refers to a class of structurally and chemically related 
compounds known as halogenated aromatic hydrocarbons. They include poly-
chlorinated dibenzo-p-dioxins (PCDD or Dioxin's), polychlorinated 
dibenzofurans (PCDF or Furans) and the "dioxin-like" Biphenyls (PCBs). 
Dioxins and planar PCBs are carcinogenic and may have adverse effects on 
reproduction. Dioxins and planar PCBs are fat soluble chemicals and exposure 
of humans to these contaminants is largely from fat-containing foods of animal 
origin. Many of the dioxin scares and crises are the result of animals fed dioxin 
contaminated feed. This was the case in France in 1998 where dioxin-
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contaminated citrus pulp from Brazil was used in feed for dairy animals and 
resulted in contaminated milk, and also in Belgium in 1999 where gross 
contamination of waste edible oil with machine oil, resulted in contaminated 
animal feed and contaminated food products such as poultry, eggs, red meat and 
milk. More recently, there have also been two dioxin crises in Ireland (2008) 
and Germany (2011). In Ireland, animal feed was contaminated with dioxins as 
a result of an improper fuel being used in a direct drying burner system used to 
dry animal feed which resulted in dioxin contaminated pork products on the 
international market. Also in Germany the substitution of dioxin-contaminated 
industrial fats for vegetable fats in animal feed resulted in the contamination in 
possibly a 1000 pig and poultry farms. As a result of these contaminations and 
the potential major health risks associated with these compounds increased 
focus should be put on the analysis of these compounds in animal feed and the 
development of multi-class method for their analysis.  
 Setting of unavoidable carryover levels of medicines in non medicated feed: 
During this research, work was carried out on the analysis of medicinal 
additives no longer authorised as feed additives. While some of these 
compounds such as nitroimidazoles are no longer licensed for use in animals 
some are still permitted to be used as medicines. Examples of these compounds 
are sulfadiazine, tylosin and chlortetracycline are still used in medicated feed. 
Part of the validation process involved sourcing blank feed material for use as 
negative controls. However this proved quite challenging as it became apparent 
that low levels of these medicines were present in a number of non medicated 
feed samples possibly due to their carryover in feed mills. Currently the EU has 
a zero tolerance policy to the presence of these substances in non medicated 
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feed. However this is not practical and a similar approach of setting maximum 
unavoidable carryover levels as used with coccidiostats in non target feed 
should be considered.  
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